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Aptamers are valuable tools in a variety of biotechnological applications, ranging from 
biosensing to in vivo cell imaging. Studying these molecules can further our understanding of the 
structure and kinetics of nucleic acid-ligand binding. The sulforhodamine B binding aptamer (SRB-2) is a 
polyanionic molecule that was selected to bind a ligand with an overall negative charge. It is also a 
somewhat promiscuous aptamer that can bind ligands that vary markedly in shape, size and charge. 
These characteristics make its binding mechanisms of interest to characterize.  
In Chapter 2, we categorized potential ligands based on their binding mode and structural 
characteristics required for high affinity and selectivity. Several known and potential ligands of SRB-2 
were screened for binding affinity using fluorescence. Promising candidates were subsequently 
characterized by biophysical assays including fluorescence, ITC, DSC, LSPR, CD and NMR spectroscopy. 
These studies showed that rhodamine B has the ideal structural and electrostatic properties for selective 
and high-affinity binding of the SRB-2 aptamer.  These are desirable properties in relevant applications 
of aptamers, indicating that of SRB-2 ligands currently commercially available, rhodamine B would be 
the most useful in those contexts. 
In Chapter 3, we show NMR experiments performed on the SRB-2 aptamer with the goal of 
elucidating a solution structure. An unlabelled sample, as well as three samples selectively labelled on a 
single type of nucleotide (A, C and U) were synthesized and analyzed using a variety of pulse sequences. 
These included multiple variations of HSQC, NOESY, TOCSY and COSY experiments. A significant amount 
of NMR data were obtained and some tentative and partial assignments were made, but ultimately the 
data were insufficient for unambiguous assignment. This resulted from several sources, but broad lines 
caused by structural heterogeneity were the primary obstacle encountered. 
In Chapter 4, we opted to pursue alternative NMR approaches which did not require isotopic 
labelling. This strategy, segmental analysis, involves breaking a molecule down into smaller segments 
vi 
 
and studying them individually. The structural information obtained from the segments was then 
combined to give an overall picture of the full-sized molecule. This method was used when there are 
multiple stem-loop segments in a sequence that form stable structures independent of the other stem-
loops. Otherwise, this method did not yield accurate depictions of the overall structure. In this chapter, 
strategies for designing representative truncations are outlined. For a 16mer containing a UUCG 
tetraloop, assignments were completed, and a structure was calculated. This allowed for several 
resonances in the spectra of full-length SRB-2 to be identified. Results with another stem-loop region 
indicate that segmental analysis beyond the UUCG tetraloop is not possible for this system due to 
interactions between the two other stem-loops. 
In Chapter 5, a Na+-binding aptamer present in several DNAzymes was investigated. These 
DNAzymes require Na+ for activity but show no activity in the presence of K+ or other metal ions. Given 
that DNA can selectively bind K+ by forming a G-quadruplex structure, the goal of this work was to 
determine whether this Na+ aptamer also uses a G-quadruplex to bind Na+. The Na+ aptamer is 
embedded in the trivalent lanthanide-dependent DNAzyme Ce13d. Its sequence consists of multiple GG 
sequences, which is also a prerequisite for the formation of G4 structures. To probe the structure of 
Ce13d for G4 presence, thioflavin T (ThT) fluorescence spectroscopy, NMR spectroscopy and CD 
spectroscopy were used. Through comparative ThT fluorescence spectrometry studies, we determined 
that a control G-quadruplex DNA exhibited fluorescence enhancement in the presence of K+. The Ce13d 
DNAzyme did not show fluorescence enhancement in the presence of K+, but displayed fluorescence 
decrease with low millimolar concentrations of Na+. This agrees with NMR experiments that suggest 
Ce13d adapts a significantly different conformation, or equilibrium of conformations, in the presence of 
Na+ versus K+. However, it does appear significantly more stable in Na+. The absence of characteristic G-
quadruplex peaks in 1D 1H NMR suggest that a G-quadruplex is not responsible for the Na+ binding and 
this is supported by the absence of characteristic peaks in the CD spectra of this sequence. Therefore, 
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we concluded that the aptamer must be selective for Na+ and binds using a structural element that does 
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Chapter 1: Literature Review 
1.1 Overview of Nucleic Acids 
Our understanding of the biological importance of nucleic acids has come a long way in the last 
three-quarters of a century. The significance of DNA and RNA in biology cannot be understated; as a 
matter of fact, their story can be summarized in Nobel Prizes alone. Modern understanding of nucleic 
acids all started with James Watson and Francis Crick’s (and Maurice Wilkins’ and Rosalind Franklin’s) 
model of DNA, and won the 1962 Nobel Prize in Chemistry [1–3]. Shortly thereafter, the mechanism of 
nucleic acid synthesis was detailed by Ochoa and Kornberg, who discovered and characterized DNA 
polymerase [4,5]. They were actually recognized by the Nobel committee for their work on nucleic acid 
synthesis a few years earlier than Watson, Crick and Wilkins, receiving their prize for physiology in 1958. 
The big picture became much clearer when Robert Holley, Har Khorana, and Marshall Nirenberg were 
able to classify the functions of biomolecules, specifically the role of DNA in protein synthesis, forming 
what we know today as the central dogma of molecular biology. Holley discovered and characterized the 
structure and function of tRNA [6], while Khorana and Nirenberg determined the genetic code, showing 
how codon triplets code for amino acids [7,8]. Their work won the Nobel Prize for physiology in 1968.  
With the fundamentals of nucleic acid structure, chemistry and function now in place, it was time 
for field of molecular genetics to shine. This was made possible by the discovery of restriction enzymes 
by Werner Arber [9]. Hamilton Smith and Daniel Nathans discovered additional restriction 
endonucleases and were then able to show how they work and how they can be used to create genetic 
maps, respectively [10,11]. These three men received the 1978 Nobel Prize in physiology. Next in line 
were Paul Berg, Walter Gilbert and Frederick Sanger, who won the Nobel Prize in chemistry just two 
years later. Berg was recognized for his work understanding the mechanisms of DNA recombination in 
viruses [12] and Gilbert and Sanger for their development of DNA sequencing methods [13,14]. Aside 
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from paving the way for the next chapter in studying nucleic acid structure and function, this work also 
planted the first seeds in the biotechnology field. Now that nucleic acids were becoming better 
characterized, scientists could begin to think of how to use these biological processes and chemistry in 
new, innovative ways. 
 To summarize this section, the biological and evolutionary importance of nucleic acids is 
immeasurable, but at their core nucleic acids are biomolecules, polymers and chemicals. They are tools 
that scientists can apply to large variety of applications, just like proteins and small molecules. 
 
1.2 History of Aptamers 
In the late ‘70s and early ‘80s another revolutionary, Nobel Prize winning discovery was made that 
would forever change the ways scientists viewed nucleic acids. Sidney Altman and Thomas Cech 
discovered RNA with self-catalytic capabilities. Altman and Cech independently found that RNA could 
cut strands of RNA, a discovery suggesting that life could have started as RNA [15,16]. This is now known 
as the RNA world hypothesis, a phrase eventually coined by the aforementioned Nobel laureate Walter 
Gilbert. This work was eventually awarded the 1989 Nobel Prize in chemistry. We will come back to 
catalytic nucleic acids later, but the importance of this discovery with respect to the eventual 
development of aptamers was that RNA could have functional roles beyond expression of the genetic 
code. This was expanded upon when research by several groups on HIV was finally able to determine 
the previously unknown role of viral-associated RNAs, short RNA sequences that had been found in 
adenoviruses [17–20]. Their role in transcriptional regulation was fascinating in and of itself, but the 
major discovery here was that short, partially double-stranded nucleic acid sequences can bind targets, 




Following the establishment of the biological functions of nucleic acids and the existence of 
functional nucleic acids, researchers began to investigate the diverse structures of single stranded 
nucleic acids. As aptamer pioneer Larry Gold has said, they are “shapes, not tapes” [21]. Their tertiary 
structures, particularly those once thought of as ‘unique’ or ‘outliers’ such as rRNA and tRNA, were now 
recognized as more similar to globular proteins than to linear DNA.  It was not lost on biochemists of the 
time that these RNA molecules somewhat resembled the antigen binding sites of monoclonal 
antibodies. Of course, by this time, the discovery of monoclonal antibodies and the creation of 
monoclonal antibody hybridomas had already won Nobel Prizes of their own and their potential to treat 
diseases was recognized. This inspired the search in the late ‘80s and early ‘90s for so called nucleic acid 
antibodies. This was done using in vitro mutagenesis, a method that would eventually be developed into 
what we now know as SELEX (the systematic evolution of ligands by exponential enrichment). 
The concept of in vitro selection originated in the 1960s with work by Sol Spiegelman. His studies on 
the Qβ RNA bacteriophage led to the discovery of its replicase protein, an RNA-dependent RNA 
polymerase [22]. This enzyme made in vitro synthesis of viral RNA possible. Spiegelman’s work with 
exogenous viral RNA was able to show Darwinian selection when various selective pressures were 
applied [23]. These experiments resulted in mutants that had eliminated large portions of their 
nucleotide sequence, retaining only those required for replication. Mutants with other interesting 
phenotypes such as resistance to ethidium were also obtained and became the basis for studies on 
selecting mutants with increased replication rates under inhibitory conditions [24]. This was some 
significant progress, but a couple of limitations existed that would not be lifted until years later. Any 
sequence of interest required a vector in order to be studied in this capacity due to their swift removal 
upon any selection pressure. In addition, the scale of amplification, in general, was still minuscule 
compared to what we have to work with today. In another decade, however, this would all change. 
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In the 1980s, Kary Mullis revolutionized the future of aptamer research when he came up with the 
concept of the polymerase chain reaction (PCR) [25]. PCR allowed for the rapid amplification of DNA, 
making millions to billions of copies in mere hours. It also made the process of amplification sequence 
independent. This allowed researchers to easily amplify any sequence(s) of interest. This invention won 
him the Nobel Prize in chemistry in 1993. Reverse transcription PCR was invented shortly thereafter and 
is a staple of aptamer selection, and many other methodologies, to this day. 
 In 1989, Arnold Oliphant and Kevin Struhl published a paper in which they had synthesized DNA 
oligonucleotides 25 base pairs in length with random sequences [26]. They screened those sequences to 
select for those that bound to a yeast transcription factor, GCN4. However, this work did not use 
amplification in any sense of the word. They simply used affinity chromatography to screen all of the 
DNA sequences that they had made. This was really the first time in vitro mutagenesis had been used on 
this scale, but it still lacked the critical components of evolution and amplification. 
Finally, by combining the in vitro mutagenesis work of Oliphant and Struhl with the PCR technique 
invented by Mullis, SELEX was established independently by two groups in 1990: first by Larry Gold and 
his student Craig Tuerk, then by Jack Szostak and his student Andrew Ellington about a month 
later[27,28]. Craig Tuerk and Larry Gold’s work focused on an RNA sequence with a known affinity to 
bacteriophage T4 DNA polymerase. They took an eight nucleotide stretch of this RNA and completely 
randomized the sequence, creating a pool of 65 536 (48) theoretical mutants.  Their initial library was 
large enough (theoretically 5 x 109 copies of each individual sequence were present) that even at the 
lowest concentrations they used, millions of copies of each sequence should be present at the start of 
the experiment, assuming relatively consistent incorporation of each type of nucleotide. This suggests a 
high statistical probability that all theoretical sequences were sufficiently represented. After initial 
transcription of the DNA library, selection was performed with the bacteriophage T4 DNA polymerase 
(gp43). These sequences were isolated and reverse transcribed, followed by PCR amplification. Four 
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“rounds” of this procedure were performed. In the original publication, they referred to this method as 
“the systematic evolution of ligands by exponential enrichment” or SELEX for short. From the 65 536 
theoretical sequences, they obtained two with high binding affinity for the bacteriophage T4 DNA 
polymerase, the wild-type sequence and a mutant with four varying nucleotides. A more detailed 
schematic of this procedure is shown in Figure 1.  
 
Figure 1.1: SELEX schematic outlining Craig Tuerk and Larry Gold’s original procedure. 
The general steps of this procedure in include construction of a DNA template for transcription, in vitro 
transcription of the RNA by T7 RNA polymerase, selection on nitrocellulose filters by the target, gp43, 
reverse transcription, and PCR.  
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 Ellington and Szostak used six rounds of essentially identical methodology (Figure 2) to select 
sequences that bound to seven different dye columns. They were interested in these particular dyes due 
to their resemblance to biological cofactors, for example, Cibracon blue, which was known to bind to the 
NAD binding site of many dehydrogenases and had previously been used for affinity chromatography. 
They were able to obtain sequences with varying degrees of affinity and selectivity for the various dye 
columns. Some of the clones obtained varied markedly while others had regions of conservation, 
suggesting that nucleic acids can fit around their targets in numerous ways but that only certain parts of 
the sequence would be involved in binding. In fact, Ellington coined the term “aptamer” from this 
observation as it comes from the Latin aptus, which means “to fit.” Ellington and Szostak also concluded 




Figure 1.2: Schematic outlining Andrew Ellington and Jack Szostak’s original protocol for in vitro 
selection. 
The general steps of Ellington and Szostak’s procedure mirror those of Tuerk and Gold, however the 
selection step was done using a column based methodology rather than a nitrocellulose membrane.  
 
Tuerk and Gold’s acronym SELEX stuck, as did Ellington and Szostak’s term “aptamer”. Today you 
perform SELEX to get aptamers. Ultimately, Craig Tuerk and Larry Gold were awarded the patent for the 
invention of their SELEX technology [29]. Larry Gold and Gilead Sciences Inc. also held many other broad 
patents on aptamer selection methodology such as solution SELEX and counter SELEX [30,31]. As a result 
of these patents and several others, the commercial interest of these molecules was largely subdued 
until their expiry in the late 2000s and early 2010s. Throughout these years, countless advances in 
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selection were made, including the improvement of libraries, selection of sequences with complex and 
dual functions and various strategies for improving the selectivity and nuclease resistance of aptamers. 
Next we will take a closer look at some of these advances and outline the general methodologies and 
considerations that go into a contemporary aptamer selection. 
 
1.3 SELEX  
 Two different schemes for RNA aptamer selection were already shown in Figures 1 and 2, but a 
generalized scheme applicable to more types of nucleic acid selections is shown in Figure 3. Each step 
shown in this scheme will be discussed briefly, followed by a few other important factors that are not 
explicitly shown here. 
 
1.3.1 Creating a Library 
  The first step of any aptamer selection is to obtain a library of sequences from which to select. A 
typical selection consists of a sequence of ~30-80 nucleotides partly or entirely randomized, flanked by 
two fixed sequences of approximately 20 nucleotides in length that are designed to contain appropriate 
PCR primers [32]. When selecting RNA aptamers, a T7 promoter is also required for transcription prior to 
each round. Random regions are synthesized by using an equimolar mixture of all nucleotides, resulting 
in a pool of ~1014 unique sequences.  The probability of finding a particular sequence is 1/4N, i.e. the 
longer the random region, the less likely it is to find a specific sequence due to sampling bias. Therefore, 
multiple selections may be required in some cases [33]. The oligonucleotide pool is also usually 
amplified to ensure multiple copies of each sequence are present to limit the potential loss of binding 
sequences. Sometimes a genomic library can be used instead of a synthetic one, but this of course limits 
possible aptamer sequences to naturally occurring ones [34]. 
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Another consideration here for selection of DNA aptamers is that the DNA must be single-
stranded for selection and for future PCR amplifications. One of the most effective and commonly used 
methods for separating the strands is by biotinylation of the reverse primer, which allows for the 
removal of the template strand after PCR amplification by binding to streptavidin. Other more cost 
efficient methods include assymetric PCR, size separation by PAGE or enzymatic digestion of the 
undesired strand [35]. 
 
Figure 1.3: Schematic outlining the steps in a single round of a general aptamer selection. 
General selection steps are still the same as those used by Szostak and Gold when they independently 
discovered this process for obtaining RNA aptamers, however, this is a more modern, general schematic 





1.3.2 Binding and Partitioning 
 As shown in Figure 1.3, there are three main steps in a single selection cycle: binding, 
partitioning and amplification. In practice, ~5-15 rounds of selection are performed. The number of 
rounds generally depends on the type of target, level of stringency used in the selection and complexity 
of the initial pool. There are no outright restrictions on the target that is used; in literature, targets 
include ions, small molecules, biomolecules, and even entire cells [36–39]. The intrinsic properties of 
nucleic acids do make for some inherent limitations, however. Nucleic acids are small, negatively 
charged and hydrophilic molecules, which makes targeting a small, positively charged molecule more 
straightforward, while it may be more difficult to target a large, hydrophobic or negatively charged 
ligand [40]. The type of matrix used for binding will also depend on the target. Common strategies, 
particularly for small molecule targets, normally involve immobilization of the target on an affinity 
column [28] or paramagnetic beads [41]. Nitrocellulose filters are often the matrix of choice when using 
protein targets [27], and agar plates are used for cell-SELEX [42]. How the target is anchored to the 
matrix is also a worthwhile consideration as the binding sequences obtained will tend to bind the most 
accessible parts of the target and may not be able to bind regions close to the linker.  
There are several reaction conditions that must be considered as well, including concentrations 
of the target and library. Buffer conditions must also be optimized to promote binding; for a small 
molecule selection, this generally consists of neutral pH, high salt and presence of divalent cations which 
often act as cofactors in target binding [43]. The incubation time and temperature are also crucial 
parameters as they must be permissive to specific binding but minimize non-specific binding. Several of 
these conditions, particularly target concentration and incubation time, are also adjusted throughout 
the cycles to increase the stringency of the selection. This is done to ensure the acquisition of only high-
affinity sequences. Stringency is usually not increased until after the first few rounds to prevent the loss 
of rare sequences and is then increased progressively throughout the rest of the selection. [40]  
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Partitioning refers to the separation of binding and non-binding sequences. This is normally 
accomplished by first washing the non-binding and weakly binding sequences away with binding buffer, 
followed by the elution and isolation of high-affinity sequences using denaturing conditions such as 
urea, EDTA and heat. In selections using column affinity, stringency can be controlled by increasing the 
volume of wash buffer used [44]. Once the binding sequences have been isolated, they move on to PCR 
amplification and sequence analysis. 
 
1.3.3 Amplification and Analysis 
 The iterative nature of the selection process is what has made SELEX such a powerful tool. It 
results in high affinity binding sequences dominating the pool, simplifying isolation and sequencing of 
relevant oligonucleotides. This, of course, would not be possible on such a large scale without Mullis’ 
discovery of PCR amplification [25]. PCR is not a perfect system however and can have inherent biases. 
For example, the negative strand of DNA can compete with primers for hybridization, resulting in the 
suppression of rarer sequences [45]. It is therefore wise to optimize the PCR protocol before selection to 
minimize the number of PCR cycles required to obtain a sufficient quantity of products for the next 
round of selection. This also holds true for transcription and reverse transcription when selecting RNA 
aptamers as formation of certain RNA secondary structures can be inhibitory [46]. 
 Another useful facet of amplification is the opportunity it presents to introduce a mutation 
mechanism if one wishes to do so. Mutant libraries are advantageous because they allow sampling of a 
larger total population, and in a focused manner. Selections with mutation mechanisms are more likely 
to produce sequences with higher affinities or enhanced catalytic properties as a result [47,48]. 
Thermostable DNA polymerases are generally fairly processive; they have an intrinsic error rate ranging 
from about 10-5 – 10-7 which is not sufficient to maintain a mutant population [49]. Common approaches 
include error-prone PCR and hypermutagenic PCR, which involve decreasing the fidelity of the 
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polymerase by using biased dNTP pools and adding Mn2+ to promote polymerization after mismatches 
[50,51]. Recombination methods can also be used if a very large degree of mutation is desired [47]. 
 Progress of a selection is tracked by measuring the proportion of total nucleic acid that is 
retained by UV absorbance at 260nm. Only a small fraction of the total nucleic acid content will be 
recovered in the elution of initial rounds and those where stringency is increased. The selection is 
complete when essentially all nucleic acid is retained in the elution. The pool is amplified one last time 
and sequenced using next generation sequencing techniques. The sequences are then analyzed using 
computational techniques to determine one or a few consensus sequences. Minimization and 
optimization of the sequence is often desirable to highlight the active motif of the aptamer. This is 
generally done using kinetic-based methodologies. In addition, sequences may be re-selected with a 
partially random or ‘doped’ pool used specifically for binding site selection. This may result in an 
aptamer with improved properties [52]. 
 
1.3.4 Counter-selection 
 Many of the factors of aptamer selection discussed thus far impact primarily the binding affinity 
of the sequence obtained, but another advantageous property of aptamers is their high selectivity. In 
fact, aptamers with enantioselectivity for (R)-ibuprofen and (S)-ibuprofen have been isolated [53]. 
Selectivity can be tailored in the selection process by using counter-selection. This describes a cycle in 
which an alternate, undesired target is used, and sequences that bind said target are discarded. For 
example, when using a small molecule target such as sulforhodamine B is used, an analogue such as 
fluorescein may be used as the counter selection step [37]. A non-target peptide may be used when 
targeting a specific protein or an unwanted cell type in the case of cell-SELEX [42,54]. Negative selection 
is also used to ensure that the sequences present are binding the target as intended and eliminate false 
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positives that survive the selection by interacting with the matrix or binding by other undesirable 
mechanisms [55].  
 
1.3.5 Modified Nucleic Acids 
 Nucleic acid aptamers hold many advantages over their protein antibody counterparts, such as 
ease of storage and modification, low immunogenicity, high-temperature stability and a wider range of 
potential targets [56,57]. One problem with aptamers, particularly those destined for in vivo 
applications, is that their in-host stability is relatively low due to nuclease susceptibility. RNA aptamers 
are degraded almost immediately, and DNA aptamers are degraded within a few hours of incubation in 
human serum [58]. Fortunately, one of the advantages of aptamers is that they are relatively easy to 
modify, and nuclease resistance can be straightforwardly conferred using various modification strategies 
before and/or after selection.  
The most common modifications are substitutions of the 2’ sugar position (Figure 1.4a-b). Initial 
modification efforts revolved around 2’-amino pyrimidines but they proved difficult to use during solid-
phase chemical synthesis (Figure 1.4c) [59]. 2’-fluoro pyrimidines are often used in libraries due to their 
increased coupling efficiency (Figure 1.4d). The famed Macugen, the only FDA approved aptamer, has 
2’-fluoro pyrimidine modifications [60]. 2’-methylhydroxy groups are favoured as post-SELEX 
modifications due to their cost efficiency and in-cell role as a ubiquitous post-translational modification 
(Figure 1.4e). Locked nucleic acids are another highly nuclease-resistant modification that consists of a 
second ring structure being created by connecting the 2’ carbon and the 4’ carbon of the sugar (Figure 
1.4f).  
Also popular are 4’-thiol sugars (Figure 1.4g) and various modifications of the inter-nucleotide 
linkage. Examples include phosphorothioate, methylphosphanate, 5’-α-P-borano and thiazole linkages 
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(Figure 1.4h-k) [59,61]. Another advantage of modified nucleic acids is that they may diversify aptamer 
libraries; they may be able to adopt previously unseen conformations or bind novel targets. 
 
Figure 1.4: Types of nucleic acid modifications used to confer nuclease resistance in aptamers.  
A) 2’-H (DNA), B) 2’-OH (RNA), C) 2’-NH2, D) 2’-F, E) 2’-OMe, F) 4’-thiol, G) locked nucleic acid (LNA), H) 
phosphorothioate, I) methylphosphanate, J) 5’-α-P-borano, K) thiazole. 
 
1.4 Fluorophore-Binding Aptamers 
1.4.1 Applications of Fluorophore-Binding Aptamers 
As discussed in section 1.2, some of the first proof of concept RNA aptamers selected by  
Andrew Ellington and Jack Szostak used organic dyes as targets due to their similarity to biological 
cofactors [28]. They used the same group of dyes to select some of the first proof of concept DNA 
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aptamers [62]. The RNA world concept was prominent at the time, and scientists were interested in 
gauging the catalytic complexity of nucleic acids. In addition, the inherent advantages of having a 
detectable signal built into the system was not lost on researchers.  
Several years later, Jack Szostak and Charles Wilson selected in parallel a DNA aptamer and an 
RNA aptamer for sulforhodamine B (SR) (Figure 1.5a) [37,63]. With the DNA aptamer, they were 
interested in finding an aptamer that could catalyze the redox reaction of the colorless compound 
dihydrotetramethylrosamine to the fluorescent product tetramethylrosamine (Figure 1.6). These 
compounds oxidize spontaneously, so they instead used the related dye, SR, as the target for their 
selection. The clones they obtained, however, had only weak redox activity, and this work was 
abandoned. 
 
Figure 1.5: Relevant ligands of fluorophore-binding aptamers. 
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A) sulforhodamine B, B) Hoechst 33258, C) Hoechst 33242, D) malachite green, E) 
tetramethylrhodamine, F) fluorescein, G) Patent blue V, H) tetramethylrosamine  
 
 
Figure 1.6: Desired redox reaction of the SRB-2 DNA aptamer. 
Gold and Wilson attempted to find an aptamer that could catalyze the redox reaction of the colorless 
compound dihydrotetramethylrosamine to the fluorescent product tetramethylrosamine. This figure 
shows the general scheme for said reaction. 
 
1.4.1.1 Controlling Gene Expression 
 Thus far, aptamers have only been discussed in a synthetic capacity. Of course, as it turns out, 
biological systems have long been using their own version of aptamers, which are generally found in 
riboswitches. Riboswitches are nucleic acid sequences most commonly found in the 5’ UTR region of 
mRNAs which control gene expression in a cis fashion through small molecule binding [64]. Riboswitches 
consist of two main domains, a gene expression platform and a metabolite-binding (aptamer) domain. 
Riboswitches function by forming secondary structure elements that impede protein function. The most 
common mechanisms include rho-independent transcription termination and translation inhibition by 
sequestering of the ribosome binding site.   
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 The suspicion of the existence of such elements has been around for some time, as proposed by 
Larry Gold et al. in 1984 [65], but substantial proof was lacking until 2002 when riboswitches were finally 
characterized by several research groups working on several different riboswitches [66–70]. Interest in 
potential gene regulation by aptamers was heightened in the late ‘90s after the establishment of SELEX 
[27,28] and further studies showing modulation of gene expression by small molecules [71–73]. Initial 
studies using synthetic riboswitches (aptamers) to control gene expression were actually done in 1998, a 
few years earlier than the ‘discovery’ of riboswitches in 2002. 
 In these studies, two aptamers that could specifically bind both the dye Hoechst 33258 (Figure 
1.5b) and the related drug Hoechst 33342 (Figure 1.5c) were selected. They were inserted in tandem 
into a mammalian β-galactosidase expression plasmid which was then transfected into Chinese hamster 
ovary cells. These studies showed that Hoechst 33342 was able to dose-dependently inhibit β-
galactosidase activity by over 90% [74].  
 The malachite green aptamer (MGA) is among the most extensively studied aptamers and has 
proven to be dynamic in its applications [75–79]. This aptamer was originally selected to improve upon 
the chromophore-assisted laser inactivation (CALI) method developed by Jay and Keshishian [80], 
wherein antibodies are covalently modified with the fluorescent dye malachite green (MG) (Figure 1.5d). 
Malachite green forms destructive hydroxyl radicals upon irradiation by laser at 630nm, resulting in the 
inactivation of the antibody and its target. Therefore, gene products can be targeted and inactivated by 
controlling the laser (Figure 1.7). The malachite green aptamer has a single nucleotide bulge that is 
cleaved upon exposure to the hydroxyl radical generated by MG. As a result, when MGA is included in 
the 5’ UTR of a gene of interest, the laser can be used in an analogous fashion to downregulate the gene 
product by reducing transcript stability and translatability [75]. Furthermore, this system was used to 





Figure 1.7: Site-specific inactivation of mRNA transcripts by chromophore assisted laser inactivation. 
Malachite green forms hydroxyl radicals when exposed to a laser of the appropriate wavelength. Due to 
close proximity and susceptibility, these radicals attack and cleave a single nucleotide bulge in MGA 
resulting in cap removal and translation inhibition.  
  
In 2010, aptamers were selected for the dye tetramethylrhodamine (Figure 1.5e) with high-
affinity and low magnesium dependence for optimal in vivo function, but no further works involving 
gene expression were conducted. Synthetic riboswitches have remained an area of interest for 
researchers after the CALI studies of MG, but studies have mostly turned to aptamers with non-





1.4.1.2 mRNA Imaging 
In 1998, in parallel with their work involving the sulforhodamine B DNA aptamer, Wilson and 
Szostak also selected an RNA aptamer for sulforhodamine B [37]. The original goal of selecting this RNA 
aptamer, SRB-2, was to develop a tool for fluorescent RNA labelling analogous to green fluorescent 
protein (GFP) and its derivatives in proteins. The methodology here involved inserting the DNA template 
sequence for SRB-2 on the end of a gene of interest, resulting in the fluorescent tagging of that 
transcript in the presence of the ligand (Figure 1.8). Wilson and Szostak recognized that this ability to 
fluorescently label nucleic acids in vivo or in vitro could open up many possible applications. They also 
used the clones obtained from the SRB-2 selection as a basis to select an aptamer for the similar dye 
fluorescein (Figure 1.5f), which has a similar structure but a different color than SR. They performed a 
proof of concept experiment in vitro that showed the two aptamers were able to discriminate between 
the two dyes which allowed localization of the aptamers to be observed when the dyes were anchored 
to separate beads [37]. This highlighted the potential for future multiple labelling as well as Forster 
resonance energy transfer (FRET) type experiments; though contemporary FRET sensors generally utilize 
aptamers that are labelled with fluorophores and/or quenchers rather than aptamers that bind them 
directly. Despite sulforhodamine B and fluorescein having a significantly greater fluorescence 
enhancement than biological cofactors such as tryptophan and flavin mononucleotide, background 




Figure 1.8: Structural basis of light-up aptamers for intracellular imaging.  
In solution, fluorogens are non-fluorescent, but when stabilized by stacking interactions with the bases 
of an aptamer adopt a fluorescent conformation. 
 
More recent studies involving the SRB-2 aptamer have utilized ligand-quencher constructs to 
increase the fluorescence enhancement of sulforhodamine B upon binding by quenching its intrinsic 
fluorescence with dinitroaniline [88,89]. This approach yielded success as its brightness surpassed even 
enhanced GFP (eGFP), and 105-fold enhancement was observed. This is impressive, but other systems 
with different fluorophores have been characterized since then that have generated even greater 
fluorescence enhancements. 
 Studies by Babendure et al. with the SRB-2 and MGA aptamers showed that significantly larger 
fluorescence enhancements are observed with triphenylmethane dyes as opposed to planar xanthene-
type dyes [76]. They observed that the triphenylmethane dyes such as patent blue V (PBV) (Figure 1.5g) 
and MG had a lower intrinsic quantum yield and higher quantum yield when bound to the aptamer, 
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which they surmised was a result of the locking of the rotationally mobile dyes into planar 
conformations more similar to the xanthene dyes tetramethylrosamine (TMR) (Figure 1.5h) and 
sulforhodamine B (SR). Malachite green had a 2360-fold fluorescence enhancement upon binding, 
significantly surpassing SRB-2 and GFP. This could be further increased by using tandem repeats of MGA 
[76]. Efforts to optimize the enhancement of aptamer-based RNA imaging has more recently turned to 
the chromophore of GFP, 4-Hydroxybenzlidene (HBI) (Figure 1.9a) and its structural analogues. 
 The first works with HBI derivatives involved the selection of an aptamer for DMHBI (Figure 
1.9b). It was then determined that the derivative 3,5-difluoro-4-hydroxybenzylidene imidazolinone 
(DFHBI) (Figure 1.9c) was significantly brighter upon aptamer binding (80% as bright as GFP, DMHBI was 
only 12% as bright), and this system was termed spinach [90]. Spinach has since spawned several 
additional light-up aptamer systems with high fluorescence enhancement and of varying color. These 
include aptamers that bind other GFP mimics, such as broccoli [91] which binds DFHBI-1T (Figure 1.9d), 
and corn [92] which binds 3,5-difluoro-4-hydroxybenzylidene imidazolinone-2-oxime (DFHO) (Figure 
1.9e) and aptamers that bind other fluorogenic dyes such as the mango aptamer [93], which binds 
thiazole orange and its derivatives. These aptamers have all been sequence optimized and used in 
various live-cell imaging experiments of different types of RNA [94–102]. In addition, the corn aptamer 
has been used for quantification of transcription [92] and the mango aptamer has been used to 
simultaneously fluorescently label and purify biologically relevant RNAs [93].  
 Although these GFP-based selection targets were able to increase fluorescence enhancement of 
these systems drastically, there is always room for improvement. These RNA aptamers have been 
successful in imaging highly abundant, non-translated sequences such as tRNA and rRNA [90,91,103]. 
However, fluorescence enhancement of these aptamers is insufficient for mRNA imaging owing to its 
low cellular abundance [104].  One method implemented to improve fluorescence enhancement is the 
use of fluorescent protein multimers [105,106]. This strategy has also been adapted for the spinach 
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aptamer, where tandem repeats showed up to a ~17-fold increase in fluorescence enhancement [107].  
Tandem repeats of fluorescent proteins can cause some issues, especially when used in organisms with 
proficient homologous recombination mechanisms [108]. Fortunately, transcription seems to be 
relatively unaffected by the presence of spinach aptamer repeats [107]. However, the G-quadruplex 
nature of the spinach aptamer may cause another unforeseen problem with this type of system. 
Although the ability of the G-quadruplex to stabilize fluorogens is likely responsible for the large 
fluorescence enhancement of HBI derivatives, it has been suggested that RNA G-quadruplex domains 
may be kept globally unfolded in eukaryotic cells. This would, of course, limit the use of such aptamers 
for in vivo imaging applications. 
This potential hurdle highlights the importance of studying ways to improve the fluorescence 
enhancement of non- G-quadruplex containing aptamers such as malachite green and SRB-2. In fact, a 
variation of the tandem strategy was recently theorized using SRB-2 [109]. In these studies, the authors 
designed a sulforhodamine B dimer called Gemini-561 and selected a linker for an SRB-2 dimer they 
termed o-Coral. This fluorogenic aptamer showed remarkable fluorescence enhancement, surpassing 
even the aforementioned HBI derivatives. It also had noticeably higher photostability than the mango, 






Figure 1.9: Chemical structure of the GFP fluorophore and its RNA aptamer mimics.  
A) 4-Hydroxybenzlidene (HBI), GFP’s fluorophore. B) 3,5-dimethoxy-4-hydroxybenzylidene imidazolinone 
(DMHBI), selection target of the spinach aptamer. C) 3,5-difluoro-4-hydroxybenzylidene imidazolinone 
(DFHBI), a brighter analogue of DMHBI and ligand for the spinach aptamer. D) 3,5-difluoro-4-
hydroxybenzylidene imidazolinone 1-trifluoroethyl (DFHBI-1T), an even brighter modification of DFHBI. 







1.4.1.3 Metabolite sensing 
 Another application that fluorophore binding aptamers are well suited for is biosensing. 
Aptamer-based fluorescent biosensors are most often FRET-based sensors that feature either a signal 
“turn-on” or “turn-off” mode involving a conformational change that alters the proximity of a 
fluorophore and a quencher [110–112]. That being said, there are several examples of innovative 
constructs that directly use fluorophore-binding aptamers.    
 The first attempt at creating such a construct was work done by Stojanovic and Kolpashchikov 
with the malachite green aptamer in 2004 [77]. They created modular aptameric sensors using 
recognition domains consisting of a binding site for ATP, FMN or theophylline and a signalling domain 
that had a binding site for malachite green (Figure 1.10a). All binding sites were based on existing 
aptamer sequences. The motivation for this work was to create a sensor for these biological cofactors 
that could be used for intracellular imaging. In contemporary research, the sensing and imaging of 
metabolite trafficking has become more popular than imaging RNA trafficking in vivo [113]. 
 Shortly after the development of these sensors, Kolpashchikov created a binary malachite green 
aptamer to be used as a probe for fluorescently reporting the presence of a specific nucleic acid 
sequence [78]. This sensor consisted of two RNA strands, each consisting of a fragment of the malachite 
green aptamer and a fragment of the complement RNA sequence to the DNA target sequence (Figure 
1.10b). In the presence of the target sequence and MG, the two strands would bind with their respective 
RNA complement forming the complete malachite green aptamer, which would then bind the dye 
resulting in a fluorescence enhancement. 
 In 2010, Lu and Xu combined aspects of these two approaches to make a sensor for adenosine 
[79]. Their sensor consisted of a construct with aptamers for MG and adenosine fused together, and a 
bridging strand that was constructed such that it could only be released upon binding of adenosine to 
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the adenosine aptamer. Once the bridging strand was released, MGA would be free to bind MG, 
resulting in a fluorescent signal (Figure 1.10c).  
 One of the problems with using MG for intracellular imaging is that its propensity for forming 
radicals results in it being relatively cytotoxic. Therefore, more recent studies in this field use aptamers 
that bind to HBI derivatives such as the spinach aptamer. Interest in this field has mostly pivoted 
towards the development of sensors for use in intracellular metabolite imaging so many of the 
constructs created in recent years bear a striking similarity to Stojanovic and Kolpashchikov’s original 
work with the malachite green aptamer. The spinach aptamer alone has since been used to image a 
variety of metabolites in cells, including adenosine, ADP, guanine, SAM, guanine, GTP, cyclic-di-GMP and 




     
Figure 1.10: Metabolite sensors based on the malachite green aptamer.  
A) A modular aptamer construct for metabolite detection was devised by fusing binding motifs from the 
malachite green aptamer (MGA) and several metabolite binding aptamers such as the flavin 
mononucleotide aptamer. A tangible increase in fluorescence was observed in the presence of FMN 
[76]. B) Another sensing approach involved a binary aptamer-based on the sequence of MGA. Each 
strand also had an arm whose sequence was the complement of a target DNA sequence. In the presence 
of the target sequence, both arms bind to a target sequence and the complete MGA forms, resulting in 
MG binding and fluorescence enhancement [77]. C) An improvement of the methodology of a modular 
aptameric sensor that utilizes a bridging strand to increase fluorescence enhancement. This strand 
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prevents binding of MGA until adenosine has already bound to the adenosine aptamer, which releases 
the bridging strand and allows MGA to bind MG.  
 
1.4.2 Structural Studies of Fluorophore Binding Aptamers 
 One characteristic that all of the aforementioned applications have in common is that their 
rational development relies heavily on fundamental structural knowledge of the aptamer’s binding 
complex. For example, if a researcher wishes to design a riboswitch to control transcription of a gene 
with a fluorophore binding aptamer, they must ensure that the bound apo-form folds sufficiently to 
block transcription and the holo-form does not. Fortunately, a distinguishing feature of aptamers is their 
adaptive binding [117–122]. That is, an aptamer in the absence of its ligand (holo-form) tends to be 
relatively unstructured but when bound to its ligand (apo-form) forms structured binding motifs. 
Therefore, aside from characterizing the fundamental binding properties of nucleic acids, obtaining 
crystal or solution structures for these systems is important because structural knowledge of a system is 
useful for implementation in various applications. It is no coincidence then that the handful of 
fluorophore-binding aptamer structures that have been determined mostly coincide with the previously 
discussed aptamers that have been used in real-world applications.  
There are six fluorophore-binding aptamers that have at least one structure available, and each 
has contributed to the understanding of ligand-induced folding in aptamer-small molecule systems. The 
first system successfully characterized was the malachite green aptamer, for which a crystal structure 
was determined when bound to the high-affinity ligand analogue tetramethylrosamine (TMR) (Figure 
1.11a) [123]. Shortly thereafter, a solution structure was determined for MGA bound to its original 
selection target MG (Figure 1.11b) [124]. Comparison of these structures led to insights regarding the 
ability of the binding pocket to adapt to both planar and non-planar ligands. 
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The spinach aptamer was successfully crystallized years later in 2014 and revealed for the first 
time a G-quadruplex motif involved in the binding of a fluorophore (Figure 1.11c) [125]. They observed 
that this G-quadruplex motif was well suited to bind and induce fluorescence in an organic dye as it was 
forced into a locked planar conformation upon binding. A crystal structure was also obtained for 
iSpinach, the result of further selection to optimize the fluorescence and folding properties of the 
original sequence [126]. This structure showed that mutations in iSpinach resulted in a more stable and 
compact binding motif than the original sequence and conferred advantageous properties such as 
thermal stability and reduced salt dependence. 
Around the same time as iSpinach, several similarly fluorogenic systems of varying color were 
also characterized by x-ray crystallography. The mango and corn aptamers were revealed to utilize g-
quadruplex motifs as well, cementing the importance of these structures in light-up aptamer systems 
[96,127]. The fluorescence properties of the mango aptamer were also optimized in a similar fashion to 
iSpinach and the structure of this mutant was recently obtained [128]. Interestingly, the dimethylindole 
red (DIR2s) aptamer, which binds the cyanin dyes dimethylindole red and oxazole thiazole blue, was 
determined to be the first fluorophore binding aptamer that did not include a G-quadruplex motif or a 
base quadruple such as that observed in MGA. Instead, it relies on a base triple as a stacking platform 
which diversifies the known range of fluorophore activation by RNA.  
Most recently, a structure for a tetramethylrhodamine aptamer (TMR3) was determined by 
NMR spectroscopy [129]. TMR3 was found to share some structural similarities with the malachite green 
aptamer, but as shown in Figure 1.11d, it has a base triple similar to DIR2s. Interestingly, the 
fluorescence of the ligand is quenched upon binding in contrast to all the other systems that have been 
characterized. The ligand binds with similar base stacking and hydrogen bonding patterns to other 
fluorogenic RNA aptamers, so it is likely that this low fluorescence conformation is a result of a pKa shift, 





A) Crystal structure of MGA bound to TMR (1F1T) [123]. B) Solution structure of MGA bound to MG 
(1Q8N) [124]. C) Crystal structure of the iSpinach aptamer bound to DFHBI (5OB3) [126]. D) Solution 
structure of TMR3 bound to tetramethylrhodamine (6GZK) [129]. Images were created with the 
modelling software UCSF Chimera, developed by the Resource for Biocomputing, Visualization, and 




Figure 1.11: Structures of selected fluorophore binding aptamers. 
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1.5 Catalytic Nucleic Acids 
1.5.1 Ribozyme Discovery 
 In 1982, Thomas Cech was the first to discover RNA with catalytic properties thanks to his work 
on the Tetrahymena intervening sequence RNA (IVS RNA), which is capable of self-splicing [16]. Cech 
shared the Nobel Prize for Chemistry in 1989 with Sydney Altman, who characterized the catalytic 
properties of the RNAse P ribozyme, which also cleaves RNA, in 1983 [15]. Several biologically relevant 
ribozymes have since been discovered, including the Varkud satellite (VS) ribozyme [131], the 
hammerhead ribozyme [132,133], the hairpin ribozyme [134], the ribosome [135] and the spliceosome 
[136], all of which catalyze cleavage and/or ligation of the nucleic acid backbone. Another interesting 
ribozyme discovery was GlmS, a self-cleaving ribozyme that acts as a riboswitch [137]. More recently, 
synthetic ribozymes that can perform a variety of chemical reactions have been developed [138–141] as 
catalytic nucleic acids can be obtained through SELEX, just like aptamers. 
 
1.5.2 Selection of Catalytic Nucleic Acids 
Gold and Szostak are usually credited with the invention of SELEX, but the other, often 
underappreciated, pioneer in this field is Gerald Joyce. Joyce and Robertson also independently came up 
with an in vitro selection method in 1990 [142]. The main difference in this work was that rather than 
selecting aptamers that bind small molecules or proteins, Joyce was interested in selecting catalytic 
RNAs. Ellington and Szostak did ponder the possibility of selecting catalytic RNAs in their work earlier in 
the year [28], but Joyce was the first to actually do it. Using in vitro selection, Joyce and Robertson were 
able to isolate a mutant of the self-splicing Tetrahymena ribozyme, which more efficiently cleaved its 
substrate than the wildtype sequence. Their iteration of in vitro selection was again striking similar to 
Gold’s and Szostak’s procedures, and contemporary selections of catalytic nucleic acids typically use the 
same general SELEX procedure as aptamers. Due to the nature of these molecules, there are some 
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differences such as immobilization not being implemented. In addition, cleaved nucleotides must be 
separated from intact sequences, which is usually achieved through the use of either polyacrylamide gel 
electrophoresis (PAGE)  or biological tags such as biotin [143]. 
 
1.5.3 DNAzymes 
Although not found in nature, DNAzymes can also be selected through SELEX. The first 
DNAzyme, which could catalyze the cleavage of RNA, was isolated by Ronald Breaker and Gerald Joyce in 
1994 [144]. DNAzymes have since been created with the capacity to perform many types of catalysis, 
including nucleic acid cleavage and ligation [144–147], DNA modifications such as phosphorylation 
[148], adenylation [149] and deglycosylation [150] and even a Diels-Alder reaction [151].  
DNAzymes have been used in several applications, including DNAzyme therapeutics, of which a 
few have participated in clinical trials. These are generally treatments involving the inactivation of mRNA 
sequences, downregulating the expression of disease-related proteins [152]. The most common class of 
DNAzymes are ribonucleases, which catalyze the cleavage of an RNA phosphodiester bond via a 
transesterifaction reaction. These self-cleaving DNAs generally require specific metal cofactors which 
has resulted in metal sensing being one of the most studied applications of DNAzymes. For use in such 
commercial applications, DNAzymes provide a couple of key advantages over ribozymes, including 
stability, cost efficiency and ease of chemical modification [153]. 
 
1.5.3 Structural and Functional Importance of Metal Ions 
Due to the polyanionic nature of nucleic acids, it is impossible to discuss their structure and 
function without also considering metal ions. The negative charges need to be shielded by cations, i.e. 
metals, to allow the formation of stable secondary structure. Due to their stabilizing effect on nucleic 
acid structures, metal ions are imperative for the biological functions of DNA and RNA: storage, reading 
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and homologous recombination of genetic information [154]. Metal-binding also has a significant impact 
on the stability and reactivity of various functional groups in nucleic acids, especially particular 
heteroatoms in the bases [155]. They also mediate the ability of nucleic acids to interact with proteins 
and other ligands [156].  
In specific sequences, the presence of metals can lead to several distinct structural motifs, 
including triplexes (Figure 1.12a), helical junctions (Figure 1.12b), quadruplexes (Figure 1.12c) and the 
loop E motif (Figure 1.12d) [157–161].  These types of motifs are all dependent on the presence and 
concentration of common intracellular metals, including Na+, K+ and Mg2+. Some metals can also bind 
specifically to certain base pairs, such as in thymine-Hg2+-thymine [162] and cytosine-Ag+-cytosine [163].  
As the diverse roles of metal ions listed may suggest, under correct conditions, DNA binds to 
certain metals in a highly selective manner. This useful trait is often exploited in biotechnological 




Figure 1.12: Metal coordination to several nucleic acid structures. 
A) Penta-hydrated magnesium stabilizes triplex formation by binding to the N7 of guanine in the tertiary 
strand. B) Nickel (II) stabilizes a three-way junction by complexing with three bipyrimidines. C) 
Potassium promotes the formation of G-quadruplex in guanine-rich sequences.  D) A unique binuclear 
magnesium cluster observed in the Loop E motif. 
 
1.5.4 Metal Biosensors 
The ability to specifically detect metal ions is important for numerous reasons. Metals have 
great physiological importance, such as their aforementioned roles with respect to nucleic acids. They 
are crucial for cell signalling and transport [164,165], and metalloproteins are thought to make up about 
half of all known proteins [166]. Maintaining proper cellular levels of metals is therefore important for 
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human health, and the ability to reliably test these levels is required for diagnosis of metal deficiencies 
and other related ailments. Metals are also important in society as anthropological activities such as 
mining, smelting, electronic waste disposal and domestic and agricultural use of metal containing 
compounds continuously results in significant pollution of heavy metals [167–170]. Heavy metals are a 
known hazard to human health and the environment, therefore the ability to test drinking water and 
other potential sources for contamination is imperative. DNA-based methodologies have been used to 
detect a large percentage of metals from the periodic table [171]. Different strategies are implemented 
depending on the metal of interest and the ways it is known to interact with DNA. For example, Na+ has 
been detected using an aptamer sequence, K+ is generally detected using G-quadruplex based 
sequences and metals such as Pb2+ use metal-dependent self-cleaving DNAzymes.  
Biosensors generally consist of a biomolecular element, which in this case is DNA and a signal 
transduction element. Most signal transduction elements in DNAzyme sensors are either fluorescence, 
colorimetric or electrochemical based. Fluorescent detection is often achieved using 
fluorophore/quencher pairs [172]. Nanomaterials such as quantum dots (QD), gold nanoparticles 
(GNPs), graphene oxide and carbon nanotubes have proven useful as vectors for these labelling pairs 
[173–175]. Additionally, the change in color between dispersed and aggregated GNPs is the basis of 
several colorimetric biosensors [176–178]. Several unique strategies have been used to develop 
electrochemical sensors with impressive detection limits for metals such as Pb2+ [179–181]. 
 
1.6 Contents of the Thesis 
In order to develop potential applications such as biosensors and cell imaging, we must have a 
thorough understanding of how aptamers bind to their targets. This allows chemical modification and 
sequence optimization of aptamer systems for their use in previously discussed commercial 
applications. This is where work on characterizing aptamer structure and binding kinetics comes into 
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play. Chapters 2,3 and 4 feature work on the aptamer SRB-2, which is an interesting one due to its ligand 
promiscuity and overall negative charge of the ligand. Chapter 2 will present work wherein a variety of 
biophysical techniques were used to characterize the binding kinetics and affinity of several known and 
screened SRB-2 ligands. These techniques are also used to categorize the ligands by mechanism of 
binding. Chapter 3 discusses the attempted determination of a solution structure for SRB-2 bound to SR 
by NMR spectroscopy. This involved the preparation of several unlabelled and selectivity isotopically 
labelled SRB-2 samples. Chapter 4 outlines further characterization of the SRB-2 complex using a 
segmental analysis approach. Several truncated versions of the SRB-2 aptamer were designed and 
characterized by fluorescence and NMR spectroscopy. Chapter 5 presents work involving a DNAzyme 
that strongly discriminates between Na+ and K+. This work uses spectroscopy techniques including ThT, 
NMR and CD to show that, despite high G content, this selective binding ability is not conferred by a G-















Chapter 2: Ligand Specificity and Affinity in the Sulforhodamine B 
Binding RNA Aptamer 
 
2.1: Foreword 
The results in this chapter have been published in the journal Biochemical and Biophysical 
Research Communications: Kyle A. Piccolo, Brooke McNeil, Jeff Crouse, Su Ji Lim, Sarah C. Bickers, W. 
Scott Hopkins & Thorsten Dieckmann. Ligand Specificity and Affinity in the Sulforhodamine B Binding 
RNA Aptamer. Biochem. Biophys. Res. Commun. 2020, 529 (3), pp 666-671. Any permission for further 
re-use of this material should be requested directly from BBRC with the DOI: 
https://doi.org/10.1016/j.bbrc.2020.06.056. 
LSPR experiments in this chapter (Figures 2.5 and 2.6, Table 2.5) were performed by Brooke 
McNeil and the electrostatic potential surfaces (Figures 2.22 and 2.23) were calculated by Jeff Crouse 
and Su Ji Lim. All other experimental work was performed and analyzed by the candidate.  
All data and figures in this chapter were published in the above article with the following 
exceptions: DSC experiments shown in (Figure 2.20), CD experiments shown in (Figure 2.21), ITC salt 
studies shown in Table 2.3 and the following NMR figures (Figures 2.8-12, 17-19). Data and figures listed 
are unchanged from the original publication, though some of the text was modified for inclusion in this 
thesis.  
 
2.2 Chapter Abstract 
Binding affinity and selectivity are critical properties of aptamers that must be optimized for any 
application. The sulforhodamine B binding RNA aptamer (SRB-2) is a somewhat promiscuous aptamer 
that can bind ligands that vary markedly in shape, size and charge. Here we categorize potential ligands 
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based on their binding mode and structural characteristics required for high affinity and selectivity. 
Several known and potential ligands of SRB-2 were screened for binding affinity using fluorescence. 
Promising candidates were subsequently characterized by LSPR, ITC, fluorescence anisotropy, DSC, CD 
and NMR spectroscopy. These studies show that rhodamine B has the ideal structural and electrostatic 
properties for selective and high-affinity binding of the SRB-2 aptamer.      
 
2.3 Introduction 
The sulforhodamine B binding aptamer (SRB-2) is an RNA aptamer that was selected by the 
Wilson group to bind the fluorescent dye sulforhodamine B (SR) [37]. The secondary structure of SRB-2 
and the structures of six of the studied ligands are shown in Figure 2.1. The structures of several other 
known and potential ligands studied are shown in Figure 2.2. Some of the very first targets used in the 
development of SELEX were small, organic, planar fluorophores due to their similarity to biological 
cofactors and comparatively high quantum yield [28]. Such aptamers, including SRB-2, continue to be 
widely studied due to their potential applications in bio-imaging and bio-sensing [79,88,89,182].  
The SRB-2 aptamer was selected for use in so-called “light-up” RNA aptamer systems [37]. This is 
a promising method wherein the complement of a fluorophore binding aptamer sequence is added to a 
gene of interest. The target fluorophores have low intrinsic fluorescence but become highly fluorescent 
upon binding the aptamer [113,182]. Several other fluorophore binding aptamers, particularly the class 
based on derivatives of fluorescent protein fluorophores such as spinach [90], broccoli [91], corn [92] 
and mango [93] have been selected and studied to create a rainbow of RNA reporter molecules for 
nucleic acid researchers analogous to the arsenal of fluorescent proteins used by protein researchers 
[113,183]. SRB-2 has been used successfully in mRNA imaging experiments with SR and with SR-
quencher constructs designed to reduce background noise in fluorescence measurements [88,89].  
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Aptamers have several characteristics that make them attractive receptors to use in biosensors 
compared to antibodies. These include similar high affinity, but with higher stability, ability to be 
produced synthetically, easy modification and wider range of potential targets. There are a few 
literature examples of fluorophore binding aptamers like SRB-2 being used in this type of application. 
One prime example is the label-free sensor discussed in Chapter 1 that incorporated the RNA aptamer 
MGA (malachite green aptamer) [79]. This sensor consisted of a fusion of MGA and the ATP aptamer, 
and a bridging strand connecting the two. The bridging strand is released upon ATP binding, allowing 
MGA to bind MG and significantly increase the fluorescence. In order to develop such systems, the 
binding mode of the aptamer needs to be well characterized, which we intend to do with the SRB-2 
aptamer.  
One of the defining characteristics of SRB-2 is its ligand promiscuity. SRB-2 can bind a variety of 
planar dyes which contain a similar xanthene ring structure, which is characteristic of rhodamine 
derivatives. These dyes are diverse in color, size, charge and selectivity. Much of the motivation of this 
work is to determine what structural characteristics of the dyes make for the best SRB-2 ligand. The dyes 
used in this work were selected on a number of factors which include structural similarity to SR, 
commercial availability and presence in prior SRB-2 studies [37,89]. The authors who originally selected 
SRB-2 used tetramethylrosamine and xylene cyanol among others in a competitive elution experiment 
with SR agarose [37]. There was also work done by Sunbul and Jaschke, where the Kd values of various 
SRB-2 ligands were determined and we took a representative sample of those including pyronin Y (PY), 
acridine orange (AO), 9-aminoacridine (9AA) and Atto 495 [89]. The problem with some of these ligands 
is that despite higher fluorescence enhancement, they are known nucleic acid stains. This means they 
bind sequence independently in the RNA/DNA backbone, which could limit their practical use [184–186]. 
All other dyes studied, including rhodamine B (RB), sulforhodamine 101 (SR101), rhodamine 6G (R6G), 
rhodamine 110 (R110), Atto rhodamine 101 biotin (AR101-B) and 5/6-biocytin tetramethylrhodamine (B-
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TMR) were chosen solely for their structural similarity to SR and commercial availability and to our 
knowledge have not been studied as SRB-2 ligands in any prior literature.  
It is worth noting that SRB-2 is also capable of binding the dyes Patent Blue V (PBV) and Patent 
Blue VF (PBVF) [76]. PBV is very similar to SR but lacks the bridging oxygen in the central ring, resulting in 
a propeller-like shape. PBVF differs from PBV by only the addition of a hydroxyl group in the meta 
position opposite the ortho sulfonate. However, these dyes bind with Kd values of just 23 µM for PBV 
and 86 µM for PBVF. These binding constants are significantly higher than the literature value of 310 nM 
for SR. This may limit the practicality of the aptamer in imaging and sensing applications. Therefore, we 
opted not to study these ligands any further. 
Another part of what makes SRB-2 an intriguing system to study is the overall negative charge of 
its ligand, SR (Figure 2.1). Negatively charged aptamer ligands are generally less common than neutral 
and positively charged ones due to potentially repulsive backbone interactions. There are few structures 
available of aptamers bound to negatively charged ligands available. One prominent example is the ATP 
aptamer. However, negative charges are not explicitly required for binding and based on the structure 
when bound the AMP, the negative charges of the phosphate do not interact directly with the RNA. 
Given the consistent presence of the xanthene-type group in ligands studied, this may well be the case 
for SRB-2 as well.  
In these studies, we use a variety of biophysical techniques to characterize and compare the 
kinetics and binding mode for several aptamer-ligand complexes of SRB-2. Fluorescence scans are used 
initially to screen ligands for binding activity. Fluorescence anisotropy, isothermal titration calorimetry 
(ITC), and light surface plasmon resonance (LSPR) are used to probe binding affinity and selectivity of 
known and potential ligands. Thermodynamic parameters of selective binders are also assessed via ITC 
and differential scanning calorimetry (DSC). Aptamer-ligand interactions are examined using 
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homonuclear nuclear magnetic resonance (NMR) spectroscopy, including 1D 1H NMR titrations and 2D 
NOESY experiments.  
Characterizing aptamer systems such as SRB-2 is essential to rationalize the motifs and 
intermolecular contacts that are critical for binding affinity and specificity. This information can then be 
used to implement aptamers in several types of applications including cell imaging and biosensing. In 
these studies, we screen several known potential SRB-2 ligands and use them to probe the structure of 
SRB-2. We determined the binding affinity, selectivity and mode of each of these ligands with the goal of 
determining what an ideal SRB-2 ligand would look like. Of the ligands studies, rhodamine B possesses 
the ideal characteristics for use in applications including selective binding, high binding affinity and 




Figure 2.1: Secondary structure of SRB-2 and chemical structures of several studied dyes.  
These include sulforhodamine B (SR), rhodamine B (RB), sulforhodamine 101 (SR101), 
tetramethylrosamine (TMR), Patent blue V (PBV) and fluorescein (FL). Chemical structures of all other 




Figure 2.2: Chemical structures of ligands screened for SRB-2 binding activity. 
These include 5/6-biocytin tetramethylrhodamine (B-TMR), Atto rhodamine 101 biotin (AR101-B), 9-
aminoacridine (9AA), Acridine orange (AO), Pyronin Y (PY), Atto 495, Rhodamine 6G (R6G), Rhodamine 
110 (R110) and Xylene cyanol FF (XC). 
 
2.4 Materials and Methods 
2.4.1 Preparation of RNA Samples and Dyes 
The SRB-2 RNA was synthesized enzymatically using a T7 RNA polymerase and a double-
stranded synthetic DNA template (Integrated DNA Technologies, Inc., Coralville, Iowa). The sequences 
used were as follows: 
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SRB-2 template DNA:  
5’-GGGACCTGAGGCGGTTAACCTTGCGCCTCTCCATCATCGCCGAAGCGAGGTCCCTATAGTGAGTCGTATTA-3’ 
SRB-2 coding DNA:  
5’-TAATACGACTCACTATAGGGACCTCGCTTCGGCGATGGAGAGGCGCAAGGTTAACCGCCTCAGGTCCC-3’ 
 
A single base-pair substitution in the original sequence of SRB-2 (A3 –> G3 and U52 –> C52) was 
introduced to increase transcriptional yield, as the presence of three consecutive G residues at the 
beginning of the sequence is thought to increase initiation of transcription [187,188]. RNA was 
transcribed using the recipe listed in Table 2.1. The transcription buffer was tris-buffered saline (TBS), 
which contains 40 µM Tris and 100µM NaCl.  
 
Table 2.1: Sample recipe for a 10mL transcription. 
Reagent Volume Stock concentration Final Concentration 
DMSO 2 mL 100 % 20 % 
MQ 400 μL N/A N/A 
TBS (pH 8.3) 1 mL 10X 1X 
MgCl2 450 μL 1 M 40 mM 
DTT 500 μL 100 mM 5 mM 
NTPs (A,C,G,U) 750 μL 100 mM 7.5 mM 
PEG 8000 400 μL 40% w/v 1.6% w/v 
DNA Template 800 μL 20 μM 1.6 μM 
T7 RNAP (in 50% 
glycerol) 




The RNA was purified on a 10% Urea PAGE gel, and the band containing the aptamer was cut 
out. The RNA was eluted from the gel by crush & soak in 300mM NaCl or by electroelution. This was 
followed by clean-up on a HiPrep 16/10 DEAE FF anion-exchange column (GE Healthcare, Uppsala, 
Sweden) and desalting on a HiPrep 26/10 Desalting column (GE Healthcare, Uppsala, Sweden). The RNA 
was also precipitated with 70% ethanol prior to running each column. Pure samples obtained from the 
desalting column were then lyophilized and dissolved in the appropriate buffer.  For the fluorescence 
assay, MGA and Mango RNA aptamers were also used. In this case, a single-stranded template annealed 
to the T7 promoter was used in place of a double-stranded template sequence. These aptamers were 
otherwise transcribed and purified using methodologies analogous to SRB-2. DNA sequences used are as 
follows: 
MGA DNA: 5’-GGATCCATTCGTTACCTGGCTCTCGCCAGTCGGGATCCTATAGTGAGTCGTATTA-3’  
Mango DNA: 5’-CTGCTCTCCTCTCCGCACCGTCCCTTCGCTCCCTATAGTGAGTCGTATTA-3’ 
T7 promoter: 5’-TAATACGACTCACTATAG-3’ 
Sulforhodamine B (Life Technologies, Eugene, OR), sulforhodamine 101, acridine orange, 9-
aminoacridine, Atto 495, rhodamine 110 chloride, fluorescein (Sigma, St. Louis, MO), rhodamine B, 
rhodamine 6G (Alfa Aesar, Ward Hill, MA), tetramethylrosamine (Invitrogen Corporation, Carlsbad, CA), 
pyronin Y (Acros Organics, Geel, Belgium) and xylene cyanol FF (EMD, Burlington, MA) were used 
without further purification. Dyes were prepared in assay buffer (10mM HEPES, 10mM KCl and 5mM 
MgCl2 at pH 7.4) or NMR buffer (10 mM potassium phosphate buffer and 10 mM KCl) and 
concentrations were verified by UV/vis spectrophotometry.  
 
2.4.2 Emission Scans 
Spectra were obtained using a Spectramax M3 Multi-Mode Microplate Reader using a 100 nm 
wide scan with 1nm intervals. SR, RB and TMR were measured at an λex of 520 nm and an λem range of 
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540-640 nm. SR101 was measured using an λex of 550 nm and an λem range of 570 nm to 670 nm. PY was 
measured using an λex of 510 nm and an λem range of 530 nm to 630 nm. AO and Atto 495 were 
measured using an λex of 460 nm and an λem range of 480 nm to 580 nm. 9AA was measured using an λex 
of 390 nm and an λem range of 410 nm to 510 nm. Readings were taken in Greiner 96-well black 
microplates (Kremsmünster, Austria). Samples were prepared with 10µM dye and 50μM RNA in assay 
buffer (10mM HEPES, 10mM KCl and 5mM MgCl2 at pH 7.4).  
 
2.4.3 Fluorescence Anisotropy 
Fluorescence anisotropy measurements were acquired on a Photon Technology International 
(Edison, NJ) LS-100 spectrofluorimeter equipped with a continuous Ushio (Cypress, CA) UXL-75Xe xenon 
arc lamp and a PTI 814 photomultiplier detection system (Photon Technology International). 
Measurements were taken using a λex of 563 nm and a λem of 585 nm, which were determined 
experimentally using excitation and emission scans. Samples were prepared with varying concentrations 
of RNA (0.1-50 µM) and 1 µM SR in assay buffer (10mM HEPES, 10mM KCl and 5mM MgCl2 at pH 7.4). 
Samples were incubated at 25°C for at least 10 minutes before measurement and then read in a Hellma 
high-performance quartz glass cuvette with a 3.00 mm optical path length and 45µL volume (Müllheim, 
Germany). The resulting binding curves were fit using a non-linear, least squares method to the simple 
hyperbolic function: % FAmax =  FAmax × [SRB-2] / (Kd + [SRB-2]) where FAmax is the maximum fluorescence 
anisotropy and Kd is the dissociation constant. Anisotropy measurements were normalized to a 
percentage of FAmax for each respective ligand.  
 
2.4.4 ITC Studies 
Experiments were performed on a MicroCal ITC 200 microcalorimeter (MicroCal Inc., 
Northampton, MA). The samples of 30-35 µM RNA and dye solutions of 0.7-1.1 mM were each prepared 
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by dissolving in assay buffer. All experiments were carried out at 25°C and performed in triplicate. For 
each dye or experimental condition, a blank run with assay buffer in the cell and fluorophore dissolved 
in assay buffer in the syringe was performed. This run was subtracted from the experimental run to 
account for the heat of dilution of the fluorophore solutions. All data sets were analyzed and fitted using 
the Origin 7 software package provided by MicroCal. All data was fit to a single-site binding model using 
a non-linear least-squares approach.  
 
2.4.5 LSPR Assay 
Localized surface plasmon resonance (LSPR) binding assays were carried out on an OpenSPRTM 
(Nicoya, Waterloo, Canada) at room temperature. For the analysis of SRB-2, 10µM biocytin TMR 
(Invitrogen Corporation, Carlsbad, CA) or biotinylated Atto Rho101 (Sigma, St. Louis, MO) were 
immobilized onto the streptavidin sensor chip. SRB-2 was then injected at a flow rate of 20 µL/min at 
concentrations of 0.9 – 7.57 µM in HEPES (10 mM HEPES, 200 mM KCl, 10 mM MgCl2) running buffer. 
The binding time was 240 seconds, and the disassociation time was 150 seconds. The sensor was 
regenerated with 10 mM glycine-HCl (pH 2.5). The data was retrieved and analyzed with TraceDrawer 
software (Ridgeview Instruments AB, Sweden). A 1:1 Langmuir interaction was fit to the data for each 
compound, and the fit delivered the on rate (ka), off rate (kd), and the equilibrium constant (Kd). 
 
2.4.6 NMR Experiments 
NMR samples were prepared by dissolving an appropriate weight of lyophilized RNA in 500μL of 
10 mM potassium phosphate buffer and 10 mM KCl (90% H20/10% D2O). Lyophilized aliquots of dye 
were added to titrate the RNA to a ~1:1 ratio unless otherwise specified. The samples were dried by 
lyophilization and re-dissolved in 500 μL of 99.996% D2O (Cambridge Isotopes) to perform experiments 
on non-exchangeable resonances. All spectra were collected on a Bruker DRX-600 spectrometer 
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equipped with an HCN triple-resonance, triple-axis PFG probe. Quadrature detection for the indirect 
dimensions in multidimensional experiments was achieved using the States-TPPI method [189]. Samples 
in 90% H2O/10% D2O that were used to observe exchangeable protons were run using 11̅-spin echo 
solvent suppression [190]. Two-dimensional NOESY spectra [191] in 90% H2O/10% D2O were acquired at 
277 K with a mixing time of 150 ms. Samples in D2O that were used to observe non-exchangeable 
protons were run with presaturation solvent suppression [192]. 2D CITY-TOCSY [193] with a mixing time 
of 50 ms, and NOESY with a mixing time of 150 ms in 100% D2O were acquired at 298 K. All NMR 
samples had a volume of 500 μL and were read in standard 5 mm NMR tubes. Relevant pulse programs 
can be found in Appendix B. 
 
2.4.7 Electrostatic Potential Surfaces 
 All electrostatic potential surface (EPS) calculations were performed using the Gaussian 16 
program package for computational chemistry. The molecules were optimized at B3LYP/def2-TZVPP 
level of theory, besides Atto Rhodamine 101, 6-Biocytin TMR, and Patent Blue V, which were optimized 
at B3LYP/def2-SVP level. Frequency calculations were performed to ensure that structures correspond 
to minima and not transition states. 
 
2.4.8 Differential Scanning Calorimetry 
DSC experiments were performed using an LLP cap DSC (MicroCal Inc., Malvern Instruments 
Ltd.). 50 μM SRB-2 in assay buffer (10mM HEPES, 10mM KCl and 5mM MgCl2 at pH 7.4) was scanned at a 
rate of 1 °C per minute over a range of 20°C to 100°C. Where applicable, 100 μM of either SR or TMR 
were also present (2x the SRB-2 concentration). When plotted, each RNA scan has a reference scan of 




2.4.9 Circular Dichroism Spectroscopy 
CD experiments were performed on a Jasco J-715 spectropolarimeter (Jasco Inc., Easton, MD). 
CD scanning experiments were run from 320 nm to 220 nm with a path length of 0.1 cm, data interval of 
0.5 nm, band width of 0.5 nm, response of 1 second, scanning speed of 200 nm minute−1 and a total of 
four accumulated scans. Samples contained 40 μM RNA in 10mM HEPES, 10mM KCl and 5mM MgCl2 at 
pH 7.4. Where applicable, samples also contained 50 μM of either SR or TMR. The samples were heated 
to 85 °C for 5min, cooled to 4 °C and incubated for at least 24hrs before acquisition at 25 °C. A blank 
containing buffer or buffer + ligand was subtracted from each sample and the resulting data was 
smoothed using a Savitzky-Golay smoothing function [194].  
 
2.5 Results 
2.5.1 Emission Scans 
Fluorescence emission spectra were obtained for each dye both on their own and bound to SRB-
2 in a 5:1 ligand:RNA ratio (Figure 2.3). Fluorescence results are collected in Table 2.2. The specificity of 
these dyes was tested using additional RNA and dsDNA sequences. Dyes that could bind SRB-2 only 
included sulforhodamine B (SR), rhodamine B (RB) and sulforhodamine 101 (SR101), as well as 5/6-
biocytin tetramethylrhodamine (B-TMR) and Atto rhodamine 101 biotin (AR101-B), which are 
functionalized analogues of RB and SR101, respectively. All other dyes listed were capable of binding all 
sequences tested. Most dyes experienced a red shift in their maximum emission wavelength and an 
increase in fluorescence upon binding. As shown in Table 2.2, 9-aminoacridine (9AA) and acridine 
orange (AO) are exceptions, likely a result of a pKa change in the amines, which alters their protonation 






Figure 2.3: Emission scans comparing free dye (blue) and dye bound to SRB-2 (red). 
The are examples of some of the emission scans performed, comparing the fluorescence of free ligands 
to fluorescence when bound to SRB-2. As seen in most of these graphs, a fluorescence increase and a 
red shift are generally observed upon aptamer binding of a fluorogenic ligand. 9AA is an exception due 
to the presence of an amine group. Upon binding, the protonation state of this amine is changed, 
resulting in a non-fluorescent conformation. This plots are normalized to the fluorescence of the more 






Table 2.2: Wavelength shifts and fluorescence changes determined by emission scans. 







   
   
   
  
Assay buffer RF 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
  max(nm) 580 576 604 573 563 526 516 435 578 605 
            
SRB-2 RF 1.52 2.05 1.48 1.38 1.15 3.08 10.82 0.06 1.11 1.11 
  Δλmax (nm) 8 6 4 10 9 -2 11 0 8 1 
                        
dsDNA 
template 
RF 0.91 0.80 0.74 0.35 0.28 2.39 2.53 0.19 0.92 0.84 
  Δλmax (nm) -2 0 0 9 9 -1 7 0 1 2 
                        
MG aptamer RF 0.87 0.78 1.04 0.37 0.28 2.90 2.50 0.26 0.92 0.92 
  Δλmax (nm) -1 0 0 6 9 -3 10 0 2 1 
                        
Mango aptamer RF 0.92 0.79 0.86 0.30 0.94 1.94 3.29 0.37 0.81 0.78 
  Δλmax (nm) -2 0 1 9 9 1 12 0 1 3 
 The max for each ligand is determined by inspection of the raw emission data of ligand in assay 
buffer. The Δλmax for each ligand-nucleic mixture is determined by taking the difference between the 
max of the ligand in assay buffer and the respective ligand-nucleic acid mixture. For purposes of 
identifying binding, the ligand-nucleic acid mixture must have a fluorescence increase of at least 10% 
and/or a max that increases by at least 5 nm.  
 
2.5.2 Fluorescence Anisotropy 
Fluorescence anisotropy was used to determine the binding affinity of the ligands tested as this 
was the method used by the authors of the original SRB-2 selection [37]. 9AA was not tested due to the 
unusual behaviour observed in the fluorescence emission scans. Through the dissociation constant, Kd, 
we find the order of binding affinities to SRB-2 is RB > SR > SR101, as shown in Table 2.3. This trend 
matches up with the ITC data listed in Table 2.4, however, affinities are reported as being lower in 
general. This may be due to the concentration of ligands not being limiting enough in these assays. TMR, 
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PY, AO and Atto 495 were also tested, but they are suspected to bind in multiple sites at SRB-2. The 
simple hyperbolic function used to fit these data is meant to represent single-site binding. Therefore, 
this methodology may be inappropriate for such ligands. The Kd for TMR is slightly higher than SR. Like 
RB and SR101, this value was also previously unreported, but due to its presumed intercalation, we were 
unable to substantiate this result with ITC. The Kd values determined for PY and AO are both lower than 
SR, which agrees with previous studies [89]. Atto 495 was determined to have the lowest binding 
affinity, though it was expected to be similar to SR based on previous studies [89]. 
 
Figure 2.4: Fluorescence anisotropy titration curves for SRB-2 and its various ligands. 
52 
 
Experimental data is shown as blue points and fit data is shown as a red line. Error bars are one standard 
deviation from the mean of the replicates acquired. 
 
Table 2.3: Dissociation constants of SRB-2 ligands determined by fluorescence anisotropy. 
Ligand Kd (µM) 
SR 3.94 ± 0.34 
RB 1.67 ± 0.18 
SR 101 10.3 ± 0.5 
TMR 4.24 ± 0.17 
PY 1.89 ± 0.14 
AO 1.16 ± 0.08 
Atto 495 0.989 ± 0.12 
 
2.5.2 Isothermal Titration Calorimetry 
Isothermal titration calorimetry (ITC) was also used to determine the binding affinity of the 
ligands due to the extra thermodynamic information it can provide. It has the inherent advantage over 
fluorescence anisotropy of being able to directly measure the molar ratio, n and the enthalpy, ΔH. The 
entropy, ΔS, and Gibbs free energy, ΔG, can also be determined indirectly. A sample ITC isotherm and its 
integrated plot are given in Figure 2.5. Through the dissociation constant, Kd, we find the order of 
binding affinities to SRB-2 is RB > SR > SR101, as shown in Table 2.4. This agrees with Kd values obtained 
from the fluorescence anisotropy experiments. 
Several other dyes, including tetramethyl rosamine (TMR), pyronin Y (PY), Atto 495, acridine 
orange (AO) and 9-aminoacridine (9AA) were tested by ITC. However, these small, planar and electron-
poor dyes intercalate between base pairs in double-stranded nucleic acid sequences. The resulting 
isotherms adhered poorly to a single-site binding model. Therefore, reasonable binding affinities and 
thermodynamic parameters were not determined by this method. PY, AO, 9AA and Atto 495 also mirror 
the trend observed in previous studies using fluorescence titrations [89].  
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The binding of ligands to aptamers is commonly dependent on divalent counter-ions to stabilize 
the negatively charged backbone. To probe this relationship, the ITC experiments were repeated in the 
absence of Mg2+. No binding was observed under these conditions for SR, SR101 or RB. Weak binding 
was observed for TMR, which carries an overall positive charge. However, due to its non-specific binding 
nature, an appropriate fit could not be determined. ITC experiments at 500mM KCl in the absence of 
Mg2+ showed weak binding of the dye ligands to SRB-2, as shown in Table 2.5. SR101 is not shown as 
binding was too weak to determine a reliable fit.  
 
Figure 2.5: Representative ITC data for the binding of SRB-2 to SR. 
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A titration curve of SR injected into SRB-2 is shown in black in the top panel. SR into buffer control is 
shown in green. The binding isotherm is shown in black in the bottom frame, with the SR into buffer 
control again being shown in green.  
 










2.5.3 Surface Plasmon Resonance Studies 
LSPR anisotropy experiments were performed in order to obtain kinetic data for the structurally 
relevant rhodamine derivatives biocytin-tetramethyl rhodamine (B-TMR) and Atto rhodamine 101 biotin 
(AR101-B). These dyes were selected based on commercial availability and ability to bind the surface of 
SPR chips. Dissociation curves are shown in Figures 2.6 and 2.7, and binding data obtained for these 
dyes is listed in Table 2.6. 
 
Ligand n Kd (μM) ΔH (kcal mol-1) ΔS (cal mol-1 K-1)      
SR 0.885 ± 0.012 1.45 ± 0.09 -13.1 ± 0.3 -17.2 ± 0.4 
SR101 0.882 ± 0.031 4.7 ± 0.70 -10.1 ± 0.5 -9.27 ± 0.8 
RB 0.922 ± 0.010 0.447 ± 0.08 -14.2 ± 0.2 -18.5 ± 1.2 
Ligand n Kd (μM) ΔH (kcal mol-1) ΔS (cal mol-1 K-1) 
     
SR 1.09 ± 0.008 11.9 ± 0.2 -36.6 ± 0.4 -99.6 ± 6.0 




Figure 2.6: LSPR response curve for Biocytin-TMR. 
LSPR response curve and 1:1 stoichiometry kinetic fit models for B-TMR. B-TMR was immobilized onto 
the streptavidin sensor chip and SRB-2 was injected at a flow rate of 20 µL/min at concentrations of 0.9 
– 3.76 µM. 
 
 
Figure 2.7: LSPR response curve for Atto Rho 101. 
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LSPR response curve and 1:1 stoichiometry kinetic fit models for AR101-B. AR101-B was immobilized 
onto the streptavidin sensor chip and SRB-2 was injected at a flow rate of 20 µL/min at concentrations 
of 3.79 – 7.57 µM. 
 
Table 2.6: Kinetic parameters of SRB-2 binding determined by LSPR. 
Ligand kon (uM-1 s-1) koff (s-1) Kd (uM) 
B-TMR 207 + 78.0 0.0292 + 0.0156 1.37 + 0.23 
AR101-B 735 + 559 0.0246 + 0.0346 4.66 + 0.47 
 
2.5.4 NMR Spectroscopy 
The binding behavior of SRB-2 with each ligand was studied by NMR spectroscopy. SRB-2 was 
titrated with each ligand in 3-5 steps. 1D 1H-NMR spectra in 90% H2O/10% D2O were used to follow the 
changes during the titrations. The spectrum of SRB-2 in the absence of dye shows relatively few and 
generally broad peaks (Figure 2.8 A). This is typical for the adaptive binding mode found in many 
aptamers [119,122], where the binding pocket in the absence of ligand is mostly unstructured. When 
the aptamer has been titrated to approximately 1:1 with SR, RB and SR101 (Figure 2.8 B-D), an NMR 
spectrum consistent with a single conformation is observed. This is indicated by the presence of 
additional peaks compared to the spectrum of the free SRB-2 and linewidths that are noticeably 
narrower. Several of the new peaks are in the 9-11 ppm region, which is typical for imino protons in 
non-canonical base pairs. Narrower line shapes in the NMR spectrum and additional peaks in the 9-11 
ppm region are consistent with a more highly structured bound conformation with more contacts 
forming between the imino protons of guanine or uridine residues and other atoms in the aptamer or 




Figure 2.8: 1D 1H NMR spectra of free SRB-2 and SRB-2 bound in a 1:1 ratio to several different ligands. 






Figure 2.9: 1D 1H NMR spectra of free SRB-2 and SRB-2 bound in a 1:1 ratio to several different ligands. 
A) 0.9 mM SRB-2 only B) 1.8 mM SR, C) 0.4 mM PY, D) 0.2 mM AO, E) 0.4 mM 9AA, F) 0.4mM Atto 495.  
 
TOCSY experiments were run on SRB-2 complexed with SR, RB and SR101. The aromatic protons 
of the ligands, particularly those on the single rings, are shifted downfield when bound to SRB-2 as a 
result of diamagnetic anisotropy experienced by these aromatic protons when they are involved in π-π 
stacking interactions with bases of the aptamer. It was qualitatively observed in these spectra that RB 
protons have a larger change in the chemical shift between free and bound forms (∆δfree-bound=δfree - 
δbound) as compared with SR, which shows larger shifts as compared with SR101. The spectrum for SR on 





Figure 2.10: TOCSY spectra of 1mM SR101 (red) and 1.1mM SRB-2 fully bound to SR101 (black). 
TOCSY was acquired with a mixing time of 50 ms. Aromatic protons of SR101 are labelled in red. Clear 
changes in the chemical shifts of these protons can be observed in free(red) vs. bound (black) spectra.  
 
NOESY experiments in 90% H2O/10% D2O are used to map interactions between imino-protons. 
The NOEs between exchangeable imino protons in adjacent base-pairs allow a comparison of the 
patterns formed in the unfolded and folded states of the aptamer. SR has the greatest number of NOEs 
between exchangeable protons (Figure 2.14). This is expected as SR was the ligand SRB-2 was initially 
selected to bind, so the binding site is optimized for this molecule. The NOESY spectra for RB (Figure 
2.15) and SR101 are almost identical to SR, except for some minor chemical shift changes. This indicates 
that they likely bind in the same location. In the NOESY spectrum of TMR (Figure 2.17), fewer stacking 
NOEs are present when compared to SR. In addition, multiple conformations were clearly observed 
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based on the excess number of peaks compared to SR, RB and SR101 in the 1D 1H-NMR spectrum (Figure 
2.8E). PY, 9AA and Atto 495 all have similar NOESY and 1D spectra to TMR (Figure 2.9 B-F and Figures 
2.18-2.20), indicating that they are also binding in multiple different locations. In addition, lack of NOEs 
present in these spectra suggest that each of these dyes intercalate in the base-paired stems, rather 
than participating in adaptive aptamer binding. A NOESY spectrum was not acquired for AO due to 
limited solubility of the low-purity dye. NOESY spectra for all dyes except SR (Figure 2.11) are listed in 
Appendix A.  
 
Figure 2.11: NOESY spectrum of 1.8 mM SRB-2 ~1:1 with sulforhodamine B in 90% H2O/10% D2O. 
Many imino-imino stacking NOEs are observed between 11-14.5 ppm, indicating the presence of several 
base paired regions, consistent with the predicted secondary structure of SRB-2. This NOESY spectrum 
was acquired with a mixing time of 150ms. 
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2.5.5 Differential Scanning Calorimetry 
Several differential scanning calorimetry (DSC) isotherms were obtained for SRB-2 in order to 
compare its melting behaviour when bound to a ligand known to bind specifically with a ligand that is 
known to bind sequence-independently. Based on observations from the emission scans, SR and TMR 
were chosen to represent each of those categories, respectively. A comparison of the melting curves of 
SRB-2 and SRB-2 + SR is shown in Figure 2.20 A and a comparison of SRB-2 + SR and SRB-2 + TMR is 
shown in Figure 2.20 B. There is melting observed around 70°C in both bound forms that is not observed 
in SRB-2 alone. This suggests that there are tertiary structures that only form when the aptamer is 
bound. The secondary structure melts at 90°C in all samples. 
 
Figure 2.12: Differential scanning calorimetry isotherms. 
A) Comparison of unbound SRB-2 to SRB-2 bound to SR and B) comparison of SRB-2 when bound to SR 
versus when bound to TMR.  
 
2.5.6 Circular Dichroism Spectroscopy 
Circular dichroism (CD) spectra were acquired to assess the possibility of any distinct tertiary 
structures being present in SRB-2. Similar to DSC, CD and UV absorbance spectra were acquired for SRB-
2 on its own, SRB + SR and SRB-2 + TMR (Figure 2.21). These dyes were again chosen as a general 
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representative of their respective binding behaviors. No distinct tertiary structure features such as G-
quadruplex or triplex RNA are observed in any of the spectra.  
 
Figure 2.13: CD and UV absorbance spectra of SRB-2. 
A) CD spectra comparing unbound SRB-2, SRB-2 bound to SR and SRB-2 bound to TMR.  
B) Corresponding UV absorbance spectra for SRB-2, SRB-2 bound to SR and SRB-2 bound to TMR. 
 
2.6 Discussion  
2.6.1 Smaller Size and Reduced Negative Charge of Ligands Result in Higher Binding Affinity 
From the fluorescence emission scans, we show that RB has a similar red shift but a greater 
fluorescence intensity increase than SR (Table 2.2) when binding to SRB-2. A comparable red shift is 
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expected due to their conjugation systems being very similar. The fluorescence intensity increase for RB 
binding is likely higher as compared with SR due to differences in the polarity of the bound dyes. RB is 
missing a negatively charged group in the para-position of the single ring, which results in the ligand’s 
conformation being locked more tightly in the binding site. Figure 2.22 shows that the negatively 
charged sulfonates in SR draw electron density from the three-ring system, creating a significant 
concentration of negative partial charge on the bottom ring (electrostatic potential surfaces of all dyes 
referenced are shown in Figures 2.22 and 2.23). RB has a single carboxyl group rather than two sulfonate 
groups. The carboxyl group of RB is smaller and less electron-dense than the sulfonates on SR, resulting 
in a dye with less overall electron density. The reduction in repulsive interactions with the RNA 
backbone and the size of groups on the extended ring would account for the small relative increase in 
enthalpy and entropy, respectively. It also makes sense that RB would have a lower Kd for SRB-2 because 
the original selection target had a PEG-anchor at the para position rather than a negative charge and 
therefore possessed an overall neutral charge like RB. The NMR spectra support this as only minor 





Figure 2.14: Electrostatic potential surfaces for sulforhodamine B (SR), rhodamine B (RB), 
sulforhodamine 101 (SR101), tetramethylrosamine (TMR), patent blue V (PBV) and fluorescein (FL). 
The upper charge limit was set by averaging the maximum positive charges in all ligands calculated. The 
lower charge limit was set by averaging the minimum negative charges in all ligands calculated and 





Figure 2.15: Electrostatic potential surfaces of 5-biocytin tetramethylrhodamine, 6-biocytin 
tetramethylrhodamine (B-TMR), Atto rhodamine 101 biotin (AR), 9-aminoacridine (9AA), Acridine 
orange (AO), Pyronin Y (PY), Atto 495, Rhodamine 6G (R6G), Rhodamine 110 (R110) and Xylene cyanol 
FF (XC). 
The upper charge limit was set by averaging the maximum positive charges in all ligands calculated. The 
lower charge limit was set by averaging the minimum negative charges in all ligands calculated and 
subtracting one standard deviation. 
 
It can also be observed from the fluorescence data in Table 2.2 that SR101 has a similar 
fluorescence increase but a smaller red shift compared to SR. The smaller red shift results from SR101 
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being more rigid in its free conformation. This would fit with the ITC results in Table 2.3, which indicate 
that the entropy loss upon binding is relatively small for SR 101. This is in agreement with the observed 
Kd values as SR101 is expectedly higher than SR as the tighter the binding pocket, the stronger the π-π 
stacking interactions will be, resulting in a larger fluorescence redshift. There is also a significant 
decrease in the entropy loss of SR101 compared to SR. This decrease in entropy loss can be attributed to 
SR101 having a more rigid ring structure in place of the freely rotating ethyl groups in SR, the more 
ordered structure results in a smaller entropy loss upon binding. Solvation entropies may also differ 
between these two ligands. The enthalpy change for SR101 binding is also smaller compared to SR, 
which can also be explained by the steric interactions between the bulkier rings, resulting in less ideal π-
π stacking with the xanthene ring structure of the dye. NOESY experiments indicate that the aptamer is 
unable to form some contacts with SR101 that are observed with SR and RB, indicating that SR101 
doesn’t fit as well in the aptamer binding pocket. 
 
2.6.3 Negatively Charged Group is Required for Selectivity but is Likely Not Directly Involved 
in Binding 
TMR binding to SRB-2 resulted in the most significant chemical shift changes in the NOESY 
spectrum as compared to SR binding. However, even with significant over-titration, multiple 
conformations appear to be present based on the number of H5-H6 crosspeaks observed. There are also 
fewer NOEs observed in the SRB-2/TMR NOESY spectrum than in the SRB-2/SR spectrum, indicating that 
TMR is not inducing the formation of a specific binding pocket at all. TMR is known, from studies with 
MGA, to intercalate between base pairs of double-stranded RNA [124]. Similar observations were made 
for the NOESY spectra of PY, 9AA and Atto 495 (Figures A.7, A.8, A.9). Overall, this suggests that all of 
these small, positively charged dyes intercalate rather than participate in specific adaptive aptamer 
67 
 
binding. These observations also indicate that selective binding of SRB-2 is only possible in the presence 
of a negatively charged ring well.  
SR101 and AR101-B differ slightly in that the para sulfonate is replaced by biotin, and the other 
is missing entirely. Little difference is observed in the Kd for complexation with SRB-2 between these two 
dyes, despite a marked change in the electrostatic potential map. This suggests that the negative charge 
often found in the ortho position of these dyes plays no significant role in binding and likely interacts 
mostly with solvent, similar to the phosphate groups of ATP when bound to the ATP aptamer [117]. 
Aside from the biocytin group, B-TMR and SR differ in that B-TMR has a carboxyl group instead of a 
sulfonate on the single ring and diaminomethyl groups in place of diaminoethyl groups. Based on the 
SRB-2 binding observations with AR101-B and SR101, the difference in charged groups is expected to 
have little impact. However, despite B-TMR being more structurally similar to RB, the Kd for 
complexation with SRB-2 is more similar to that found for SR using ITC. This could be due to the 
presence of the smaller methyl groups in B-TMR versus ethyl groups in SR, however this cannot be 
concluded for certain as these Kd values were determined using different methodologies (SPR vs. ITC). 
 
2.6.4 Size and Shape of the Alkyl Groups are Crucial for Binding 
Concerning the nature of these alkyl groups, the SRB-2 aptamer has specific requirements. 
Fluorescein was used in a counter selection step during SELEX [37], resulting in the removal of 
sequences capable of binding to a dye with electron-withdrawing oxygens rather than the tertiary 
amines found in SR. The resulting consensus sequence would be expected to have electrostatic 
interactions with the RNA backbone preventing the correct folding of the aptamer in this case. Dyes 
such as Xylene cyanol FF (XC) and Patent Blue V (PBV) are missing the bridging oxygen in the middle ring, 
resulting in a propeller-like structure rather than a planar structure. It is probable then that stacking 
interactions are much less ideal in this case due to its freedom of mobility and steric hindrance by the 
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additional methyl groups adjacent to the aminoethyl groups. Interestingly, PBV has been shown to bind 
SRB-2 weakly [76], indicating a molecule of this shape can fit in the SRB-2 binding site. However, XC 
cannot bind, and the only difference is that PBV has the traditional diaminoethyl groups while XC has 
aminoethyl groups, which are secondary amines. Rhodamine 6G has the same aminoethyl groups as XC 
and also cannot bind, despite being planar like SR. Rhodamine 110 has primary amines and likewise is 
unable to bind. This suggests that, despite the similarities in electron density, SRB-2 is selective for 
tertiary amine groups. This fact indicates that with respect to SR101, the steric hindrance of the bulky 
ring groups is the limiting factor in binding, likely preventing the aptamer from coming in close enough 
contact to the negative charges for them to have an effect on binding affinity. Supporting this idea are 
the association and dissociation rates also obtained in LSPR experiments. As seen in Table 2.5, the 
difference in binding constant between TMR-B and AR101-B clearly comes from the association rate. 
The aptamer’s structure may have to adapt and strain further to allow AR101-B to bind compared to 
TMR-B, resulting in a slower rate of binding. The ligands are released by the aptamer at a comparable 
rate due to their relative similarity in charge distribution. 
 
2.6.5 SRB-2 Binding is Salt and Concentration Dependent 
Adaptive binding of aptamers is commonly dependent on counter-ions for stabilization of the 
negatively charged backbone of RNA. In order to investigate this further, ITC experiments were 
conducted in the absence of divalent cation. Binding was not observed under these conditions for SR, 
SR101 or RB. Some weak binding was observed for TMR, which is likely due to its positive charge 
interacting considerably more favourably with the RNA backbone than the other dyes, all of which 
contain negative charges. However, NMR titrations show ~1:1 binding in the absence of magnesium, 
indicating that a ~10 to 50 fold higher concentration of aptamer is enough to push the system to bind.  
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ITC experiments were also run at 500mM KCl (Table 2.4) to observe the ability of excess 
monovalent cations to assume the role of divalent cations. Binding was observed in the presence of high 
KCl for all ligands but with lower affinity than with magnesium present. This indicates that a high enough 
concentration of monovalent cations can result in enough positive charges being present in appropriate 
positions to assume the role of divalent cations in ligand binding, albeit less effectively. 
 
2.6.6 SRB-2 Lacks any Easily Discernable Tertiary Structure Elements  
In attempts to further characterize the structure of SRB-2 and solidify the categorization of its 
ligands into two distinct groups, DSC and CD experiments were performed.  
The rationale behind the DSC experiments was to see if the tertiary structure formed upon 
ligand binding was able to increase the melting temperature (Tm) of SRB-2 when bound to ligands 
involved in adaptive binding versus intercalation. Results from isotherms of bound and unbound SRB-2 
(Figure 2.20 A) clearly show that the secondary structure of the aptamer melts at 90 °C. This is relatively 
high for nucleic acids and can certainly be attributed to the presence of the highly stable UUCG 
tetraloop. In comparing the isotherms of SRB-2 bound the SR and TMR (Figure 2.20 B), their tertiary 
structures unfold at approximately 67 °C and 69 °C, respectively. They also have similar heat capacities, 
with TMR’s being slightly higher. Based on knowledge from other methodologies, we concluded that the 
slightly higher Tm and heat capacity of TMR is very likely due to electrostatics rather than formation of 
stable tertiary structures, and therefore, this line of investigation was abandoned due to the lack of 
obvious structural differences. 
CD was similarly used to assess tertiary structure formation upon SRB-2 binding of the ligands SR 
and TMR. An ellipticity change is observed in Figure 2.22 A that expectedly indicates stabilization of the 
aptamer structure when bound to either SR or TMR [195]. However, the general topology of unbound 
SRB-2 and the two bound conformations are quite similar to each other and are analogous to literature 
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CD spectra for double-stranded nucleic acids [196,197]. This indicates that no significant tertiary 
structure elements such as a G-quadruplex exist in this sequence before or after ligand binding. UV 
absorbance spectra are also nearly identical for the three samples tested (Figure 2.22 B). Small 
differences in SR compared to TMR and unbound can likely be attributed to minute differences in the 
aptamer structure or to the ligand itself.   
It can be concluded from these methodologies that notable tertiary structure elements such as 
G-quadruplex are not responsible for ligand binding of SRB-2. 
 
2.7 Conclusion 
In summary, we have shown that an ideal ligand for SRB-2 has several requirements. For optimal 
binding affinity, the amine groups must have small alkyl constituents that are able to participate in 
hydrophobic interactions but are not so large as to interfere with the aptamer’s binding conformation. 
The absence of a negative charge in the para position on the single ring also contributes positively to 
binding affinity. A negatively charged group on the ortho position has little impact on binding affinity but 
is required for selective binding of SRB-2 as repulsive interactions with the RNA backbone prevent these 
ligands from intercalating in base paired regions of the aptamer. As observed with AR101-B, bulky amine 
constituents can also confer selective binding of SRB-2 in the absence of this negative charge but at a 
considerable loss of binding affinity. Taking these observations into account, rhodamine B was shown to 
be the SRB-2 ligand with the best properties among those tested. We also show that SRB-2 binding is 
strongly dependent on divalent cations at low concentration and that its binding mechanism does not 








Chapter 3: Characterizing the Solution Structure of the Sulforhodamine 
B Binding RNA Aptamer by NMR Spectroscopy 
 
All experiments outlined in this chapter were performed and analyzed by the candidate. 
 
3.1 Chapter Abstract 
Aptamers are valuable tools in a variety of biotechnological applications, ranging from 
biosensing to in vivo cell imaging. Studying the structure of these molecules can further our 
understanding of the structure and kinetics of nucleic acid-ligand binding. The SRB-2 aptamer is a 
polyanionic molecule that binds a ligand with an overall negative charge, making this an interesting 
binding mechanism to characterize. Here, we show NMR experiments performed on the SRB-2 aptamer 
with the goal of working towards a solution structure. An unlabelled sample, as well as three samples 
selectively labelled on a single type of nucleotide (A, C and U) were synthesized and analyzed using a 
variety of pulse programs. These included multiple variations of HSQC, NOESY, TOCSY and COSY 
experiments. Some partial assignments were made, but ultimately the data obtained were not sufficient 
for unambiguous assignment. This structure remains an interesting one to study, and initial NMR studies 
show some promise, especially if more optimal experimental conditions are found.  
 
3.2 Introduction 
Structure determination of biomolecules is invaluable to researchers as it can reveal the 
intricacies of how these molecules move, fold, function and interact with other molecules. With respect 
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to aptamers, for example, this information can then be used to elucidate unknown binding mechanisms 
and to rationally design mutations and/or ligands. This may result in optimization of the binding 
properties discussed in Chapter 2 for use in desirable applications such as biosensing or cell imaging. As 
discussed in Chapter 2, the SRB-2 aptamer is of particular interest due to both its ligand promiscuity and 
ability to bind ligands with an overall negative charge. For these reasons, we set out to investigate the 
structure of this aptamer using NMR spectroscopy.  
NMR spectroscopy is a powerful tool to study biomolecules in solution. As shown in Chapter 2, it 
is quite useful for mapping structural changes in varying solution conditions. It will also be shown in 
Chapter 5 that it is a helpful technique to use, particularly in combinations with others like CD, to assess 
the presence of specific sequence motifs such as G-quadruplex or triplex DNA [198,199]. But perhaps 
most valuable is its ability to determine high-resolution 3D structures, offering an alternative, and often 
complementary, method to x-ray crystallography [200,201]. NMR is particularly useful for studying 
molecules that are poor candidates for crystallization, such as those that are flexible or have 
unorganized intermolecular interactions. Proteins have a diverse set of functional groups that can result 
in charge complementarity between molecules, while nucleic acids are primarily covered in negative 
charges which results in intermolecular repulsion. This makes it difficult to pack them into an 
appropriate crystal lattice structure for x-ray analysis [202]. For this reason, a much higher percentage of 
nucleic acid structures (37.8%) are determined by NMR compared to proteins (7.5%) and protein-nucleic 
acid complexes (18.0%) as shown in Table 3.1 [203]. Cryo-EM is another methodology for structure 
determination that is currently on the rise [204]. It has proven quite powerful, particularly in studying 
membrane-bound proteins, which previously lacked a reliable methodology for structure determination. 
It is a promising technique for studying nucleic acids as well, though only a handful of structures are 
available thus far [203]. NMR is the technique of interest in this case, so some assignment strategies will 
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be reviewed below. The general scheme for this overview is loosely based on volume 338 of the 
Methods in Enzymology book series [205].  
 
Table 3.1: PDB Statistics by Molecular Type as of September 21st, 2021 [200]. 
Molecular Type X-ray NMR EM Multiple Neutron Other Total 
Protein (only) 141397 11638 5718 176 70 32 159165 
Protein/Oligosaccharide 8370 31 913 5 0 0 9319 
Protein/NA 7468 271 1943 3 0 0 9685 
Nucleic acid (only) 2362 1369 53 8 2 1 3802 
Other 149 31 3 0 0 0 183 
Oligosaccharide (only) 11 6 0 1 0 4 22 
 
 A critical type of experiment in the characterization of 3D molecule structures is nuclear 
Overhauser effect spectroscopy (NOESY). Through-bond couplings (J-coupling) are studied in most NMR 
experiments, but NOESY takes advantage of 1H-1H dipolar couplings. This type of coupling provides a 
means for cross-relaxation to occur, resulting in the detection of resonances that are close in space, 
regardless of connectivity [206,207]. Peak intensity, I, can then be correlated to inter-proton distance, r, 
by the sixth inverse power, (I α 1/r6), which in turn can be used to set distance restraints for structure 
calculations [208]. NOESY experiments are extremely useful for studying tertiary structures of 
biomolecules or receptor-ligand interactions because it allows resonances that are very far apart in the 
molecule or in different molecules entirely to be correlated.  
With respect to structure determination of nucleic acid-ligand complexes, the first step is to 
prepare a sample of the sequence fully bound to ligand. To determine a high-resolution structure, there 
must be only a single conformation present to prevent spectral overlap and ambiguity in the resonance 
assignment. This is done by titrating of the sequence of interest with aliquots of lyophilized ligand. 1H 
NMR spectra are acquired for each aliquot and the titration continues until changes in the imino region 
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of the spectrum are no longer observed upon addition. A chart illustrating the chemical shift ranges of 
nucleic acids is shown in Figure 3.1.  
 
Figure 3.1: Proton chemical shift ranges of nucleic acids. 
Blue and red boxes show the approximate literature chemical shift ranges for each type of proton in 
RNA and DNA. A- Adenine, G- guanine, C- cytosine, T- thymine, U-uracil. 
 
Resonance assignment in unlabelled nucleic acids is possible but generally limited to smaller 
molecules. This type of assignment involves the contemporary through bond experiments DQF COSY 
[209] and TOCSY [193], as well as through-space NOESY [191] experiments. One generally begins by 
acquiring a NOESY in 90% H2O/10% D2O [210], since the sample is titrated in these conditions to observe 
changes of the exchangeable protons. This NOESY spectrum is used to establish base-pairing by 
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assigning imino-imino and amino-amino NOEs. It is also used to assign imino to base and imino to sugar 
correlations. The sample is then lyophilized, resuspended in 100 % D2O and NOESY, TOCSY and DQF 
COSY experiments are acquired. The D2O experiment is the primary source of sequential assignments. 
This is done by ‘walking’ through the H6/H8-H1’ region in the NOESY, as described in Figure 3.2. The 
H6/H8-H2’ region is also useful for this purpose, particularly in DNA where H2’ and H2” are well resolved 
from the other sugar protons. Methyl groups from thymine residues may also aid in the sequential 
assignment of DNA. TOCSY and/or COSY experiments allow the identification of C/U base spin systems 
(H5/H6) that also appear in this region. TOCSY and COSY are also used to identify sugar spin systems and 
provide information about sugar puckering. Lastly, 31P experiments may be performed on unlabelled 
samples since this isotope, which has the highest natural abundance, is an NMR-active nucleus. These 
experiments, usually heteronuclear correlation sequences (HETCOR) [211], are used to confirm or 
extend sugar spin systems and assign phosphorus resonances. In short sequences, the experiments 
listed may be sufficient for structural determination. However, in longer sequences, the spectral overlap 




Figure 3.2: Important interactions in RNA backbone assignment. 
The NOEs used to ‘walk’ between sugars and bases (H1’-H6/H8) are shown with red arrows. The H5-H6 
TOCSY cross-peaks are shown with green arrows. These signals are used to differentiate pyrimidines 
from purines in the NOESY walk. Based-paired regions of RNA can be sequentially assigned using imino-
imino interactions between stacked bases. An example of this type of interaction is shown with a blue 
arrow. 
 
Isotopic labelling with 13C  and 15N is an extremely powerful method for deconvolution of more 
complex spectra, particularly for RNA. The enzymatic synthesis of RNA by T7 RNA polymerase allows for 
simple incorporation of isotopically labelled nucleotide triphosphates which can be isolated from E.coli 
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cells grown on 15N ammonium chloride and 13C glucose, for example. This allows for simple, uniform 
labelling of single or multiple nucleotide types. Labelling of DNA is not so straightforward due to the lack 
of viable precursors readily available for solid-phase phosphoamidite chemistry, though it does have the 
advantage of labelling by position rather than being limited to the type of nucleotide. SRB-2 is an RNA 
aptamer, so we will focus on RNA methodologies here.  
As indicated above, isotopically labelled nucleoside triphosphates are incorporated into RNA 
sequences via in vitro transcription. As a result, any combination of the four bases may be labelled in a 
given synthesis. Because the ligand titration is performed in water, it is generally most efficient to run all 
experiments that are required to be in H2O first, then lyophilize and switch over to D2O. For this reason, 
exchangeable proton/nitrogen correlations are generally acquired first.  
2D 1H-15N-HSQC experiments [212,213] are used to correlate imino (G N1H, U N3H) and amino 
(A N6H2, C N4H2, G N2H2) protons to their respective nitrogen atoms. A 2D HNN COSY [214] or variation 
thereof may be used to directly identify any hydrogen bonds involving two nitrogen atoms. Sequential 
assignment of exchangeable proton/nitrogen resonances in based paired regions of RNA may be 
accomplished using 3D 1H-15N -NOESY-HSQC [213] type experiments. Edited versions of 3D 1H-15N-
NOESY-HSQC may be used to correlate imino and amino resonances to non-exchangeable protons. This 
can also be done using a through bond experiment such as HCCNH or HCCNH-TOCSY [215].  
Once information about exchangeable resonances is acquired, the next step is the sequential 
assignment of sugar-base correlations. There are two main strategies for doing this, NOE-based 
assignment and through-bond coherence transfer assignment. NOE-based assignment involves filtered 
and edited type NOESY experiments, where protons attached to 13C are either filtered out or selected 
for, respectively. Filters can be applied in both F1 and F2, resulting in experiments selecting for protons 
that originate on a specified nucleus, end up on a specified nucleus or both. These filters are most often 
applied to 2D NOESY [191] or 3D 1H-13C-HSQC-NOESY pulse sequences. With a fully labelled sample, a 3D 
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1H-13C-HSQC-NOESY can also be used to distinguish NOEs originating from the (unlabelled) ligand. The 
through-bond approach involves triple resonance experiments that allow correlation between the base 
and sugar of each nucleotide, including HCN [216], HCNH [217], HCNCH [218] experiments. HMBC [219] 
may also be used to correlate H2/H8 protons in purines. Sequential sugar-phosphate assignments may 
be completed using 1H, 13C, 31P experiments such as HCP, PCCH-TOCSY and HPHCH [220–224].  
After sequential assignment, the next step is to assign carbon resonances and the remaining 
sugar protons. 2D 1H-13C-HSQC [212,213] experiments are used to identify carbon-proton spin systems, 
and remaining carbon and proton resonances, particularly those in the sugars, are assigned using either 
HCCH-TOCSY [225] or HCCH-COSY [226] experiments. Finally, 31P resonances are assigned via HETCOR if 




Figure 3.3: Heteronuclear through-bond NMR experiments used for resonance assignment of nucleic 
acids. 
The transfers of magnetization in each type of experiment are shown by arrows. Relevant nuclei are 
colored to match the name of their pulse sequence. A) HNN-COSY [214], which correlates the hydrogen 
bond donor imino group in either G or U to the hydrogen bond acceptor nitrogen in C or A (shown in red 
for G-C base pair). Exchangeable protons can also be correlated to non-exchangeable protons in HCCNH 
or HCCNH-TOCSY [215] experiments. An example of an H5-H3 correlation in cytidine is shown in blue. B) 
HCCH-TOCSY [225] (shown in red) and COSY [226] experiments are used to assign sugar spin systems. 
Pulse programs for detection of 13C are also available. C) Correlation of sugar to base resonances may be 
achieved using triple resonance experiments such as HCNCH [218] (shown in red) and HCNH [217] 
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(shown in blue, overlap with HCNCH is shown in purple). It is also possible to obtain the same 
information from two separate HCN [216] experiments, one optimized for the ribose and the other 
optimized for the base. D) HCP [221–223] experiments correlate H3'/C3', H4'/C4' on the 5' side and 
H4'/C4' and H5',H5''/C5' resonances on the 3' side of a given phosphorus atom. An HCCP-TOCSY 
[220,221,224] experiment may be used to extend assignments to the rest of the ribose.  
 
This is by no means a step-by-step guide, as the experiments required to assign RNA will vary 
significantly with sequence complexity. There are also many other pulse sequences available that may 
be useful depending on gaps of information that need to be filled for a particular project. Also, it is 
important to note that the types of labelled sequences synthesized will affect the relevant pulse 
programs that one may use. A common strategy is to acquire spectra with fully labelled 13C, 15N and/or 
15N samples and either single or dual nucleotide 13C, 15N labelled samples to allow unambiguous 
assignment of resonances belonging to each type of base. That being said, isotopic labelling is rather 
expensive, so it is generally the goal of a researcher to assign the sequence with as few labelled samples 
as possible. 
 Another valuable labelling technique not covered above is deuterium (2H) labelling. For nucleic 
acids, this generally refers to either site-specific ribose (D3’, D4’, D5’ and D5”) or base 
deuteration/enrichment of perdeuterated bases. Partial deuteration of the ribose simplifies a NOESY 
spectrum significantly, as removing spins unimportant for sequential assignment drastically reduces the 
amount of dipolar relaxation experienced by the other protons, decreasing signal linewidth [227]. Due 
to the established lability of H8 protons, particularly under alkaline conditions, it is possible to either 
selectively deuterate fully protonated purine bases or selectivity proton-enrich perdeuterated bases 
[228]. Procedures have also been reported for H5 or H6 deuteration with pyrimidine 5′-
monophosphates [229,230]. This type of labelling results in relevant NOESY regions, including only 
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signals from particular bases, thereby simplifying assignment. Deuterating the H5 or H6 position has an 
added linewidth reduction benefit, similar to site-specific ribose labelling. This is due to a combination of 
large dipolar and scalar couplings between these positions [231].  
 In our work with the SRB-2 aptamer, we acquired the standard homonuclear spectra listed 
above, as well as some of the heteronuclear spectra discussed with three different single-nucleotide 13C, 
15N samples (A, C, U). Some regions of these spectra had unusually broad peaks, which is generally the 
result of chemical exchange. In fast chemical exchange, only one signal that represents the average of 
the contributions from each environment is observed. In slow chemical exchange, multiple sharp signals 
for each environment are observed. In intermediate exchange, one or multiple broad peaks may be 
observed. Because this is an aptamer-ligand complex, the chemical exchange and hence broad lines 
being observed is likely due to the presence of at least one additional aptamer conformation. This, 
among other reasons, resulted in the spectra listed above being of insufficient quality to assign 
unambiguously. 
 
3.3 Materials and Methods 
3.3.1 Preparation of RNA Samples and Dyes 
The SRB-2 RNA was synthesized enzymatically using a T7 RNA polymerase and a double-
stranded synthetic DNA template (Integrated DNA Technologies, Inc., Coralville, Iowa). The sequences 
used were as follows: 
SRB-2 template DNA:  
5’-GGGACCTGAGGCGGTTAACCTTGCGCCTCTCCATCATCGCCGAAGCGAGGTCCCTATAGTGAGTCGTATTA-3’ 





A single base-pair substitution in the original sequence of SRB-2 (A3 –> G3 and U52 –> C52) was 
introduced to increase transcriptional yield, as the presence of three consecutive G residues at the 
beginning of sequence is thought to increase initiation of transcription [187,188]. RNA was transcribed 
using the recipe listed in Table 2.1, and labelled samples were synthesized by incorporating the 
respective labelled nucleotide triphosphates in place of their unlabelled version. Single nucleotide 
labelled samples were synthesized with A, C and U. The RNA was purified on a 10% Urea PAGE gel and 
the band containing the aptamer was cut out. The RNA was eluted from the gel by crush & soak in 
300mM NaCl or by electroelution. This was followed by clean-up on a HiPrep 16/10 DEAE FF anion-
exchange column (GE Healthcare, Uppsala, Sweden) and desalting on a HiPrep 26/10 Desalting column 
(GE Healthcare, Uppsala, Sweden). The RNA was precipitated with 70% ethanol prior to running each 
column. Pure samples obtained from the desalting column were then lyophilized and dissolved in 500μL 
of 10 mM potassium phosphate and 10 mM KCl (90% H20/10% D2O). 
 
3.3.2 NMR Experiments 
Lyophilized aliquots of Sulforhodamine B (Life Technologies, Eugene, OR) were added to the 
90% H20/10% D2O samples to titrate the RNA to slightly above a 1:1 ratio. Once experiments examining 
exchangeable resonances were performed, the samples were dried by lyophilization and re-dissolved in 
500 μL of 99.996% D2O (Cambridge Isotopes) to perform experiments on non-exchangeable resonances. 
All spectra were collected on a Bruker DRX-600 spectrometer equipped with an HCN triple-resonance, 
triple-axis PFG probe. Quadrature detection for the indirect dimensions in multidimensional 
experiments was achieved using the States-TPPI method [189]. Samples in 90% H2O/10% D2O that were 
used to observe exchangeable protons were acquired at 277 K, and water suppression was achieved 
using a 11̅-spin echo [190]. As for the experiments in D2O that were used to observe non-exchangeable 
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protons, 2D NOESY [191], 2D CITY-TOCSY [193] and DQF COSY [209] were run with presaturation solvent 
suppression [192]. Double half x-filtered and F2 half x-filtered NOESY experiments [232,233] used the 
WATERGATE suppression sequence [234]. All other heteronuclear experiments had echo-antiecho 
coherence selection where solvent signals are suppressed using the inherent dephasing effects of pulsed 
field gradients [235]. All 2D NOESY spectra [191] were acquired with a mixing time of 150 ms, and TOCSY 
experiments were acquired with a mixing time of 50 ms. All NMR samples had a volume of 500 μL and 
were read in standard 5 mm NMR tubes. The labelled C sample was an exception with a volume of 200 
μL and was read in a 5mm Shigemi tube with 8mm bottom matched to D2O. Relevant pulse programs 
can be found in Appendix B. 
 
3.4 Results 
3.4.1 Homonuclear NMR Experiments 
As discussed in Chapter 1, aptamers are known to use an adaptive binding mechanism [117–
122]. This means that they undergo a significant conformational change upon binding their ligand. For 
this reason, the first step of the NMR studies was to titrate an SRB-2 sample with SR. This was done by 
preparing three lyophilized aliquots of ligand that each contained enough ligand to bind one-third of the 
RNA sample. 1H NMR spectra were acquired for the RNA sample on its own (Figure 3.4 D) and after each 
aliquot of SR was added (Figure 3.4 A-C). The imino range of these spectra is shown in Figure 3.4 
because these protons have the highest degree of variation in NMR when tertiary structure is formed or 
altered. These resonances can exchange with the solvent and have inherently broad lines as a result. 
They are also mostly unobservable in NMR in the absence of hydrogen bonding. In adaptive binding, the 
aptamer folds tightly around the ligand. This results in more opportunities for imino protons in single-
stranded regions to hydrogen bond with other parts of the molecule and protects imino protons in 
general from being exposed to solvent. Therefore, observing new peaks forming and/or existing peaks 
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sharpening in this region is a good way to observe changes in nucleic acid structures upon binding 
ligands. For SRB-2, it was observed that the linewidths of the peaks decreased throughout the titration, 
and clear changes in chemical shift and intensity of peaks could be identified. This suggests a change in 
conformation is occurring upon ligand binding.  
 
Figure 3.4: 1D titration of 1 mM SRB-2 with SR. 
Imino proton range showing the change in structure upon binding of the ligand in three aliquots. A) SRB-
2 fully bound, B) SRB-2 two-thirds bound, C) SRB-2 one-third bound, and D) SRB-2 completely unbound. 
 
 While the sample was still in 90% H2O/10% D2O, a 2D NOESY was acquired (Figure 3.5). Initially, 
NOESY experiments may be useful in assessing the likelihood of assignment based on the number of 
NOEs that are present and their resolution. Additionally, folding simulators such as UNAfold [236] are 
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often used to predict secondary structure formation in nucleic acids and looking at the number of G and 
U imino resonances present may give an indication of whether or not predicted stems are forming. 
Ultimately, the NOESY in 90% H2O/10% D2O is used to assign NOEs involving imino and amino protons.  
With respect to SRB-2, a significant number of NOEs from each imino proton were observed, 
even at lower RNA concentrations. Partial assignments of the stem regions were made from these NOEs, 
including unambiguous assignment of the UUCG tetraloop as shown in Figure 3.5 B. After the acquisition 
of this experiment, the sample was lyophilized and transferred into D2O.  
 
 
Figure 3.5: NOESY of 1.8 mM SRB-2 bound to SR in 90% H2O/10% D2O. 
A) Full spectrum. B) Imino-to-imino region. Assignments for the UUCG tetraloop determined in Chapter 





Recalling the initial titration, a clear change in conformation was observed. However, we must 
be sure that this is a single conformation and that an equilibrium of multiple conformations is not what 
was observed. When multiple conformers are present, the resulting overlap renders multidimensional 
spectra unassignable. In order to determine whether or not SRB-2 was in a single bound conformation, a 
TOCSY in 100% D2O was acquired (Figure 3.6). Cytosine and uridine bases have H5 and H6 protons, 
giving rise to a strong cross-peak in TOCSY experiments due to the 3-bond j-coupling. Therefore, the 
number of H5-H6 cross-peaks observed in a TOCSY is correlated to the number of U and C residues in 
the sequence. If significantly more peaks are observed, then there a likely multiple conformations 
present. For example, in the SRB-2 spectrum, approximately 32 peaks were counted in this region. There 
are 16 cytosine and 9 uridine residues. Therefore, the number of peaks observed exceeds the expected 
number, which indicates that multiple conformations are likely present. Having a single conformation 
present is generally a required condition for assignment. Due to several of these peaks being 
substantially weaker than most, we carried on with NMR experiments and classified these peaks as 





Figure 3.6: TOCSY of 0.6 mM SRB-2 bound to SR. 
A) Full spectrum. B) Close-up of the H5-H6 region. Strong peaks that are likely from the dominant 
conformation are marked as red, and weaker ones from other conformations are marked as blue.  
 
 A DQF COSY was acquired as well (Figure 3.7), which provides similar information to the TOCSY 
with respect to H5-H6 cross-peaks. The TOCSY, however, tends be easier to resolve in this respect due to 
the peaks being in-phase. Because of the antiphase multiplet structure observed in COSY [237], 
destruction of overlapped, opposite phase signals is possible, resulting in more difficult assignment. 
However, COSY experiments are extremely valuable when doing structure calculations because of the 
information they provide regarding J-coupling constants. For example, the presence and magnitude of  
3JH1′ – H2′ and 3JH3′ – H4′ couplings indicates the type of sugar pucker that a particular residue has adopted 
(C3′-endo, C2′-endo or an intermediate) [238]. In this spectrum, 22 H5-H6 cross-peaks were counted. 
This is less than the expected 25, but due to the antiphase multiplet structure, it is possible that some of 





Figure 3.7: DQF COSY of 0.6 mM SRB-2 bound to SR. 
Positive peaks are shown in black and negative peaks are shown in red. 
 
Now that the sample was in D2O, a second NOESY was acquired, this time optimized for the 
chemical shift range of non-exchangeable protons in the RNA and ligand (Figure 3.8). Non-exchangeable 
protons are plentiful in nucleic acids, resulting in the NOESY in D2O containing a vast amount of 
information. In short sequences, residues are sequentially assigned using a sequential walk in the 
H6/H8-H1’ region of the spectrum. The location and orientation of the sequence in this assignment 
process is determined with the help of the TOCSY as it highlights C and U residues. Once the backbone 
sequence has been determined, assignments are extended throughout the ribose, resulting in a large 
number of NOEs to be used in structure calculations. Therefore, with regards to short oligonucleotide 
sequences, the NOESY can be responsible for the overwhelming bulk of assignments. This highlights the 
significance of acquiring a high-resolution NOESY spectrum in D2O. In larger sequences such as SRB-2, 
the overlap is significant, and unambiguous sequential assignment using the base-sugar walk is not 
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possible. However, the NOESY is still critical as other experiments such as filtered/edited NOESYs are 
often overlayed on it for assignment. The spectrum acquired for SRB-2 is of decent quality and many 
strong NOEs are present, indicating that the SR-SRB-2 complex is highly structured. However, there are 
regions in this spectrum with broad peaks. Some of these may be a result of overlap, but this also 
suggests, like the TOCSY, that there is some chemical exchange happening here.  
 
Figure 3.8: NOESY of 1.8 mM SRB-2 bound to SR in D2O. 
A) Full spectrum. B) Close-up of the H1’ to H6/H8 region. Mixing time: 150ms.  
 
SRB-2 was originally selected using a buffer that contained MgCl2, so in an attempt to reduce the 
chemical exchange observed in Figure 3.8, we acquired a NOESY in D2O that contained 2 mM MgCl2 
(Figure 3.9). Some minor changes in the spectrum were observed when compared to the spectrum 
acquired in the absence of MgCl2, but this did not help significantly with the problem of spectral overlap. 
MgCl2 was not used in future experiments because despite its role as an important cofactor, Mg2+ is also 





Figure 3.9: Effect of Mg2+ on NOESY of 0.8 mM SRB-2. 
A) H1’-H6/H8 region of NOESY in the absence of Mg2+ B) H1’-H6/H8 region of NOESY with 2 mM MgCl. 
Mixing times: 150 ms. 
 
In another attempt to reduce the amount of chemical exchange observed, we took a cue from 
Chapter 2 and acquired a NOESY in D2O of SRB-2 bound to the best ligand, RB (Figure 3.10). This 
spectrum looked near identical to the one with SRB-2 bound to SR in Figure 3.8, albeit with a slightly 




Figure 3.10: H1’-H6/H8 region of NOESY in D2O of 1.3 mM SRB-2 bound to RB. 
A significant degree of spectral overlap is observed even when a ligand with higher affinity, RB, is used in 
place of SR. Spectrum was acquired with 150 ms mixing time.  
 
In addition to NOEs from the RNA, the intra- and inter- molecular NOES from the ligand are also 
clearly observed in Figure 3.8. In order to determine which signals in the NOESY are coming from the 
ligand and which cross-peaks involve interaction with the RNA, a TOCSY was acquired for 
sulforhodamine B (Figure 3.10). There appear to be a number of NOEs between the ligand and the RNA, 
and this is especially obvious with the ethyl groups from the ligand, as there are no resonances in RNA 




Figure 3.11: TOCSY spectrum of 1 mM sulforhodamine B. 
This spectrum was acquired with a mixing time of 50 ms. Aromatic protons of SR are labelled in red and 
their locations on the ligand are indicated on the structure to the right. 
 
3.4.2 Homonuclear NMR Experiments Without Ligand 
In an effort to probe the native secondary structure of SRB-2, a NOESY in D2O (Figure 3.11 A) and 
a TOCSY (Figure 3.11 B) of SRB-2 in the absence of ligand were acquired. Due to the adaptive binding 
nature of aptamers, they tend to lack a significant amount of tertiary structure in the absence of ligand. 
It is therefore likely that only protons in structured (double-stranded) regions of the aptamer are 
observable under these conditions. This could potentially be useful in assignments by helping to 
distinguish residues that are in the stem regions of the RNA. These experiments are also very convenient 
to run as they are simply acquired using a sample that will later be titrated with ligand for further study. 
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Unfortunately, the number of TOCSY H5-H6 peaks observed in the SRB-2 spectrum did not match the 
number of C and U residues in base paired regions and the variance in the intensity of signals was quite 
large, which significantly limits the practicality of this experiment. In the NOESY spectrum acquired in 
D2O, similarly underwhelming results were obtained. An obvious reduction in the quantity of peaks was 
observed as expected. However, the signals remained somewhat overlapped and many are clearly 
TOCSY peaks. For a few peaks, it may be inferred that the residue they belong to is in a base-paired 
region, but ultimately there is not a lot of information provided here. 
 
 
Figure 3.12: NMR spectra acquired on 0.5 mM unbound SRB-2. 
A) Close-up of the H1’-H6/H8 region of the NOESY spectrum in D2O. B) Close-up of the H5-H6 region of 
the 2D CITY TOCSY.   
 
3.4.3 Heteronuclear NMR Experiments with Single-nucleotide Labelling 
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As discussed above, spectral overlap is great in sequences as large as SRB-2 and homonuclear 
experiments are not sufficient for structural determination. Therefore, we prepared isotopically labelled 
samples to gain additional information. Three samples were prepared, and each had a single type of 
nucleotide fully 13C and 15N labelled (i.e. all nitrogen and carbons atoms in the base and in the intra-
residue sugar). These are henceforth denoted as [13C 15N]-Ade, [13C 15N]-Cyt and [13C 15N]-Ura to 
represent the samples where adenine, cytidine and uridine are labelled, respectively.  
 
3.4.3.1 HSQC Experiments 
The first experiments acquired with each sample were two 13C HSQC experiments, one 
optimized for H1’ and the other for aromatic protons. These spectra are used to identify sugar carbon 
spin systems and proton/carbon aromatic spin systems, respectively. These spin systems are assigned 
using 3D HCCH-TOCSY/COSY experiments. Proton chemical shift information, particularly with respect to 
the aromatic protons, can also be used to aid in NOESY assignment. Spectra for the [13C 15N]-Ade sample 
are shown in Figure 3.12. The experiment optimized for the sugar is shown in panel A. H2 and H8 
aromatic proton regions from the aromatic optimized experiment are shown in panels B and C, 
respectively. There are 10 adenine residues in this sequence, but despite ~10 C2-H2 peaks being 
observed, there are 16 observed for both C1’-H1’ and C8-H8. This indicates a high degree of 





Figure 3.13: 1H-13C HSQC spectra of 0.7 mM [13C 15N]-Ade SRB-2 bound to SR. 
Optimized for A) C1’-H1’ B) C2-H2 and C) C8-H8. 
 
 Spectra for the [13C 15N]-Cyt sample are shown in Figure 3.13. The experiment optimized for the 
sugar is shown in panel A. H5 and H6 aromatic proton regions from the aromatic optimized experiment 
are shown in panels B and C, respectively. There are 16 cytidine residues in SRB-2, and similar to 
adenine, exchange is observed. This is not evident for the C1’-H1’ or C5-H5 regions, but at least 18 peaks 
are observed in the C6-H6 region.  
 
Figure 3.14: 1H-13C HSQC spectra of 0.5 mM [13C 15N]-Cyt SRB-2 bound to SR. 
Optimized for A) C1’-H1’ B) C5-H5 and C) C6-H6. 
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 Spectra for the [13C 15N]-Ura sample are shown in Figure 3.14. The experiment optimized for the 
sugar and in this case, the H5, are shown in panels A and B, respectively. The experiment optimized for 
H6 is shown in panel C. For the [13C 15N]-Ura sample, a 15N HSQC in 90% H2O/10% D2O (Figure 3.13 D) 
was acquired in addition to the 13C HSQC experiments. This HSQC not only provided the exchangeable 
nitrogen-proton correlations, but the proton chemical shifts also allowed for partial assignment of 
imino-imino NOEs in the NOESY in 90% H2O/10% D2O, as shown in Figure 3.5. A significant contribution 
from structural heterogeneity is again observed in these spectra. There are 9 uridine residues in SRB-2, 
but at least 12 peaks were counted in all regions of the 1H-13C HSQCs. Six were observed in the N3-H3 




Figure 3.15: HSQC spectra of 0.9 mM [13C 15N]-Ura SRB-2 bound to SR. 
A) 1H-13C HSQC optimized for C1’-H1’ and B) C5-H5. C) 13C HSQC optimized for C6-H6. D) 1H-15N HSQC 
optimized for N3-H3. 
 
3.4.3.2 2D HCCH-COSY 
Also acquired for the [13C 15N]-Ura sample was a 2D HCCH-COSY (Figure 3.15). This experiment 
was acquired primarily to distinguish between uridine and cytidine residues in the 2D CITY-TOCSY 
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experiment. It also contains pertinent chemical shift information about sugars in U residues, however, 
3D TOCSY/COSY experiments will be required for a full assignment.  
 
 
Figure 3.16: 2D HCCH-COSY spectrum of 0.9 mM [13C 15N]-Ura SRB-2 bound to SR. 
 
3.4.3.3 Filtered and Edited NOESY Experiments 
One of the primary goals with these labelled samples was to help reduce overlap in the NOESY 
in D2O so that sequential assignments could be made. For this reason, several filtered and edited NOESY 
experiments were performed with each sample. These types of pulse programs allow for the selection 
or elimination of protons bound to isotopically labelled heteroatoms. The resulting spectra can be 
overlayed on the unlabelled NOESY spectrum in D2O, which allows for the classification of residue type. 
Two filtered NOESY spectra were acquired with the [13C 15N]-Ade sample. The first spectrum, shown in 
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Figure 3.16, is a 2D double half x-filtered NOESY, which has two separate filters, one in each acquisition 
dimension. This effectively filters out magnetization that originates and/or ends up on a proton bound 
to 13C.  
 
 
Figure 3.17: Double half-x-filtered NOESY of 0.7 mM [13C 15N]-Ade SRB-2 bound to SR. 
A) Full spectrum. B) Close-up of the H1’-H6/H8 region. Spectrum acquired with mixing time of 150 ms. 
 
 The second filtered NOESY acquired for the [13C 15N]-Ade sample is a 2D half F2 x-filtered NOESY 
(Figure 3.17). This experiment only has a filter in F2, resulting in signals that originate on an adenine 
being filtered out of the spectrum. In combination with the double half x-filtered NOESY, this may 
distinguish signals originating on an A from those ending up on an A. The spectra suffer from the same 





Figure 3.18: F2 half-x-filtered NOESY of 0.7 mM [13C 15N]-Ade SRB-2 bound to SR. 
A) Full spectrum. B) Close-up of the H1’-H6/H8 region. Spectrum acquired with mixing time of 150 ms. 
 
 A 2D half x-filtered NOESY was also obtained for the [13C 15N]-Cyt sample (Figure 3.18). 
Unfortunately, the concentration was lower, and therefore, the signal-to-noise ratio was somewhat 




Figure 3.19: Half x-filtered NOESY of 0.5 mM [13C 15N]-Cyt SRB-2 bound to SR. 
A) Full spectrum. B) Close-up of the H1’-H6/H8 region. Spectrum acquired with mixing time of 150 ms. 
 
 In addition to the 2D NOESYs, 3D edited 13C HSQC-NOESY experiments were acquired for the [13C 
15N]-Ade and [13C 15N]-Ura samples (Figure 3.18). They were both optimized for the sugar in the carbon 
dimension. These spectra can be used to identify which peaks in the NOESY in D2O are from protons in 
adenine or uridine residues which is critical in the sequential assignment of a rather large RNA molecule 
like SRB-2. The F1-F3 projections for [13C 15N]-Ade and [13C 15N]-Ura are shown in Figure 3.18 A and B, 
respectively. The signal-to-noise ratio of the [13C 15N]-Ura spectrum is significantly higher despite only 





Figure 3.20: F1-F3 projections of 3D 13C HSQC-NOESY experiments. 
A) 0.7 mM [13C 15N]-Ade SRB-2 bound to SR. B) 0.9mM [13C 15N]-Ura SRB-2 bound to SR. Spectra were 
acquired with 150 ms mixing times. 
 
3.4.3.4 HCN Experiments 
In order to correlate imino and amino resonances to non-exchangeable base protons, we also 
attempted to acquire 3D HCCNH and 3D HCCNH-TOCSY experiments with the labelled-U sample. Despite 
meticulous optimization, no accumulation of signal was observed in the FID of these experiments, so we 
were unable to acquire a spectrum with either pulse program. We also ran a 3D HCN experiment to see 
if it would be possible to correlate the N1 to H1’ and/or H6 but obtained the same unsuccessful results 







As evidenced in section 3.4, a large quantity of NMR data was obtained on SRB-2. Some nice 
quality spectra were acquired, such as the HSQC experiments, filtered 2D NOESYs with [13C 15N]-Ade and 
the 2D HCCH-COSY and 3D HSQC NOESY with [13C 15N]-Ura. From these spectra, some assignments could 
be made, however, this was far from sufficient to fully assign and calculate a structure for SRB-2. There 
were a number of obstacles encountered that prevented the completion of this project, including broad 
lines, low-resolution spectra, structural heterogeneity, low sensitivity of pulse programs, degradation of 
samples, and lack of required samples. These barriers and possible resolutions will be discussed in detail 
below. 
 
3.5.1 Linewidth and Spectral Resolution 
As discussed in 3.2, many of the spectra acquired were of decent quality. However, they were 
plagued with broad lines caused by conformational heterogeneity. It is likely that heterogenous 
sequences were being observed in these spectra. This is evidenced by the presence of two distinct types 
of peaks in many of the spectrum acquired. Some peaks appeared to be strong and sharp, likely from 
the dominant binding conformation, while some regions contained weak, broad peaks, which appear to 
be the result of structural heterogeneity. We tried to separate these peaks when attempting to assign 
the various spectra, but the amount of heterogeneity coupled with significant overlap from the large 
number of signals in a 54nt sequence made assignment difficult. It is possible that conditions may exist 
that shift the equilibrium of conformations. For example, we tried adding MgCl2, but this did not solve 
the problem as discussed in 3.4.1. 
There were also several spectra, including the 3D HSQC NOESY with [13C 15N]-Ade and the 
filtered 2D NOESY with [13C 15N]-Ura, which were of overall poor quality. Only one attempt at the 3D 
HSQC NOESY was made before the sample degraded, so we were unfortunately not able to further 
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optimize the experiment at that time. The same pulse program was run with [13C 15N]-Ura and the 
spectral resolution was much higher, so I believe that this was at least partially a result of parameter 
adjustment. It should also be noted that the concentrations of the three labelled samples were all 
different. [13C 15N]-Ade was 0.7 mM, [13C 15N]-Cyt was 0.5 mM and [13C 15N]-Ura was 0.9 mM. The fact 
that the concentration of [13C 15N]-Ura was higher may have also contributed to the difference in 
spectral resolution. This was also likely a factor with the filtered 2D NOESY with [13C 15N]-Cyt. This 
sample was the lowest concentration and was also acquired in a Shigemi tube with a sample volume of 
only 200 µL. The concentrations of all these samples are significantly lower than the 1.8 mM unlabelled 
sample. This is an inherent disadvantage of a filtered NOESY compared to an edited one, as peaks 
disappearing may be a result of lower sensitivity due to concentration rather than being filtered out due 
to the NMR-active 13C. For this reason, it is difficult to confidently extract information from the filtered 
2D NOESY with [13C 15N]-Cyt. To resolve this problem, more RNA would likely need to be produced. This 
is quite cost-prohibitive, especially when labelling is involved. Another possibility, which will be 
discussed more in Chapter 4, is the optimization of transcription initiation by changing the first 5-8 
nucleotides of the sequence. At the very least, acquisition of edited NOESYs should be prioritized over 
filtered NOESYs.  
 
3.5.2 Structural Heterogeneity 
There are quite a few possibilities for the origin of the structural heterogeneity, several having 
to do with in vitro transcription by T7 RNA polymerase. Despite its usefulness in molecular biology, T7 
RNA polymerase is known to produce a number of undesirable side products that result in careful 
analysis and purification being required. Side reactions can result in aborted products [240,241], use of 
alternative template initiation sites [242,243], polymerase slippage [244], non-templated nucleotide 
additions at the 3’ end of RNA and [187,245] and 5’ sequence heterogeneity [240,242,246].  
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 Aborted sequences and sequences varying significantly in length resulting from alternative 
initiation sites are easily removed from a sample by gel purification. However, products with 3’ and 5’ 
heterogeneity are the same length or within a couple of nucleotides. Even with high resolution gels, it is 
not always possible to separate these kinds of products. There are several possible methods that could 
be used to reduce or eliminate these side products. For example, it has been shown that using a DNA 
template with C2’-methoxyl modifications at the 5’ end can be effective in reducing these additional 
nucleotides [247]. For both 3’ and 5’ heterogeneity, it has been shown that using self-cleaving or 
cleavable tags can be highly effective in reducing side products [246]. It may also be prudent to reduce 
3’ phosphate cyclization and ensure homogeneity by incubation with T4 polynucleotide kinase–
phosphatase [248]. Of particular concern to us, it has been shown that sequences beginning with GGG 
are particularly susceptible to 5’ heterogeneity [240,242,246]. However, we had issues with low 
transcription yields with other 5’ sequences. Therefore, it would certainly be of benefit to spend more 
time optimizing the 5’ sequence for a combination of reduced heterogeneity and sufficient product 
yield. 
Another source of heterogeneity sometimes encountered in nucleic acid samples, especially at 
concentrations required for NMR spectroscopy, is dimerization. Dimerization often results when self-
complementary regions exist in a nucleic acid sequence. Based on the SRB-2 sequence, it is possible that 
one of the regions in what we will later refer to as loop 3 could do this. However, we did not observe 
any conclusive NMR evidence, such as additional NOEs consistent with this type of base pairing, that 
would support this notion. In addition, a native gel run by a former student on various SRB-2-ligand 
complexes also showed no indication of dimerization or oligomerization.   
Finally, one source of heterogeneity possible with any receptor-ligand complex is if saturation 
has not been reached. We did not include MgCl2 in the NMR despite ITC studies indicating that it may be 
required. This is due to initial NMR titrations we did in the absence of Mg2+, wherein changes in the 
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spectrum were not observed after approximately a 1:1 titration with ligand. We titrated multiple 
equivalents of the ligand initially, but this was not enough to induce any observable differences in the 
spectrum. As a result, we generally aimed for ~1.2:1 ligand:RNA in our NMR samples. It is possible that 
the absence of peak observed in ITC has to do with thermodynamics of binding in the presence of MgCl2 
rather than an actual absence of binding. A control SPR experiment without any magnesium may be 
useful to confirm this theory. Another possibility here is that other residual metal ions present may have 
taken on the role of Mg2+. However, despite not de-metalating our solutions, there was a significant 
amount of EDTA present both in the gel and anion exchange buffers, giving little reason to believe that 
this was the case. For these reasons, we believe that the 5’ and 3’ heterogeneity discussed were more 
likely to be the source of heterogeneity.  
 
3.5.3 HCN Experiments 
One of the biggest disappointments of this project was our inability to acquire any triple 
resonance experiments with our labelled samples. These experiments are desirable as they can reduce 
ambiguity in NOESY experiments, but they are not without their challenges. Spectral resolution and 
sensitivity of RNA are known to decrease significantly with increasing molecular weight [227,249], and 
these types of pulse programs involve several transfers of magnetization, resulting in significant signal 
losses. Because SRB-2 is relatively large (54 nt), and these pulse programs used several resonance 
transfers, we postulate that the sensitivity of these programs was too low to detect signal in these 
multiple-transfer experiments. If this project were to continue, I would suggest synthesizing a very short 
[13C 15N] oligonucleotide, which could be used as positive control to confirm this hypothesis and rule out 
any issues with the pulse programs themselves or relevant parameter settings. It is also worth noting 
that the console of the Bruker DRX-600 spectrometer used was replaced and the software used to run it 
was updated during the period in which these experiments were run. This may have resulted in spectra 
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of varying quality before and after the change. It may have also resulted in compatibility issues with 
some pulse programs.  
 
3.5.4 Sample Stability 
In addition to the low resolution of some spectra, there were additional spectra that we 
intended to acquire but were unable to due to degradation of samples. Hence the missing NOESY 
experiments for some samples in section 3.4. RNA is particularly susceptible to degradation due to the 
ubiquitous presence of RNases on surfaces and in reagents that are not certified RNase-free. RNase 
activity has even been observed in RNA samples frozen at -20 °C [250]. Even if much care is taken to 
avoid RNase contamination, RNA is often only stable for up to a year when frozen at -20 °C or -80 °C and 
mere days at room temperature [251–254]. Despite -80 °C storage, certified nuclease-free labware and 
reagents, and re-suspension with ultra-pure Milli-Q water, all three of the labelled samples degraded 
within weeks or months of synthesis. Unfortunately, two of these samples ([13C 15N]-Cyt and [13C 15N]-
Ura) degraded during the months of storage resulting from the provincial lockdown in the spring of 
2020.  
Although RNA degradation is sometimes out of a researcher’s control, there are a few things I 
would do differently in the future. It has been suggested in the literature, that although freezing RNA in 
an aqueous solution at -80 °C is commonplace, storage as either a lyophilized powder or ethanol 
precipitate may be more effective long-term storage techniques [251,254]. Storage in an air-tight 
container should be ensured as atmospheric humidity is known to play a role in RNA degradation [251]. I 
also took time to analyze each spectrum before running more, and I believe that more meticulous 
planning and efficient scheduling of experiments could help guarantee the acquisition of all desired 




3.5.5 Additional Resources for Assignment 
The reality is that even if a full complement of high-resolution spectra were acquired for the 
three samples studied here, it is nearly certain that more data would still be required. This would likely 
involve the uniformly labelled samples [U- 15N] and [U- 13C 15N]. It may be useful to have another single 
(or dual) nucleotide labelled sample that has guanine, since it is has not been labelled in any of our 
previous samples. It also possible that selectively deuterated samples would be required to assign the 
severely overlapped H1’-H6/H8 region of the NOESY in D2O. Unfortunately, the isotopically labelled 
nucleotide triphosphates that are required to synthesize these samples are extremely cost prohibitive. 
There are alternative paths that may somewhat decrease the price tag of these samples, such as 
preparing the nucleotides ourselves. However, this requires significant time and expertise, and the 
starting materials and enzyme cocktail required are still very expensive. In addition to the quality of 
spectra obtained, cost was a factor in the stalling of this project after the three existing samples had 
degraded.  
 
3.6 Conclusions and Future Work 
In summary, the solution structure of SRB-2 was probed using homonuclear NMR techniques as 
well as with the three single-nucleotide labelled samples [13C 15N]-Ade, [13C 15N]-Cyt and [13C 15N]-Ura. 
The major obstacle encountered was the detrimental effects of multiple conformations on the spectra. 
This resulted in an insufficient amount of quality data for the unambiguous assignment of SRB-2. There 
are a few things one could do to potentially improve quality of these spectra. There were some minor 
changes observed with low Mg2+ concentrations, so investigations with more salt concentrations may be 
useful. Spectra obtained using other ligands were not promising, however, we could also consider 
looking at SRB-2 mutants that may have a stronger equilibrium of preferred to alternative 
conformations. This includes sequences with optimized 5’ and 3’ sequences, and perhaps other 
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modifications such as C2’-methoxylation of the DNA template, or cleavable RNA tags discussed in 3.5.2. 
In terms of NMR spectroscopy, there are also methodologies available that look at molecular dynamics, 
which may provide some insight into what is happening in this system [255]. 
If we found a solution for these structural heterogeneity issues, we would likely start by 
synthesizing [U- 15N], [U- 13C 15N] and either a single or dual nucleotide labelled sample involving G. With 
these samples, we would consider replicating some of the strategies used by Duchardt-Ferner et al. who 
recently characterized the solution structure of the TMR3 aptamer bound to tetramethylrhodamine 
[129]. This aptamer is a similar size (48 nt) as SRB-2 (54 nt) and binds tetramethylrhodamine (TMR), an 
analogue of SR. The binding affinity and kinetics of TMR with respect to SRB-2 were discussed back in 
Chapter 2. With the [U- 15N] sample, we would acquire standard and long-range 2D HNN-COSY 
experiments and a 15N HSQC-NOESY. With respect to NOESYs, Duchardt-Ferner et al. similarly acquired 
3D 13C HSQC NOESYs with their selectively labelled samples [13C 15N]-Ade, [13C 15N]-Ade, Cyt and [13C 
15N]- Gua, Ura. These largely provide the same information as our single-nucleotide labelled samples. 
The major difference is we never synthesized a sample with labelled G residues, which would be useful 
to have. Another sample that would be quite useful to have is [U- 13C 15N]. With this sample, a double x-
half filtered 2D NOESY could be acquired to isolate intra-ligand NOEs. An F1-filtered 3D 13C HSQC could 
also be acquired to specifically identify RNA-ligand NOEs. Similarly, a sample bound to 13C-labelled ligand 
could also prove valuable. 
As discussed in 3.5.3, HCN experiments did not work out, and there is little motivation to pursue 
them further. If we needed to further reduce ambiguity in the NOESYs, I would suggest using at least 
one partially deuterated sample, likely with one or more nucleotides deuterated in the H3’, H4’, H5’ and 
H5” positions. Removing some of these spins would drastically reduce the amount of dipolar relaxation 
experienced by the other protons, narrowing the linewidths of their cross-peaks and therefore reducing 
overlap in the spectrum [227]. 
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As will be described in Chapter 4, we opted to pursue a ‘divide and conquer’ approach as an 
alternative to isotopic labelling. This involves designing and synthesizing various truncations of the SRB-2 
























Chapter 4: Probing the Structure of the SRB-2 Binding Aptamer 
All experiments in this chapter were performed and analyzed by the candidate. 
 
4.1 Chapter Abstract 
The SRB-2 aptamer is a polyanionic RNA that binds a ligand with an overall negative charge, 
making this an interesting system to characterize. There are various NMR strategies that can be used to 
acquire structural information, many of which involve isotopic labelling, as described in Chapter 3. Due 
to the lack of success for this sequence, we opted to pursue alternative approaches which do not, at 
least initially, require isotopic labelling. Segmental analysis, or the “divide and conquer” approach, 
involves resolving the structure of smaller pieces of a sequence then combining the information to 
produce a single, overall structure. This is a particularly useful method if there are multiple stem-loop 
segments in a sequence that may form stable structures independent of the other stem-loops. In this 
chapter, strategies for designing representative truncations are outlined. For a 16mer containing a 
UUCG tetraloop, assignments are completed, and a structure is calculated. This allowed for several 
resonances in the spectra of full-length SRB-2 to be identified. A similar study was attempted with 
another stem-loop structure (loop 3) from SRB-2. However, results obtained suggested that the 
structure of loop 3 alone is heterogenous, and in SRB-2 the structure of loop 3 is likely co-dependent 
with loop 2. These results indicate that segmental analysis beyond the UUCG tetraloop is not possible 
for this system.  
 
4.2 Introduction 
As established in previous chapters, SRB-2 is a desirable system to study due to its intrinsic 
properties including ligand promiscuity and overall negative charge. The kinetics and binding affinity of 
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SRB-2 ligands are outlined in Chapter 2. Structural NMR studies of SRB-2 bound to SR are presented in 
Chapter 3. These NMR studies involved unlabelled samples as well as the single nucleotide labelled 
samples [13C 15N]-Ade, [13C 15N]-Cyt and [13C 15N]-Ura. The spectra acquired with these samples were 
insufficient for unambiguous assignment due to structural heterogeneity, and further labelling was cost 
prohibitive, so we sought other avenues to pursue the goal of elucidating a solution structure of SRB-2.  
One such strategy that has been used to characterize numerous large RNAs by NMR is the so-
called divide and conquer approach [256–259]. This approach involves characterizing smaller pieces of 
the sequence, often individual stem-loop structures from a multi stem-loop complex. These shorter 
sequences are more amenable to assignment and are relatively inexpensive to synthesize. These smaller 
sequences potentially provide partial assignments for the overall sequence, and when all the data is 
pieced together, the result is significant deconvolution in the NMR spectra for the full-length sequence. 
This also provided an opportunity to become familiar with how structure calculations are done, as it 
became clear in Chapter 3 that a full structure determination was unlikely.  
Of course, there are several assumptions that must hold in order for this approach to work. 
First, the individual segments must be folded. Otherwise, unambiguous assignment will not be possible. 
Secondly, because we are talking about an aptamer, the segments must also retain the same structure 
in the presence and absence of ligand. It is highly unlikely that such severe truncations would retain any 
binding activity, so these experiments would be performed in the absence of ligand and if their structure 
is significantly different than when bound, assignments of the segment will not translate to the full-
length sequence. Finally, the structure of each stem-loop segment must not be dependent on the 
presence of other such segments from the full sequence. For example, if there is base-pairing between 
two distinct loop regions, then segmental analysis of the independent stem-loops will not be an 
effective method of assignment.  
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With regards to segmental analysis of the SRB-2 aptamer, the most logical place to start is the 
UUCG tetraloop. Tetraloops are highly stable secondary structure elements that often cap stems in RNA. 
They were first discovered by Woese et al. in 1983 when they noted a disproportionate number of 
hairpin loops consisting of four nucleotides in 16S rRNA [260]. The vast majority of these sequences fell 
into two main families, GNRA and UNCG. Further studies indicated that the UUCG tetraloop is the most 
stable tetraloop as a result of its high thermodynamic and structural favorability [261]. It was later noted 
by Tuerk et al. that a probable function of these biologically abundant hairpins is to organize the correct 
folding of large, complex RNA sequences [262]. Some tetraloops, including GAAA [263] and AUUA [264] 
are known to interact with receptors or proteins. However, the UUCG tetraloop lacks any known 
propensity for protein-RNA or RNA-RNA interactions [265]. For these reasons, UUCG tetraloops are 
often incorporated in aptamer sequences where possible to promote proper folding while avoiding 
unwanted interaction with the ligand or other parts of the RNA sequence. High stability and low 
interactivity are also properties that make the UUCG tetraloop of SRB-2 an ideal candidate for segmental 
NMR analysis.  
Due to its unusually high stability and experimental practicality, the structure of the UUCG 
tetraloop is well characterized. Several structures have been determined for UUCG tetraloops with 
varying short stems [266–268] and in larger RNA molecules such as a self-splicing intron [269], an 
influenza virus promoter [270], and the ATP-binding aptamer [77]. A schematic of the UUCG tetraloop is 
shown in Figure 4.1. The first solution structure was a 12-mer elucidated in 1991 by Varani et al. and this 
structure revealed many of the unusual contacts that result in the high stability of the UUCG tetraloop 
[266]. These include a U1-G4 reverse wobble base pair where G4 is in a syn conformation, a C3 base 
stack on U1 and a hydrogen bond between the N4 of C3 and a phosphate oxygen of U2 [266]. A few 
years later, the first crystal structure of the UUCG tetraloop was determined as part of a 57nt segment 
of the 16s rRNA. This structure revealed additional hydrogen bonds between O2’ of U2 and O6 of G4, 
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and between O2’ of C3 and O2 of C3, which were not observed in the solution structure. In the years 
since several NMR structures of higher quality have been reported for a UUCG 14mer as a result of 
improvements in both NMR and computational methodologies [268,271–273]. In recent studies on the 
same 14mer, the existence of a low-populated, non-native conformation where U1 and G4 do not pair 
was shown using exact NOE (eNOE) measurements and molecular dynamics simulations [273]. 
 Because of the high stability and well-defined structure of the UUCG tetraloop, this segment 
should be an ideal candidate for our segmental analysis. It provided a suitable model for learning how to 
do structure calculations and proving the efficacy of our assignment and calculation processes. We also 
designed several versions of what we termed loop 3, the other stem-loop structure in SRB-2. The goal 
for designing these segments was to optimize transcriptional yield while maintaining the structural 
integrity of the aptamer. For this reason, the binding of affinity of some modified versions of SRB-2 were 
tested to ensure that the sequence changes implemented would be representative of the original SRB-2 
sequence. In these studies, a complete NMR structure of a UUCG-containing 16mer was elucidated. 





Figure 4.1: Schematic of the cUUCGg tetraloop. 
Solid black lines indicate bonds, horizontal black lines indicate stacking interactions and purple dashed 
lines indicate hydrogen bonds. This tetraloop was inserted into the SRB-2 sequence (Figure 2.1) by the 
original authors  to promote proper folding [37]. 
 
4.3 Materials and Methods 
4.3.1 Preparation of RNA Samples and Dyes 
RNA was synthesized enzymatically using a T7 RNA polymerase and either a double-stranded 
synthetic DNA template or a single-stranded DNA template with T7 promoter. DNA was purchased from 
Integrated DNA Technologies, Inc. (Coralville, Iowa) and Eurofins (Huntsville, Alabama). The sequences 






Table 4.1: List of relevant DNA template sequences  
Aptamer  Aptamer Template Sequence 
SRB-2 5’-GGG ACC TGA GGC GGT TAA CCT TGC GCC TCT CCA TCA TCG CCG AAG CGA GGT CCC 
TAT AGT GAG TCG TAT TA-3’ 
SRB-2 
reverse 
5’-TAA TAC GAC TCA CTA TAG GGA CCT CGC TTC GGC GAT GGA GAG GCG CAA GGT TAA 
CCG CCT CAG GTC CC-3’ 
SRB-2 min 5’-GGG ACT GAG GCG GTT AAC CTT GCG CCT CTC CAT CAT CGC ACC CTA TAG TGA GTC 
GTA TTA-3’ 
L3 5’-GGG GCG GTT AAC CTT GCG CCC CTA TAG TGA GTC GTA TTA-3’ 
L3 reverse 5’-TAA TAC GAC TCA CTA TAG GGG CGC AAG GTT AAC CGC CCC-3’ 
L3A 5’-GGG ACG GTT AAC CTT GCG TCC CTA TAG TGA GTC GTA TTA-3’ 
L3B 5’-GGG CCG GTT AAC CTT GCG GCC CTA TAG TGA GTC GTA TTA-3’ 
L3C 5’-GGG AAA GGT TAA CCT TGC TTT CCC TAT AGT GAG TCG TAT TA-3’ 
SRB-2C 5’-GGG ACC TGG GAA AGG TTA ACC TTG CTT TCC CTC CAT CAT CGC CGA AGC GAG GTC 
CCT ATA GTG AGT CGT ATT A-3’ 
SRB-2D 5’-GGG ACC TGG GAA GGT TAA CCT TGC TTC CCT CCA TCA TCG CCG AAG CGA GGT CCC 
TAT AGT GAG TCG TAT TA-3’ 
UUCG 5'-GGG CGC CGA AGC GCC CTA TAG TGA GTC GTA TTA-3' 
T7 
promoter 
5’-TAA TAC GAC TCA CTA TA-3’ 
 
RNA was transcribed using the recipe listed in Table 2.1. The RNA was purified on a 10% Urea 
PAGE gel and the band containing the aptamer was cut out. The RNA was eluted from the gel by crush & 
soak in 300mM NaCl or by electroelution. This was followed by clean-up on a HiPrep 16/10 DEAE FF 
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anion-exchange column (GE Healthcare, Uppsala, Sweden) and desalting on a HiPrep 26/10 Desalting 
column (GE Healthcare, Uppsala, Sweden). The RNA was also precipitated with 70% ethanol prior to 
running each column. Pure samples obtained from the desalting column were then lyophilized and 
dissolved in 500μL of 10 mM potassium phosphate buffer and 10 mM KCl (90% H20/10% D2O). 
 
4.3.2 Fluorescence Emission Scans 
Spectra were obtained using a Spectramax M5 Multi-Mode Microplate Reader using a 100 nm 
wide scan with 1nm intervals. Samples were measured at an λex of 535 nm and an λem range of 560-660 
nm. Readings were taken in Greiner 96-well black microplates (Kremsmünster, Austria). Samples were 
prepared with 10µM dye and 40μM RNA in assay buffer (10mM HEPES, 10mM KCl and 5mM MgCl2 at pH 
7.4). Samples were incubated at 25°C for at least 10 minutes before measurement. All data was 
normalized as a percentage of the fluorescence recorded at λmax (563nm) of SRB-2 bound to SR. 
 
4.3.3 Fluorescence Titrations 
Titrations were performed on a Spectramax M5 Multi-Mode Microplate Reader with a Greiner 
384-well black microplate (Kremsmünster, Austria). Measurements were taken using a λex of 563 nm and 
a λem of 585 nm, which were determined experimentally using excitation and emission scans. Samples 
were prepared with varying concentrations of RNA (0.4-20 µM) and 1 µM SR in assay buffer (10mM 
HEPES, 10mM KCl and 5mM MgCl2 at pH 7.4). Samples were incubated at 25°C for at least 10 minutes 
before measurement. The resulting binding curves were fit using a non-linear, least squares method to 
the simple hyperbolic function: % of Fmax =  Fmax × [SR] / (Kd + [SR]) where Fmax is the maximum 
fluorescence and Kd is the dissociation constant. Raw fluorescence values were normalized to a 




4.3.4 NMR Experiments 
Once experiments in 90% H20/10% D2O were acquired, the samples were dried by lyophilization 
and re-dissolved in 500 μL of 99.996% D2O (Cambridge Isotopes) to perform experiments on non-
exchangeable resonances. Experiments in 90% H2O/10% D2O that were used to observe exchangeable 
protons were run using 11̅-spin echo solvent suppression [190]. Two-dimensional NOESY spectra [191] 
in 90% H2O/10% D2O were acquired at 277 K with a mixing time of 150 ms for both the UUCG and L3C 
samples. Experiments in D2O that were used to observe non-exchangeable protons were run with 
presaturation solvent suppression [192]. For the UUCG sample, DQF-COSY [209], a 2D CITY-TOCSY [193] 
with a mixing time of 50 ms, and NOESYs with mixing times of 80, 150 and 200 ms in 100% D2O were 
acquired at 298 K. For the L3C sample, a 2D CITY-TOCSY and a NOESY with a 240ms mixing time were 
acquired. All NMR samples had a volume of 500 μL and were read in standard 5 mm NMR tubes. All 
spectra were collected on a Bruker DRX-600 spectrometer equipped with an HCN triple-resonance, 
triple-axis PFG probe. Quadrature detection for the indirect dimensions in multidimensional 
experiments was achieved using the States-TPPI method [189]. Relevant pulse programs can be found in 
Appendix B. 
 
4.3.5 Input Restraints and Structure Calculations 
Interproton distance restraints for hydrogens were obtained from NOESY spectra of the sample 
in D2O acquired at 298 K with 80, 150 and 240 ms mixing times.  Exchangeable NOE distances were 
obtained from a 2D NOESY in 90% H2O/10% D2O at 277 K with a 150 ms mixing time. Based on 
resonance assignments from these spectra, NOE peak intensities were examined and initially grouped 
into three distinct categories: strong (~2.5 Å), medium (~3.5 Å) and weak (~5 Å). These were based on an 
internal standard of 2.5 Å for H5-H6 NOESY cross-peaks. Upper bounds were set at a very conservative 
2.0 Å above the proposed distance and lower bounds were set at the Van der Waals distance. The 
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structure of the UUCG tetraloop is known from previous studies [266,267], and the remainder of the 
16mer UUCG sequence is a stem similar to that of the 12mer used in those studies. After a few rounds 
of calculation, it was apparent that the 16mer consisted of a standard UUCG tetraloop and a stem of 
RNA in A-form as expected. Once this was established, further refinement of the distance restraints was 
performed based on the literature interproton distances of the UUCG tetraloop and of A-form RNA, 
particularly for intra-residue distances. Upper and lower restraints were set at 0.5 Å for strong NOES, 1.0 
Å for medium intensity NOEs and 1.5 Å for weaker NOEs. Planarity restraints were included for each of 
the six Watson-Crick base pairs in the sequence to prevent tilting of the bases. Standard hydrogen bond 
restraints were also included for these base pairs. A few hydrogen bond restraints were also included for 
well-established contacts in the UUCG tetraloop, including U7 O2 to G10 N2 and H22, U7 O1P to C9 H41 
and U8 O2’ to G10 O6. The dihedral angles of all residues in Watson-Crick base pairs as well as U7 were 
restrained to a standard A-form helix and an N-type sugar pucker. The ribose angles ν1 and ν2 in U8 and 
C9 were restrained to an S-type sugar pucker based on coupling constants observed in the DQF COSY, 
while all other sugar and backbone angles in these residues were left unconstrained. G10 is known to 
adopt a syn conformation [266,267] and is evidenced by the very strong H8-H1’ correlation observed in 
the NOESY in D2O. For simplicity, all dihedral angles for this residue were left unconstrained. Lists of all 
chemical shifts, distance restraints and dihedral angles used in structure calculations can be found in 
Appendix C.  
All structure calculations were done with CNSsolve version 1.3 [274,275]. A total of 20 structures 
were calculated with 8200 simulated annealing steps per conformer. This consisted of 4000 high 
temperature steps of torsion angle molecular dynamics followed by two slow-cool annealing stages with 
1000 and 3000 steps, respectively. Finally, a minimization stage consisting of 200 steps was performed. 





4.4 Results and Discussion 
4.4.1 Sequence Design and Fluorescence Screening 
The two main domains of SRB-2 we investigated for segmental analysis were the UUCG 
tetraloop (loop 1) and loop 3. One of the first considerations that must be made in the design of these 
sequences is the effect of the sequence on T7 RNA polymerase activity. Optimizing activity is particularly 
important for NMR studies because relatively large (mg) quantities of RNA are required for an NMR 
sample of adequate concentration. It has been established in previous literature that having G residues 
in the +1 to +3 positions of the sequence is often optimal for in vitro transcription [277]. The +1 G base 
has been shown to have several specific interactions with residues in the active site of T7 RNA 
polymerase, which explain its strong preference for this type of nucleotide [278,279]. During 
transcription initiation, the T7 polymerase binds the DNA promotor from nucleotide position −17 to −5. 
The DNA template is then melted from position −4 to +3 to prime RNA synthesis, followed by expansion 
of this initiation bubble to at least the +7 position. It has been suggested that the triplet of G residues 
may help prevent slippage between the RNA-DNA complex and the active site during translocation, 
which in turn reduces the frequency of aborted sequences [280]. Expansion of the bubble becomes 
much less favourable after the +8 position, highlighting the possible significance of the +4 to +8 region. It 
has also been demonstrated in more recent studies that altering the nucleotides in positions +4 to +8 
can affect transcription activity by up to 5-fold [280]. A major observation from these studies was 
sequences that are AU-rich in the +4 to +8 region generally had the highest activity. This is likely due to 
the facilitation of strand melting upon transcription initiation [280]. These observations were taken into 
account when designing truncations of the SRB-2 aptamer.  
As seen in Figure 4.2 A, the original sequence of the UUCG stem-loop in SRB-2 is a 12mer with 
the sequence 5’-UCGCUUCGGCGA-3’. In order to make this sequence more suitable for transcription 
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while maintaining maximum sequence analogy, the A-U base pair was removed, and three consecutive 
G-C base pairs were added (Figure 4.2 B). The middle ten bases are identical to SRB-2. Due to the A-U 
base pair being situated at the end of the stem in SRB-2, the chemical environment of these two bases 
would likely be significantly different with the addition of a G triplet, and therefore, they do not warrant 
inclusion here.  
In our initial attempt to design a truncation for loop 3, the A-U base pair in the stem was simply 
changed to a G-C base pair, resulting in a run of four G-C base pairs to begin the sequence (Figure 4.2 C) 
The transcriptional yield of this sequence, titled L3, was quite poor, even when a double-stranded DNA 
template was used. For this reason, several modified versions of this sequence were designed and 
screened in order to optimize transcription (Figure 4.2 D-F). In the sequence L3A, the fourth G-C base 
pair was substituted with an A-U base pair to increase the A-U content as described above. The presence 
of an A-U base pair in the stem may also help to simply resonance assignment. In L3B, the fourth G-C 
base pair was again replaced but this time by a C-G base pair. This was done to replicate the start of the 
full SRB-2 aptamer sequence, where transcription activity was already sufficient. In the third and final 
version, L3C, the fourth G-C base pair and the following C-G base pair were removed and replaced with 
three A-U base pairs. This was done to substantially increase the AU content and attempt to replicate 
the results of the literature referenced above. These sequences were transcribed, run on a urea PAGE 
gel and qualitatively assessed by UV shadowing. The transcription yield observed was L3 << L3A < L3B < 





Figure 4.2: Segments of the SRB-2 aptamer designed for NMR studies. 
A) SRB-2, B) UUCG, C) L3, D) L3A, E) L3B and F) L3C. The UUCG tetraloop (loop 1) is shown in red and 
loop 3 is shown in blue. The remainder of the sequence is shown in black. 
 
Before an NMR sample was synthesized, we wanted to ensure that the structure of L3C was 
representative of the original sequence. To do this, we designed two versions of the full SRB-2 sequence 
with alterations to the stem of loop 3. SRB-2C has a stem identical to L3C, and SRB-2D has a stem similar 
to L3B. SRB-2C was designed as a direct comparison for L3C, but this sequence involves an additional 
base pair in the stem. That means that differences in binding affinity observed may be a result of either 
a change in sequence or a change in stem length. In order to distinguish these effects, the SRB-2D 
sequence was created, as it carries some of the same alterations as SRB-2C, but its stem is the same 
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length as the original SRB-2 sequence. These sequences were examined using fluorescence techniques. 
They are shown in Figure 4.3. 
 
 
Figure 4.3: SRB-2 variants studied using fluorescence titrations. 
A) SRB-2, B) SRB-2C, C) SRB-2D and D) SRB-2 min. For B and C, region that varies is shown in green. 
 
Some of the sequences discussed above were screened for SR binding using fluorescence 
emissions scans (Figure 4.4). UUCG and L3C by themselves showed no discernable binding activity, 
which is unsurprising due to the large amount of sequence that was removed. It was also observed that 
the binding activity of both SRB-2C and SRB-2D were comparable to SRB-2. The final sequence included 
in the emission scans was SRB-2 min. This was a truncation created by the authors who originally 
selected SRB-2, and we tested it to see if it was worth studying further. However, this sequence showed 
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only a slight shift in maximum emission wavelength and no change in fluorescence intensity. This 
indicates that at best, this sequence binds extremely weakly, which is unsuitable for NMR studies.  
 
 
Figure 4.4: Fluorescence emission scans of SRB-2 mutants and truncations. 
Emission spectra of ligand on its own are shown in red and emission spectra of ligand in the presence of 
excess SRB-2 are shown in blue. SRB-2, SRB-2C and SRB-2D all clearly bind SR, while L3A, UUCG and SRB-




In order to compare the binding affinities of SRB-2, SRB-2C and SRB-2D, fluorescence titrations 
were performed (Figure 4.5). As shown in Table 4.2, it was determined from these experiments that 
SRB-2C and SRB-2D had only slightly weaker binding affinity than SRB-2. This observation shows that the 
same general structure is likely being formed in the presence of ligand and that the sequence alterations 
have minimal effect on this structure. L3C should therefore be a reasonable representation of loop 3 in 
NMR studies.  
 
 
Figure 4.5: Fluorescence titrations of SRB-2 mutants with SR. 
Experimental data is shown as blue points and fit data is shown as a red line. Concentration of SR was 5 
µM and SRB-2 ranged in concentration from 0.5-25 µM. Error bars are one standard deviation from the 
mean of the replicates acquired. 
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Table 4.2: Dissociation constants of SRB-2 mutants determined by fluorescence titration. 
Sequence Kd (µM) 
SRB-2 2.09 ± 0.12 
SRB-2C 2.69 ± 0.30 
SRB-2D 2.23 ± 0.27 
 
4.4.2 NMR Structure of the UUCG 16mer  
 
Due to its small size and stable structure, resonance assignment of the UUCG 16mer was 
completed using only homonuclear experiments, including a NOESY in 90% H20/10% D2O and NOESY, 
TOCSY and COSY in D2O. Inter-residue connectivity was first established by assigning the cross-peaks in 
the H6/H8 to H1’ region of the NOESY in D2O. This NOESY is shown in Figure 4.6 A, and a close up of the 
H6/H8 to H1’ region is shown in Figure 4.6 B. After the chemical shifts of the H6/H8 proton from each 






Figure 4.6: NOESY of 2.0 mM UUCG 16mer in D2O. 
A) Full spectrum. B) Close-up of the H1’ to H6/H8 region. A sequential ‘walk’ is labelled on this spectrum, 
where cross-peaks connected by horizontal purple lines are two different bases that see the same sugar, 
and cross-peaks connected by vertical red lines are two different sugar protons that see the same base. 
Blue dots indicate intra-nucleotide cross-peaks. G11 has an H1’ with an uncharacteristically low chemical 
shift and appears outside of this figure’s chemical shift range. This is represented by a purple arrow. 
Spectrum was acquired with mixing time of 150 ms. 
 
Upon completing resonance assignments for the non-exchangeable protons, the NOESY in 90% 
H20/10% D2O was used to assign the exchangeable imino and amino protons on the bases where 
possible. The full spectrum is shown in Figure 4.7 A, and a close up of the imino-imino region of the 
spectrum is shown in Figure 4.7 B. Assignment was relatively straightforward for imino protons 
belonging to nucleotides in the tetraloop, but unambiguously assignments were not determined for the 
amino and imino protons in the stem due to significant overlap. The absence of any A-U content in the 
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stem contributed to this problem, resulting in a lack of chemical shift variation. Stacking NOEs between 
adjacent guanines in the stem were not clearly observed in this spectrum. This limited the usefulness of 
the imino-imino region shown in Figure 4.7 B. Assignment of the UUCG tetraloop resonances in the full-
length SRB-2 sequence was made possible by this work as shown in Figure 3.5. 
 
 
Figure 4.7: NOESY of 2.0 mM UUCG 16mer in 90% H2O/10% D2O. 
A) Full spectrum. B) Imino-to-imino region. Relevant assignments from the tetraloop are shown in red. 
Spectrum was acquired with mixing time of 150 ms. 
 
 A TOCSY experiment was also used to help identify the H5-H6 cross-peaks from C and U in the 
NOESY in D2O and to distinguish base-sugar cross-peaks involving the pyrimidine residues from those 
involving purine residues (Figure 4.8 A). There are nine C and U residues in the UUCG 16mer and ten 
peaks observed in the TOCSY. However, it appears likely that the two weakest peaks belong to the same 
resonance, allowing unambiguous assignment of the spectrum. A DQF COSY was also obtained and was 
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used to confirm the known S-type sugar puckers in the tetraloop, U8 and C9. This spectrum is shown in 
Figure 4.8 B. 
 
 
Figure 4.8: TOCSY and COSY spectra of 2.0 mM UUCG 16mer. 
A) H5-H6 region of the TOCSY spectrum. Strong signals from the dominant conformation are marked in 
red, and weaker signals experiencing chemical exchange are marked in blue. B) DQF COSY where 
positive contours are shown in black and negative contours are shown in red. Spectrum was acquired 
with mixing time of 50 ms. 
 
 Distance constraints and dihedral angles were obtained as outlined in 4.3.5. A total of 540 NOE 
distance constraints and 135 dihedral angles were used, which corresponds to an average of 33.8 
distance and 8.4 dihedral angle restraints per nucleotide as listed in Table 4.3. The distance constraints 
include a total of 40 hydrogen bonds that were added for the six base-pairs in the stem of the molecule 
as well as four in the tetraloop since previous studies indicate that these exist and are observed in 
experimental data. Within the tetraloop portion of the molecule, 145 NOEs were obtained, 47 of which 
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were inter-residue NOEs. Therefore, the tetraloop structure was defined by an average of 36.3 NOE 
constraints per nucleotide. 
 
Table 4.3: Structure determination statistics for UUCG 16mer 
Distance Restraints 
Tetraloop (7-10) intra-nucleotide 98 
Tetraloop (7-10) inter-nucleotide 47 
Total intra-nucleotide 363 
Total inter-nucleotide 137 
Hydrogen Bonds 40 
Total distance restraints 540 
Dihedral Restraints 
Ribose pucker 67 
Backbone 68 
Total dihedral restraints 135 
Structural Statistics 
NOE violations  None>0.5 Å 
Angle violations None>5° 
Loop (6-11) RMSD 0.629 Å 
Stem (1-5, 12-16) RMSD 1.808 Å 
 
 For visualization and RMSD calculation, the structure was separated into two segments. Due to 
the lack of long-range restraints included in the calculation, large variations in the bending of the stem 
were observed and aligning the two halves separately resulted in the structure being displayed more 
clearly. The first segment, shown in Figure 4.9 A, includes the tetraloop and the first base pair of the 






Figure 4.9: Stereo view of the superposition of the 20 lowest energy structures of the UUCG 16mer. 
Separated into A) UUCG tetraloop and first base of the stem (nucleotides 6-11) and B) The stem 
(nucleotides 1-5 and 12-16). G residues are shown in blue, C’s in red and U’s in green.  
 
 Figure 4.10 shows a comparison between one of the 20 structures obtained in previous studies 
[268] and one of the 20 obtained in this work. As expected, there is little discernable difference between 
the two sets of structures. This is partly due to the inclusion of hydrogen bond restraints based on these 
previous structures. These include several of the defining interactions in the tetraloop: the trans-wobble 
U7-G10 base pair, the C9 amine to the U8 phosphate and the O6 of G10 to the O2’ of U8 [266,268]. 
These were all confirmed experimentally. As shown in Table 4.3 and Figure 4.9, a reasonably small 
deviation between structures was obtained. Additionally, this structure was already well defined and 
our calculation compared to literature versions relatively well. As such, we were not justified in spending 





Figure 4.10: Literature comparison of the UUCG tetraloop. 
Lowest energy structure of A) the UUCG tetraloop as determined by Allain and Varani (1HLX) [269] and 
B) the UUCG tetraloop as determined in these studies.  
 
4.4.3 NMR Studies of the SRB-2 Truncation L3C 
Following the successful resonance assignment and structure calculation of the UUCG 16mer, 
the next step was to design and study another segment of the SRB-2 aptamer. Several variations of the 
‘loop 3’ stem-loop were designed, and we proceeded with NMR studies of L3C, for reasons discussed 
above. As with the UUCG 16mer, NOESYs in both D2O and 90% H2O/10% D2O were collected for this 
sample, as well as a TOCSY. From the NOESY spectra, it is evident that some of the heterogeneity issues 
seen with the full SRB-2 sequence were significantly worse with this sequence. The peaks in the D2O 
spectrum are very broad, resulting in poor resolution. In the NOESY in 90% H2O/10% D2O (Figure 4.11), 
only two imino resonances are observed, likely from the middle of the stem region. There are no peaks 
in the region where non-Watson-Crick type pairing is typically seen. This suggests that L3C is highly 





Figure 4.11: 2D NOESY spectra of L3C. 
1.5 mM RNA in A) D2O and B) 90% H2O/10% D2O. Very little structure is observed in these spectra. 
Spectra were both acquired with a mixing time of 150 ms. 
 
This is supported by the TOCSY (Figure 4.12), where it is clear that multiple conformations exist. 
There are eleven peaks expected in the H5-H6 region of the TOCSY (six C and five U in L3C), but at least 
17 peaks can be counted in this spectrum. At this point, we concluded that resonance assignment was 
not possible for this segment of SRB-2. Based on the results obtained, it is highly likely that nucleotides 
in the loop 3 region of the sequence interact with some of those in the center loop to form the binding 





Figure 4.12: H5-H6 region in the 2D TOCSY of 1.5 mM L3C. 
Peaks are labelled to show how they were counted. Peaks labelled in red are strong, and those labelled 
in blue are weak. Blue peaks are likely a result of structural homogeneity. 
 
4.5 Conclusions 
Overall, the segmental analysis of SRB-2 yielded mixed results. The UUCG 16mer was 
successfully assigned, and 20 structures of satisfactory energy and residual violations were acquired. As 
shown in Figure 4.10, no discernible differences were observed between the experimental and literature 
structures. When compared to SRB-2 spectra, cross-peaks in the tetraloop can be easily identified, 
particularly those belonging to exchangeable resonances in the NOESY spectrum in 90% H2O/10% D2O 
(Figure 3.5). Unfortunately, studies with the L3C sequence were unsuccessful due to the lack of tertiary 
structure present. This was not an unexpected result considering that the ligand is unable to bind this 
sequence. There is also a palindromic sequence in the loop that may cause dimerization and therefore 
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structural heterogeneity in the NMR spectra. Based on this significantly lower degree of structure 
observed in the NMR spectra for L3C compared to SRB-2, it is highly likely that there is significant 
interaction between loop 3 and loop 2 in the folded structure SRB-2. Therefore, segmental analysis will 
not be useful beyond the UUCG tetraloop. A minimal version of SRB-2 aptamer, SRB-2 Min, was 
proposed by the authors who originally selected SRB-2 [37]. The UUCG tetraloop is absent in this 
structure, while loop 2 and loop 3 are intact. However, fluorescence studies shown in Figure 4.4 indicate 
that the binding affinity of this sequence is quite low at best, which does not make NMR studies a 
realistic option. If future NMR studies are done on this system, finding conditions to limit exchange and 
hence peak broadening, would be the primary goal. Then, the isotope labelling strategies discussed in 

















Chapter 5: Thioflavin T Fluorescence and NMR Spectroscopy Suggesting 
a Non-G-quadruplex Structure for a Sodium Binding Aptamer 
 
5.1 Foreward 
The results in this chapter have been accepted for publication in the Canadian Journal of 
Chemistry: Runjhun Saran, Kyle A. Piccolo, Yanping He, Yongqiang Kang, Po-Jung Jimmy Huang, 
Chunying Wei, Da Chen, Thorsten Dieckmann, and Juewen Liu. “Thioflavin T fluorescence and NMR 
spectroscopy suggesting a non-G-quadruplex structure for a sodium binding aptamer embedded in 
DNAzymes.” Any permission for further re-use of this material should be requested directly from the 
Canadian Journal of Chemistry. 
 
*R.S., K.A.P. and Y.H. contributed equally to this work. 
  
ThT fluorescence spectroscopy experiments were performed and analyzed by Runjhun Saran, 
Yanping He, Yongqiang Kang, Po-Jung Jimmy Huang, Chunying Wei and Da Chen. NMR and CD 
experiments were performed and analyzed by the candidate. All authors contributed to the text in the 
abstract, introduction, and conclusion sections, while the methods and results and discussion sections 
were written primarily by the author(s) who used those respective methodologies.  
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5.2 Chapter Abstract 
Recently, a Na+-binding aptamer was reported to be embedded in a few RNA-cleaving 
DNAzymes, including NaA43, Ce13d and NaH1. These DNAzymes require Na+ for activity but show no 
activity in the presence of K+ or other metal ions. Given that DNA can selectively bind K+ by forming a G-
quadruplex structure, this work aims to answer whether this Na+ aptamer also uses a G-quadruplex to 
bind Na+. The Na+ aptamer embedded in Ce13d consists of multiple GG sequences, which is also a pre-
requisite for the formation of G4 structures. To delineate the structural differences and similarities 
between Ce13d and G-quadruplex in terms of metal binding, thioflavin T (ThT) fluorescence 
spectroscopy, NMR spectroscopy and CD spectroscopy were used. Through comparative ThT 
fluorescence spectrometry studies, we deciphered that while a control G-quadruplex DNA exhibited 
notable fluorescence enhancement up to 5 mM K+ with a Kd of 0.52 mM, the Ce13d DNAzyme 
fluorescence was negligibly perturbed with similar concentrations of K+. Opposed to this, Ce13d 
displayed specific remarkable fluorescence decrease with low millimolar concentrations of Na+. NMR 
experiments at two different pH values suggest that Ce13d adopts a significantly different conformation 
or equilibrium of conformations in the presence of Na+ versus K+ and has a more stable structure in the 
presence of Na+. Additionally, absence of characteristic G-quadruplex peaks in 1D 1H NMR suggest that 
G4 is not responsible for the Na+ binding. This theory is confirmed by absence of characteristic peaks in 
the CD spectra of this sequence. Therefore, we concluded that the aptamer must be selective for Na+ 
and binds using a structural element that does not contain G4. 
 
5.3 Introduction 
Understanding metal-binding to DNA is important not only for studying the biological functions 
of DNA, but also for biosensor development [171,281], drug development [282], and nanotechnology 
[283]. In biological studies, Na+ and K+ are among the most abundant physiological metal ions. They can 
138 
 
control the ionic strength of buffers and solutions and screen the negative charges on DNA, resulting in 
more stable DNA duplexes [284]. In addition, they can also have specific binding interactions with 
certain single-stranded DNA sequences [171]. The most famous example is of the stabilization of G-
quadruplex (G4) DNA [285]. Normally K+ is much more effective than Na+ in stabilizing G4 structures 
[286,287]. Na+ is less effective, often attributed to its smaller size and also because thermodynamically it 
has a higher energy of dehydration [287].  
 Recently, a Na+-binding DNA aptamer has been reported, [288,289] which was derived from the 
conserved sequences of the DNAzymes NaA43, NaH1, and Ce13d all originally discovered through in-
vitro selections [290–293]. The NaA43 DNAzyme was reported by Lu and co-workers [290], and it 
specifically requires Na+ for cleaving an RNA containing substrate. NaA43 shares its conserved sequence 
with the Ce13d DNAzyme, which was selected by our group in a lanthanide-dependent selection [291]. 
The conserved sequence is the main part of a Na+-binding aptamer [294–297]. The identification of this 
Na+-aptamer proved instrumental in understanding the reason for the specificity of NaA43 and Ce13d 
DNAzymes for Na+, although the mechanism underlying specific Na+ binding by the DNA still remains 
intriguing [289,296,298,299]. Our knowledge on specific Na+ binding by DNA is limited and from the 
literature known, and a possible mechanism may rely on G4 structures. In such a case, the G4 structure 
would require a superior Na+-induced stabilization than K+, as the aptamer is known to show a higher 
affinity to Na+ in comparison to K+, especially at room temperature [288,295,298,300]. Outside the G4 
context, Na+ binds more strongly to DNA than K+ since it can better increase the melting temperature 
(Tm) of DNA [301]. With respect to G4 structures, so far only a few specialized examples are known 
where Na+ can stabilize G4 more than K+ does. Alberti and coworkers reported a structure containing 
two contiguous G4 units with a greater stabilization by Na+ [302]. Other examples of Na+ being a better 
stabilizer were all from mutated human telomeric sequences, but the advantage of Na+ was extremely 
small. For example, by replacing a certain guanine with a O6-methylguanines, the Tm was enhanced by 
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just 1 C with Na+, while the Tm of the original DNA was 8 C higher with K+ [303]. Moderate advantages 
were also observed by replacing certain guanines by abasic sites [304], or adenines [305]. Overall, such 
mutations significantly decreased the overall stability of the G4 structures. Sun et al. reported an 
unmodified G4 sequence that showed different folding in the presence of Na+ and K+, and Na+ 
appeared to have an even tighter binding [306]. For unmodified simple G4 sequences, no examples are 
known for Na+ being a better stabilizer. Therefore, it would be extremely intriguing to probe whether 
the mechanism underlying Na+-binding to the aptamer derived from NaA43 and Ce13d DNAzymes 
involves Na+-G4 interactions.  
 Another interesting facet regarding Ce13d is its ability to act as a detection beacon for trivalent 
lanthanides [291]. Lanthanides are used in commercial applications such as magnets, batteries, lasers 
and contrasting agents, so the ability to detect these metal ions is important to identify and prevent 
pollution [307–310]. Their similarity in physical properties makes them difficult to separate without the 
use of complex instrumentation methods [311]. Previous studies with Ce13d indicate that several 
trivalent lanthanides can be detected in the low nanomolar concentration range [291]. This DNAzyme 
was the product of the first selection to contain lanthanides as the sole metal cofactor, though 
lanthanides have been noted to have activating or inhibitory effects on nucleic acid catalysis in the past 
[312–316]. From a practical perspective, lanthanides are a promising choice of cofactor for nucleic acid 
cleavage since their ability to act as strong Lewis acids make them adept at performing non-specific 
nucleic acid hydrolysis [309,317,318]. Here we examine by NMR the structural effects that lanthanide 
presence has on Ce13d. 
 Thioflavin T is a popular dye that becomes fluorescent upon binding to G4 DNA, and it has been 
extensively used to probe G4 [319]. In addition, NMR is a powerful method for studying G4 structures 
[199,320] and for studying biomolecule-ligand interactions in general. In this work, we used ThT to study 
Na+ binding by the Ce13d DNAzyme and a comparison was made with a G4 structure. In addition, NMR 
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spectroscopy was performed to further analyze the Ce13d DNAzyme structure. The results argued 
against the presence of a G4 structure to be responsible for the specific Na+ binding by the aptamer. 
NMR results also show that sodium and a lanthanide together are not sufficient to observe Cis13d in a 
single rigid conformation. 
 
5.4 Materials and Methods 
5.4.1 Chemicals 
The DNA sequences were obtained from Integrated DNA Technologies (Coralville, IA) and 
Eurofins (Huntsville, AL). Metal salts including lithium chloride (LiCl), sodium chloride (NaCl), lanthanum 
(III) nitrate (La(NO3)3), KH2PO4, K2HPO4, Na2HPO4, and NaH2PO4 were obtained from Sigma-Aldrich, VWR, 
and Fischer Scientific Canada at the highest purity available. ThT was from Sigma-Aldrich. 99.996% D2O 
was from Cambridge Isotope Laboratories.   
 
5.4.2 ThT Fluorescence Spectroscopy 
For ThT fluorescence spectroscopy, the Ce13d DNAzyme or G4 complexes were annealed at a 
final concentration of 20 µM in buffer A (25 mM LiCl, 50 mM HEPES, pH 7.5) by heating the samples to 
85 C for 5 min and then gradually cooling to 4 C over 30 min. For the experiments, final concentration 
of 0.6 µM DNA complexes were added to a final concentration of 3 µM ThT solution in buffer B at room 
temperature (500 mM tris-acetate, pH 8). After 15 min reaction at 4C, the sample was recovered to 
room temperature. Then fluorescence readings were collected on a Cary Eclipse fluorometer in a 1x1 cm 
quartz fluorescence cuvette with the excitation wavelength (λexc) as 442 nm and the scanning emission 





5.4.3 Nuclear Magnetic Resonance 
DNA for NMR experiments was purified by 10% denaturing polyacrylamide gel electrophoresis 
(dPAGE). The DNA was eluted from the dPAGE using 300 mM LiCl. This was followed by purification on a 
HiPrep 16/10 DEAE FF anion-exchange column (GE Healthcare, Uppsala, Sweden), and desalting on a 
HiPrep 26/10 Desalting column (GE Healthcare, Uppsala, Sweden). Buffers containing only Li+ cations (no 
Na+ or K+) were used throughout purification. NMR samples were prepared by dissolving an appropriate 
weight of lyophilized powder in 400μL of either water (no salt samples), 5 mM sodium phosphate buffer 
and 5 mM NaCl, 5 mM potassium phosphate buffer and 5 mM KCl, 80 mM NaCl or 80 mM KCl. The pH 
was adjusted to 5.8 or 6.8 with ammonia, NaOH or KOH depending on the cation already present. The 
samples were dried by lyophilization and re-dissolved in 500 μL of 90% H20/10% D2O or 99.996% D2O. 
Samples were heated to 85°C for 5min and cooled to 4°C before spectra were acquired. All spectra were 
collected on a Bruker DRX-600 spectrometer equipped with a HCN triple-resonance, triple-axis PFG 
probe (Bruker, Billerica, MA). NMR experiments were carried out at 277 K in 90% H2O/10% D2O or 298 K 
in D2O. Solvent suppression was achieved using 11̅-spin echo pulse sequences [190] for 90% H2O/10% 
D2O or presaturation [192] for D2O samples. All 1D spectra were processed using identical parameters 
and window function. The 2D CITY TOCSY experiments [193] were run with a mixing time of 50 ms and 
NOESY experiments [191] were run with a mixing time of 150 ms. Quadrature detection for the indirect 
dimension was achieved using the States-TPPI method [189]. All NMR samples had a volume of 500 μL 
and were read in standard 5 mm NMR tubes. Relevant pulse programs can be found in Appendix B. 
 
5.4.4 Circular Dichroism 
CD experiments were performed on a Jasco J-815 spectropolarimeter (Jasco Inc., Easton, MD). 
CD scanning experiments were run from 330 nm to 200 nm with a path length of 0.1 cm, data interval of 
0.5 nm, bandwidth of 0.5 nm, response of 1 second, scanning speed of 200 nm minute−1 and a total of 
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four accumulated scans. Samples contained 5 μM DNA at pH 6.8 and either H2O, 80 mM KCl or 80 mM 
NaCl. The samples were also heated to 85 °C for 5min, cooled to 4 °C and incubated for at least 24hrs 
before acquisition at 25 °C. 
 
5.5 Results and Discussion 
5.5.1 The Ce13d DNAzyme 
The secondary structure of the Ce13d DNAzyme is shown in Figure 5.1 A [291]. Its substrate 
strand (shown in green) contains a single RNA linkage (rA in red for ribo-adenine) that serves as the 
cleavage site. For most of the studies in this work, this RNA linkage was replaced by its DNA analog to 
avoid cleavage (dA in red for deoxyribo-adenine). Previous assays have shown that such a change does 
not perturb Na+ binding [288,300]. The two ends of the enzyme strand (shown in blue) bind the 
substrate via two stems (shown as blue/green duplexes in Figure 5.1 A) respectively, and between these 
two stems the enzyme contains a hairpin (shown as blue) followed by a large loop (shown as red and 
purple), which is the main part of the Na+ aptamer. Stretches of G bases present in the catalytic loop of 
Ce13d DNAzyme as well as the substrate strand are highlighted in purple (Figure 1A). G4 structures are 
composed of stacked G-quartet, where each quartet consists of 4 guanines Hoogsteen base-paired in a 
square planar array (Figure 5.1 D). G4s may form by one to four nucleic acid strands that bear 




Figure 5.1: Secondary structure of molecules used in ThT fluorescence experiments. 
(A) the Ce13d DNAzyme and (B) G4 construct, designed by replacing the Ce13d catalytic loop by a G4 
DNA. The guanine stretches are marked in purple. (C) The structure of ThT. (D) Structural representation 
of a G-quartet, where the hydrogen bonds are shown in pink color, G stands for guanine, and R depicts 
the rest of the nucleic acid chain attached to G. 
 
From the secondary structure of Ce13d, we can find four GG or GGG stretches (purple, Figure 
5.1 A) in its catalytic loop, and thus it has the chemical components to form a G4. From the previously 
published DMS foot-printing experiment, most of these guanines in the enzyme strand were protected 
in presence of Na+, indicating that these guanines are involved in the Na+-binding pocket [288]. 
However, this DNAzyme is known to be inactive with K+ [298]. In addition, upon replacing one of the 
critical guanines in the enzyme catalytic loop with base hypoxanthine, the modified Ce13d DNAzyme still 
retained the same Na+-induced activity [323]. This modification must disrupt G4 structures, however it 































































































address this problem through comparative studies, we designed a G4 construct as a positive control, in 
which we replaced the Ce13d catalytic loop with a G4 sequence (Figure 5.1 B). 
 
5.5.2 ThT fluorescence spectroscopy 
We started by using ThT to probe for the presence of G4 structures in the Ce13d DNAzyme and 
the G4 control sequence. The structure of ThT is shown in Figure 5.1 C, and it is commonly used for 
staining G4 DNA [319,324–326] although ThT also has its limitations such as it prefers to bind parallel G-
quadruplex over anti-parallel ones [327,328]. Before studying our Ce13d DNAzyme, we first did a control 
experiment using the G4 construct in Figure 5.1 B. We mixed ThT with this G4 structure, and an emission 
peak at 488 nm was observed with 442 nm excitation (Figure 5.2 A, black spectrum). Upon adding 10 
mM K+, an increase in the fluorescence was observed, suggesting formation of a G4 structure (Figure 5.2 
A, red spectrum). For quantitative understanding, we gradually titrated K+ (Figure 5.2 B, green trace) to 
see a concentration-dependent effect. A sharp increase in fluorescence occurred between 0 and 5 mM 
K+ and then the fluorescence saturated. A Kd of 0.52 mM K+ was obtained by fitting the curve. With more 
than 10 mM K+, the fluorescence started to drop, which might be attributed to the general effect of salt 
in screening the interaction between ThT and the DNA. While the increase in fluorescence in Figure 5.2 
B was sharp, it was relatively small in terms of fold-enhancement i.e. ~ 2-fold. This could be attributed to 
the long DNA structure in which only a small fraction of the nucleotides makes the G4 structure. The 
non-guanine nucleotides may non-specifically bind ThT and thus may have contributed to a high 
background fluorescence [326]. In addition, this G4 DNA might fold into an anti-parallel structure, which 
would also limit the amount of fluorescence increase (see discussion on its CD spectra later). When Li+ 
was titrated, no fluorescence increase was observed and it even dropped slightly (Figure 5.2 B, black 
trace). When Na+ was titrated, the drop in fluorescence was even more (Figure 5.2 B, red trace). Overall, 
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the control G4 experiment indicated that ThT can stain the G4 structure in our two-strand system 
(Figure 5.1 B), and only K+ promoted formation of the G4 structure.  
 We then titrated the metal ions to the Ce13d DNAzyme containing the non-cleavable substrate 
(Figure 5.2 C). Interestingly, we observed decreased fluorescence intensity upon addition of Na+, while 
K+ almost had no influence on the signal, similar to the response to Li+. We reason that Na+ can fold the 
DNAzyme into a tight binding structure, releasing previously associated ThT to decrease its fluorescence. 
Such a binding structure was unlikely to be a G4 sequence due to the drastic fluorescence quenching by 
Na+ and the lack of response to K+. To ensure that the data is representative, we also performed the 
metal titration in the presence of a lower buffer concentration (Figure 5.3). Still, Na+ showed the largest 
ThT fluorescence decrease, confirming specific Na+-binding but likely to a non-G4 structure.  
 
 
Figure 5.2: ThT fluorescence spectra of Ce13d and G4 control. 
(A) Fluorescence spectra of the G4/ThT mixture without and with 10 mM K+. Fluorescence titration of 
the (B) G4/ThT, and (C) Ce13d/ThT mixture with various monovalent metal ions in 500 mM Tris-acetate 






Figure 5.3: ThT fluorescence intensities in lower buffer concentration.  
(A) G4/ThT, and (B) Ce13dA/ThT mixture with various monovalent metal ions in 50 mM Tris-acetate 
buffer, pH 8.0. The ratio of the G4/Ce13dA to ThT was 0.6 µM : 3 µM. 
 
Another possibility is the formation of inter-molecular G4 complexes by multiple DNAzymes 
specifically interacting with each other. To test this, we varied the concentration of the Ce13d DNAzyme 
(keeping the ThT concentration the same). As we increased the concentration of DNAzyme, the initial 
fluorescence increased, which is consistent with formation of increasing DNA/ThT complexes. However, 
this response to Na+ was observed to be independent of DNAzyme concentration, upon plotting the 
relative fluorescence change (Figure 5.4). This data advocate that the effect of the Na+-binding is 
conferred upon individual DNAzyme molecules rather than the formation of inter-molecular complexes. 
An important aspect of ThT staining to be considered is the possibility of G4-induced 
fluorescence reduction. It has been previously reported that using ThT to stain G4 DNA followed by 
addition of metal ions may not always accompany fluorescence increase, and sometimes fluorescence 
decrease may also be observed [319]. Based on the available literature, in most common cases with 
unmodified DNA we expect K+ to be better than Na+ to stabilize G4 structures, although exceptions were 
also reported [306,329]. The fact that only Na+ had a strong response of decreasing fluorescence with 
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negligible fluorescence perturbation in presence of K+ (Figure 5.2 C) did not provide a strong support for 
a G4 structure in Ce13d with Na+. The insights from previous 2-aminopurine spectroscopy studies [298], 
in addition to the data fished out in our study herein, strengthen the notion of Ce13d DNAzyme to fold 
differently than G4 structures in presence of Na+. Due to the limitations of ThT as a G4 probe, the ThT 
data alone cannot conclude the structure of the Ce13d DNAzyme in the presence of Na+. Therefore, we 
then used spectroscopic methods that do not require labelling or staining of the DNA.
 
Figure 5.4: Fluorescence intensity at different DNA concentrations.  
(A) G4/ThT and (B) Ce13dA/ThT mixture in the G4/Ce13dA : ThT ratio of 1.2 µM : 3 µM, with various 
monovalent metal ions. Fluorescence spectra of the (C) G4/ ThT and (D) Ce13dA/ ThT mixture in the 
G4/Ce13dA : ThT ratio of 0.6 µM : 3 µM, with various monovalent metal ions. This data is collected in 
500 mM Tris-Acetate buffer pH 8.0. 
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5.5.3 Design of a cis-DNAzyme for NMR Spectroscopy 
To further test the structure of the DNAzymes, we then performed NMR spectroscopy. One of 
the main bottlenecks in obtaining information from nucleic acid NMR is the length of the sequence 
under study. The chemical diversity of the nucleotide monomers (i.e. adenine, thymine/uracil, cytosine, 
and guanine) present in naturally occurring nucleic acids is very low. Due to this there is high spectral 
overlap in their NMR peaks [227]. This problem becomes more and more significant as the number of 
nucleic acid polymers or the number of nucleotides increase [330]. The DNAzyme version used for ThT 
experiments (Figure 5.1 A) contains two separate strands, and the full Ce13d DNAzyme used for 
previous studies had nearly 90 nucleotides. It is difficult to prepare a homogenous NMR sample with the 
two-strand system since it is hard to control the presence of any unhybridized strand by having exactly 
the same ratio of the two strands. Such heterogeneity adds spectral overlap of NMR peaks as well, 
making NMR analysis even more difficult. Therefore, to lessen the probability of spectral overlap, short 
cis versions of Ce13d were designed for NMR studies. 
 
 
Figure 5.5: Ce13d sequence variations used for NMR spectroscopy. 
(A) trans-cleaving DNAzyme Ce13d with the conserved nucleotides (red) numbered from 3-18, and its 


















































 The secondary structure of the trans-cleaving Ce13d previously used for biochemical 
characterizations [323], and the two short cis versions: Ce13dA and Ce13dB used for NMR studies are 
shown in Figure 3. The two substrate-binding arms of these two cis DNAzymes are 6 base pair (shown in 
green color) and 5 base pairs (shown in blue color) long, much shorter than those in Ce13d. Previous 
studies showed that the hairpin size and composition can be changed as long as a hairpin structure is 
retained [291,295,298]. In the catalytic loop, the length of the hairpin was also shortened. The only 
difference between Ce13dA and Ce13dB is that the adenine in the tip of the hairpin loop was changed to 
a cytosine. Shortened cis-DNAzymes were used to solve the DNA length and substrate/enzyme ratio 
problems. The region shown in dark red is the same for all three versions shown. These conserved 
nucleotides present in the enzyme loop of Ce13d are most important for Na+-binding as well as catalytic 
activity (nucleotides numbered 3-18 in Figure 5.5 A). A systematic mutation study of the conserved 
enzyme loop, in which each nucleotide was mutated to the other three has revealed interesting insights 
[295]. It was found that most of the mutants except for A3G, A8G, G14A, and G14T, were incapable of 
specific Na+-binding. In terms of catalytic activity, the nucleotides A3, G14 and T17 exhibited tolerance 
to mutations, and mutants C7A, A8G, and T13C were found active. Except for these, all the other 
mutants remarkably hampered the Ce13d catalysis. These data present a good correlation between Na+-
binding and catalytic activity, showing that Na+-binding is a key factor for catalysis to take place. These 
data also validate the usage of Ce13dA and Ce13dB for NMR, as these have the conserved set of 
nucleotides preserved. In the trans-cleaving Ce13d DNAzyme (Figure 5.5 A), the cleavage site is denoted 
with a black arrow, and the cleavage site ribonucleotide ‘rA’ is colored in cyan.  The cis-versions of 
Ce13d are designed to be non-cleavable by replacing the cleavage site ‘rA’ to deoxy-ribonucleotide ‘A’ 





5.5.4. Folding of Ce13d in Li+, Na+ and K+. 
To see if we could gain a deeper understanding of the folding of Ce13d in the presence of 
various monovalent ions we probed the 1D 1H spectrum of Ce13dA in the presence of various 
monovalent ions at two different pH values (Figures 5.6 and 5.7). The imino proton regions of 90% 
H2O/10% D2O 1D 1H NMR spectra of Ce13dA were collected with no salt added (only trace amounts of 
Li+ present) at pH 6.8 (Figure 5.6 A), 10 mM K+ at pH 6.8 (Figure 5.6 B), and 10 mM Na+ at pH 6.8 (Figure 
5.6 C) respectively. The imino region of the 1D 1H spectrum contains peaks for the exchangeable imino 
protons of guanine (H1) and thymine (H3) [331]. More specifically, the region of 12-14 ppm represents 
signals from imino (NH) protons which are strongly hydrogen bonded in Watson-Crick base pairs, while 
the signals in the region around 9-12 ppm belong to imino protons that are typically involved in non-
canonical base pairs which are useful for characterizing the secondary structures formed by complexed 
DNA [332,333]. A comparison of the three spectra in the region of 12-14 ppm in Figure 4 suggests that 
there are similar number of peaks and several shared chemical shifts between each of the three spectra, 
suggesting that the structure of the base paired regions shown in Figure 3B was relatively rigid and 
stable in the presence of traces of Li+, or 10 mM Na+, and K+ at pH 6.8. However, the region of 9-12 ppm 
is quite different with respect to the number of peaks and chemical shifts of the peaks for each of the 
three spectra, indicating that Ce13dA adopted a different conformation and/or equilibrium of 
conformations in the presence of no salt (Li+ traces), Na+ and K+.  
 In Figure 5.7, similar spectra were acquired but at a lower pH of 5.8 and with higher salt 
concentrations of 80 mM K+ (Figure 5B) and 80 mM Na+ (Figure 5.7 C) to drive the binding of the cations. 
Under these conditions, the spectra for K+, and to a lesser extent, Li+, had much broader linewidths and 
more spectral overlap, resulting in poorly defined peaks. This is indicative of the presence of multiple 
conformations, which is unsurprising at a lower pH where exchange occurs more readily due to higher 
H+ concentration. On the other hand, it can be observed in Figure 5.7 C that there are shifts in the Na+ 
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spectrum from higher salt concentration and lower pH, but in general it retains its structured 
conformation. From Figure 5.6, it is evident that many of the peaks affected in presence of Na+ are 
different from those affected with K+, and at the lower pH of 5.8 where the exchange rate is higher, 
Ce13dA visibly retains much more structure in the presence of Na+ than the free DNA or in the presence 
of K+. This emphasizes that Ce13dA adopts a different conformation and/or equilibrium of 
conformations in the presence of Na+ versus K+. It is also worth noting that in Figure 5.6, there are fewer 
peaks with a narrower distribution present in the absence of salt than there are in the presence of Na+ 
or K+ which implies that some features of the folded structures are unable to form without cation 
stabilization. Most of these differences are observed in the lower ppm range of the imino region, which 
is characteristic of non-Watson Crick base pairing. These interpretations support the conclusions of 
previous results, where using intrinsic fluorescence changes of 2-aminopurine labelled at the cleavage 
site, it was shown that the folding pattern with Na+-binding was completely different from K+-binding, 




Figure 5.6: Imino proton region of 90 % H2O / 10 % D2O 1D 1H NMR spectra of Ce13dA at 277K. 
(A) 600 μΜ Ce13dA with no salt added (only trace amounts of Li+ from purification present), pH 6.8, (B) 
150 μM Ce13dA in 10mM K+, pH 6.8, (C) 150μM Ce13dA in 10mM Na+, pH 6.8. 
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Figure 5.7: Imino proton region of 90 % H2O / 10 % D2O 1D 1H NMR spectra of Ce13dA at 277K. 
(A) 150 μΜ Ce13dA with no salt added (only trace amounts of Li+ from purification present), pH 5.8, (B) 
150 μM Ce13dA in 80mM K+, pH 5.8, (C) 150μM Ce13dA in 80mM Na+, pH 5.8.  
 
5.5.5 NMR Spectra Suggest the Na+-binding Structure is not a G-quadruplex 
 Many G-rich DNA aptamers contain G-quadruplex structures for molecular recognition, and 
these structures have fairly well defined guanine imino 1H NMR shifts between 10.5-12.5 ppm [198,334–
336]. G-quadruplex DNA is a highly stable structure and therefore these peaks are typically defined by 
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high intensity and narrow linewidth. Due to the Na+ dependence of the Ce13d DNAzyme and its 
sequence containing sufficient G-rich regions, NMR was also used to qualitatively assess the presence of 
G-quadruplex DNA. This needed the investigation of Ce13d in presence of Na+ due to its functional role, 
and also in presence of K+ because of the well-established preference of G-tetrads for K+ [337,338]. The 
spectra in Figures 4 and 5 were analyzed for this purpose. However, no compelling evidence supported 
the presence of a G-quadruplex in Ce13dA in the presence of Na+ or K+. There are some peaks between 
10.5 ppm and 12.5 ppm at both pH ranges, but this is not atypical of DNA, and based on the linewidths, 
G-quadruplex is not conclusively present in any of the spectra. At pH 5.8, it is highly likely that a G-
quadruplex would be stable and retain its characteristic, narrow imino peaks between 10.5-12.5 ppm 
and it is clear that this is not the case for free DNA or in the presence of K+. In the presence of Na+, the 
peaks in this region have narrower linewidths but this simply indicates that conformational stability is 
conferred but not necessarily due to a G-quadruplex. Analysis of Figure 5.6 shows that there are not 
significantly more peaks in the presence of Na+ than K+. Based on these observations and the fact K+ is 
known to have a higher propensity for G-quadruplex formation than Na+, it is unlikely that Ce13dA forms 
a G-quadruplex. However, despite the lack of evidence, it is possible that different G-quadruplexes are 
formed in presence of different cations and it cannot be explicitly ruled out by these spectra alone that 
G-quadruplex is formed. Therefore, we sought additional evidence to support this claim. In order to 
collect this evidence, we lyophilized the three samples from Figure 5.7 after the previous spectra were 
obtained and resuspended them in 100% D2O for acquisition of further 1D 1H NMR spectra. Under these 
conditions, signals from exchangeable imino and amino resonances from G-quadruplex G residues may 
survive for up to two or more weeks in D2O [339]. There were no residual imino or amino peaks 
observed in any of these spectra, despite being observed within 30 minutes of resuspension. These 
findings, in combination with those from spectra in Figures 5.6 and 5.7, support the conclusion that 
there is no G-quadruplex formation in the presence of Na+ or K+. To summarize, these 1H NMR spectra 
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show that Ce13d is unique in its ability to discriminate between monovalent cations and supports the 
idea that there is an aptamer specific for Na+ within the catalytic loop of Ce13d. This NMR data also 
indicates that this aptamer is not based on a G-quadruplex structure. 
 
5.5.6 CD Spectra Confirm the Absence of G-quadruplex Structure. 
 CD spectra were then obtained for Ce13dA under the same three salt conditions used for NMR 
experiments (no salt added, 80 mM Na+ and 80 mM K+). We chose the cis-cleaving Ce13dA to better 
match the results of the NMR experiments. All three spectra had maxima at approximately 280 nm, 
minima at 250 nm and a cross-over point from positive to negative intensity around 260 nm which is 
typical of duplex DNA (Figure 5.8) [196,340]. G-quadruplex DNA can have different forms, all with 
characteristic CD signatures, such as parallel (~264 nm max, 245 nm min), antiparallel (~ 295 max, 260 
min) or hybrid (~ 295 max, 260 max, 245 min) [341,342]. These peaks are clearly not present in any of 
the CD spectra obtained. In addition to this, all three salt conditions give nearly identical CD spectra, 
which is not consistent with the presence of a G-quadruplex. Since G-quadruplex formation is 
dependent on salt, a sequence containing G-quadruplex would experience significant shifts in 
wavelengths and increases in peak magnitudes in the presence of K+ compared to the absence of K+ 
[343]. We previously measured the CD spectra of the trans-cleaving Ce13d DNAzyme and also the G-
quadruplex control shown in Figure 5.1 A and 5.1 B, respectively [299]. The trans-cleaving Ce13d spectra 
were very similar to that of the cis-cleaving Ce13dA presented in Figure 5.8, suggesting that they had a 
similar overall folding. The G4 control, on the other hand, had the peaks shifted to 290 nm and 250 nm 
in the presence of K+, suggesting its folding into an anti-parallel G-quadruplex. The peaks did not 
perfectly match with the ideal values since a portion of the DNA was in duplex. This evidence indicates 




Figure 5.8: CD spectra of Ce13dA in the presence of no added salt, K+ and Na+. 
No significant changes are observed in CD spectra when different ions are present and characteristic G-
quadruplex peaks are absent, indicating a lack of G-quadruplex structure in this sequence. 
 
5.5.7 Potential Structural Information from 2D NMR 
 In addition to the 1D 1H NMR, we probed the structure of Ce13d with 2D NMR. For this, we used 
the Ce13dB construct. The Ce13dB differs from Ce13dA by a cytosine residue in its hairpin-loop (shown 
in pink in Figure 5.5 B and 5.5 C). This change could be afforded as this position is known to be 
insignificant in Na+ binding and catalysis of Ce13d [291,323]. This was done to increase the number of 
cytosine residues as it proves beneficial for spectral assignment of peaks, and therefore in determining 
the homogeneity of the sample. Typically for cytosines, the H5 and H6 protons show up peaks between 
5-6 ppm and 6.9-7.9 ppm, respectively. The through-bond interaction between H5 and H6 protons is 
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unique to cytosines, and the number of peaks coming from this interaction directly correlates to the 
number of cytosines in the structure. To determine if Ce13dB is present in a single homogeneous 
conformation, we probed the structure of Ce13dB with a 2D TOCSY experiment (Figure 5.9) and looked 
at the peaks generated by the through-bond interactions of H5/H6 protons in the cytosine nucleotides 
(Figure 5.10). The number of cytosines in Ce13dB is 12 (Figure 5.5 C), while the number of peaks 
showing up in the 100 % D2O 1H5/1H6 2D TOCSY is 18 (Figure 5.9). This clearly indicated that Ce13dB is 
present in multiple three-dimensional conformations. Since conformational homogeneity is a 
prerequisite for structure determination through NMR, any further spectra for structure determination 
were not acquired in this study. 
 
Figure 5.9: 2D-TOCSY spectrum of 450 μM Ce13dB in 5 mM LiPO4 pH 6.8, 200 mM Na+. 
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This is the full TOCSY spectrum of Ce13dB in the presence of high Na+. Spectrum was acquired with a 




Figure 5.10: H5/H6 proton region of the 2D-TOCSY spectrum of Ce13dB.  
The spectrum shows cross-peaks generated by through-bond interactions of H5/H6 hydrogens of the 
cytosine residues of Ce13dB. These peaks are conservatively counted in blue text. The chemical shift 
range of H5 protons is 5-6.2 ppm (y-axis) and the chemical shift range of H6 protons is 6.8-8.0 ppm (x-




5.5.8 Structural Effects of Lanthanum Titration on Cis13dB 
It has been noted in previous work on Cis13d that cleavage activity is catalyzed by several 
trivalent lanthanides [291]. There was a distinct lack of structural homogeneity observed in TOCSY 
experiments with the non-cleaving Cis13dB, even in the presence of sodium. Because of Cis13d’s ability 
to interact with lanthanides at the cleavage site, we decided to probe Cis13dB with lanthanum to see if 
any structure-stabilizing effects were observed in its presence. To do this, we acquired TOCSY 
experiments after the addition of several aliquots of lanthanum, as shown in Figure 5.11. A clear change 
in conformation and/or equilibrium of conformations was observed over the course of this titration. 
After the addition of the final aliquot (4:1 lanthanum to DNA), shown in red in Figure 5.11, four fewer 
peaks are counted than at the beginning of the titration (no lanthanum, 80mM NaCl), shown in blue in 
Figure 5.11. This is still more than expected for a single conformation but is an obvious improvement 
over the spectra obtained with sodium alone. An additional aliquot (6:1 lanthanum to DNA) was 
obtained, but little difference was observed compared to the 4:1 aliquot so the titration was concluded 
at that point. Though the TOCSY titration suggests that multiple conformations are still present, NOESY 




Figure 5.11: Titration of Cis13dB with lanthanide. 
Blue- 600 µM DNA, 80 mM NaCl, Green- 600 µM DNA, 80 mM NaCl, 600 µM La(NO3)3, Orange- 600 µM 
DNA, 80 mM NaCl, 1200 µM La(NO3)3, Red- 600 µM DNA, 80 mM NaCl, 2400 µM La(NO3)3. All spectra 
were acquired with mixing times of 50 ms. 
 
 A NOESY in 90% H2O/10% D2O (Figure 5.12) and a NOESY in D2O (Figure 5.13) were acquired on 
the same sample used for the TOCSY experiments in Figure 5.11 (6:1 lanthanum to DNA and 80mM 
NaCl). Though spectra of reasonable resolution were acquired, the significant lack of NOEs is evident, 
particularly when comparing to high-quality spectra of a sequence of similar length (Figure 3.8). This is 
indicative of a lack of tertiary structure forming. At this point, no further spectra were acquired as it 




Figure 5.12: NOESY of Cis13dB in 90% H2O/10% D2O. 




Figure 5.13: H1’-H6/H8 region in the NOESY spectrum of Ce13dA in D2O. 
Sample contained 600 µM DNA, 80 mM NaCl, 3600 µM La(NO3)3 and was run with a 150 ms mixing time. 
 
5.6 Conclusions 
In this study, ThT staining, NMR spectroscopy and CD spectroscopy were employed to study Na+ 
binding by its aptamer, which is embedded in the Ce13d and NaA43 DNAzymes. By accomplishing 
comparative analysis between Ce13d Na+-aptamer versus a G4 construct, it was observed that both 
show a distinct fluorescence change in the presence of Li+, Na+ and K+. In the case of Ce13d, while most 
of the binding was observed with Na+, no evidence supported that formation of a G4 structure makes 
the basis of Na+-binding, and thus this aptamer likely uses other mechanisms to bind Na+. NMR provided 
a similar conclusion arguing against a G4 structure in the presence of Na+. This is further supported by 
163 
 
the lack of G4 observed in CD. This report not only explicitly demonstrates the presence of a uniquely 
folding novel Na+-aptamer in Ce13d, but also substantiates the fact that isolation of novel aptamer 
containing DNAzymes or Aptazymes is a prudent way of discovering novel distinctly folding metal-
binding aptamers. Additionally, this study highlights the possibility of utilizing monovalent metal ions to 
play novel and unique roles in DNA scaffolding and DNA nanotechnology in general, other than just 





















Chapter 6: Summary and Future Work 
 
In Chapter 2, we screened and investigated SRB-2 ligands for optimal binding properties, namely 
affinity and selectivity. We determined that the amine groups on the ligand must have small alkyl 
constituents that are able to participate in hydrophobic interactions. They must not, however, be so 
large as to interfere with the aptamer’s binding conformation. Binding affinity is also increased when the 
total number of negative charges is decreased. A single negatively charged group was shown to have 
little impact on binding affinity but is required for selective binding of SRB-2. This is due to repulsive 
interactions with the RNA backbone preventing these ligands from non-specifically binding to A-form 
regions of the aptamer. As observed with AR101-B, bulky amine constituents can also confer selective 
binding of SRB-2 in the absence of a negative charge but at a considerable loss of binding affinity. 
Considering all these observations, we determined rhodamine B was the best ligand out of those we 
tested. We also showed via ITC that SRB-2 binding is dependent on divalent cations at low concentration 
and determined using CD that its binding mechanism does not involve a G-quadruplex and does not 
form any new helical regions upon binding. 
In Chapter 3, the solution structure of SRB-2 was probed using homonuclear NMR techniques as 
well as with the three single-nucleotide labelled samples [13C 15N]-Ade, [13C 15N]-Cyt and [13C 15N]-Ura. 
The presence of structural heterogeneity ultimately resulted in insufficient quality of data to pursue 
structure calculations. There were some minor changes observed with low Mg2+ concentrations so 
investigations with more salt concentrations may be useful. Initial spectra obtained using RB as the 
ligand were not successful. However, sequence modification of SRB-2 to address 3’ and 5’ heterogeneity 
may be more successful. If such changes were impactful, one could then consider re-acquiring some of 
the NMR experiments performed and perhaps synthesize additional samples that may be of use, such as 
a uniform 13C 15N sample. Another potentially useful strategy to address spectral overlap would be to 
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use at least one partially deuterated sample, likely with one or more nucleotides deuterated in the H3’, 
H4’, H5’ and H5” positions. Removing some of these spins would drastically reduce the amount of 
dipolar relaxation experienced by the other protons, resulting in a significantly sharpened spectrum that 
may reduce some of the remaining peak overlap.  
In Chapter 4, we pursued a “divide and conquer” strategy to acquire more structural 
information about SRB-2. Resonance assignments for a UUCG 16mer were acquired using homonuclear 
spectra, and a family of 20 structures was calculated. These structures were in agreement with literature 
structures, and characteristic cross-peaks from the tetraloop could be easily identified in the NOESY 
spectra of SRB-2. NMR studies with the L3C sequence were unsuccessful due to the high degree of 
structural heterogeneity present. Using this truncation clearly did not solve the overlap or heterogeneity 
problems discussed in Chapter 3. Based on the NMR spectra for L3C, it is likely that there is significant 
interaction between loop 3 and loop 2 in the folded structure SRB-2. Therefore, this “divide and 
conquer” approach will not be useful beyond the UUCG tetraloop. A minimal version of SRB-2 aptamer, 
SRB-2 min, was proposed by the authors who originally selected SRB-2. The UUCG tetraloop is absent in 
this structure, while loop 2 and loop 3 are intact. However, NMR studies are not possible due to the 
extremely low binding affinity observed in fluorescence experiments. If future NMR studies are done on 
this system, finding conditions to limit exchange and hence peak broadening would be the primary goal. 
Then, the isotope labelling strategies discussed in Chapter 3 may be more effective.  
In Chapter 5, ThT staining, NMR spectroscopy and CD spectroscopy were used to study Na+ 
binding by its aptamer, which is embedded in the Ce13d and NaA43 DNAzymes. By accomplishing 
comparative analysis between Ce13d Na+-aptamer versus a G4 construct, it was observed that both 
show a distinct fluorescence change in the presence of Li+, Na+ and K+. In the case of Ce13d, most of the 
binding was observed with Na+, but no evidence supported that formation of a G4 structure makes the 
basis of Na+-binding. NMR and CD provided similar conclusions regarding the absence of G4 structure in 
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the presence of Na+. However, based on the metal selectivity observed in this system, we were able to 
demonstrate the presence of a uniquely folding novel Na+-aptamer in Ce13d, but also suggests that 
isolation of novel aptamer containing DNAzymes or Aptazymes may be a practical way of discovering 
novel metal-binding aptamers. Additionally, this work highlighted the possibility of utilizing monovalent 
metal ions to serve novel and unique roles in DNA scaffolding and DNA nanotechnology in general. 
To conclude this thesis, I would like to briefly state the most significant impacts of this research. 
The binding kinetics investigated in Chapter 2 were able to show, with respect to SRB-2, that a ligand 
that was not the selection target, rhodamine B, actually had the most ideal binding properties of those 
studied, including a higher binding affinity than the original ligand, sulforhodamine B. Advances in 
aptamer selection methodologies have come a long way since SRB-2 was selected in 1997, so perhaps 
this indicates more optimal sequences could exist for some of these ligands. In literature, several SRB-2 
ligands showed promise due to their high fluorescence enhancement in previous studies, but we 
showed here that they were in fact binding to the aptamer non-specifically, questioning the usefulness 
of these ligands in potential applications. In Chapter 5, we studied a DNAzyme containing a Na+ aptamer 
that clearly discriminates between Na+ and K+ without the use of a G-quadruplex, as would generally be 
expected. This existence of a selective Na+ aptamer is also encouraging with respect to biosensor 
development for metal ions. Distinguishing ions as similar in properties to Li+, Na+ and K+ is no small feat 
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Appendix A: Supplementary Figures 
 
Figure A.1: 1D titration of 1 mM SRB-2 with SR.  
Imino proton range showing change in structure upon binding of the ligand in three aliquots. A) SRB-2 























































Appendix B: NMR Pulse Programs  
 
1D 1H with 1?̅?-Spin Echo Solvent 
Suppression 
;SD_11echozg 
;1D sequence for 11 spin echo  water suppression with 
gradients 
;low power mode 
;4.8.94 vladi sklenar 











  d11  
2 d13  
  d13 
  LOCKH_OFF 
  d1  
  LOCKH_ON 
  p1 ph1 
  d2 
  p1 ph2 
  p16:gp1 
  d16 
  p1 ph3 
  d2 
  d2 
  p1 ph4 
  p16:gp1 
  d16  
  go=2 ph31  
  wr #0  
  LOCKH_OFF 
exit 
 
ph1 = 0 0 0 0  1 1 1 1  2 2 2 2  3 3 3 3 
ph2 = 2 2 2 2  3 3 3 3  0 0 0 0  1 1 1 1 
ph3 = 0 1 2 3  1 2 3 0  2 3 0 1  3 0 1 2 
ph4 = 2 3 0 1  3 0 1 2  0 1 2 3  1 2 3 0 
ph30= 0 
ph31= 0 2 0 2  1 3 1 3  2 0 2 0  3 1 3 1 
 
;pl1: 1H high power(~0 dB) 
;p1 :  90 degree ecoupler pulse 
;d1 : relaxation delay; 1-5 * T1 
;d2 : 1/4*d2 excitation maximum calculated based on  
;     CNST2 = distance in Hz to first exitation max 
 
1D 1H with Presaturation 
;SD_1Dpresat 
;avance-version 








2 d12 pl9:f1 
  p18*0.6 ph28 
  d13 
  p18*0.4 ph29 
  d12 pl1:f1 
  p1 ph1 
  go=2 ph31 
  wr #0 
exit 
 
ph1=0 2 2 0 1 3 3 1 
ph28= 0 
ph29= 1 
ph31=0 2 2 0 1 3 3 1 
 
;pl1 : f1 channel - power level for pulse (default) 
;pl9 : f1 channel - power level for presaturation 
;p1 : f1 channel -  90 degree high power pulse 
;d1 : relaxation delay; 1-5 * T1 
;d12: delay for power switching         [20 usec] 
;d13: short delay                                    [3 usec] 
 
2D NOESY with 1?̅?-Spin Echo Solvent 
Suppression 
;SD_noe11ezg 
;2D NOE with 11echo and gradients 
;phase sensitive using States-TPPI 
;with presaturation during relaxation delay and mixing 
time 
;the shortest mixing time ~50 ms!!!! otherwise problems 
with radiation 
;damping 
;added decoupling, 9/15/94; thorsten 
;changed for DRX, 05/01/96; thorsten 
 
;Allows you to center spectrum anywhere. 
;Uses a frequency list: 
; 1) set the first value to the desired center of 
spectrum in f1 
; 2) set the second value to water 
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; 3) set the third value to the desired center of 
spectrum in f2 
; 4) Set o1 to the desired center of spectrum in f2 
(needed for DQD) 
;changed 1/21/97 - ELW 
 














1  ze 
   d11 
2  d11 
3  d11 pl1:f1 
4  d11 
   LOCKH_OFF 
   d1 fq1:f1   ;Center 
   LOCKH_ON 
   p1 ph1 
   d0 
   p1 ph2 
   d8 
    p16:gp1 
    d16 fq1:f1   ;Water 
   p1 ph3 
   d2 
   p1 ph6 
    p16:gp2 
    d16 
   p1 ph7 
   d2 
   d2 
   p1 ph8 
    p16:gp2 
    d16 fq1:f1   ;Center 
   go=2 ph31 
   d11 wr #0 if #0 ip1 zd 
    lo to 3 times 2 
     d11 id0 
      lo to 4 times l3 
   LOCKH_OFF 
exit 
 
ph1= 0 2 0 2  1 3 1 3  2 0 2 0  3 1 3 1 
     2 0 2 0  3 1 3 1  0 2 0 2  1 3 1 3 
ph2= 0 0 2 2  1 1 3 3  2 2 0 0  3 3 1 1 
     2 2 0 0  3 3 1 1  0 0 2 2  1 1 3 3 
ph3= 0 0 0 0  1 1 1 1  2 2 2 2  3 3 3 3 
ph6= 2 2 2 2  3 3 3 3  0 0 0 0  1 1 1 1 
ph7= 0 0 0 0  1 1 1 1  2 2 2 2  3 3 3 3 
ph8= 2 2 2 2  3 3 3 3  0 0 0 0  1 1 1 1 
ph20=0 0 0 0  0 0 0 0  2 2 2 2  2 2 2 2 
ph31=0 2 2 0  1 3 3 1  2 0 0 2  3 1 1 3 
 
;pl1: Proton power level 
;p1 :  90 degree proton pulse 
;d9 : the mixing time 
;d0 : incremented delay (2D) = in0/2-(4/pi*p1) 
;d2 : delay for exitation maximum, calculated based  
;     on cnst2 = offset of first max in Hz 
;d11: delay for disk I/O                           [30 msec] 
;gp1: Homospoil during mixing time 
;gp2: Watergate gradient 
;in0: 1/(SW)  
;nd0: 1 
;NS: 2,4 8,16 or 32 * n 
;DS: 4 
;td1: number of experiments 
;MC2: States-TPPI 
 
2D NOESY with Presaturation 
;SD_noesypr 
;avance-version 
;2D homonuclear correlation via dipolar coupling  
;dipolar coupling may be due to noe or chemical exchange. 
;phase sensitive using States-TPPI method 
;with presaturation during relaxation delay 
 

















4 d12 pl9:f1    
  LOCKH_OFF 
  p18*0.8 ph29 
  d13 
  p18*0.2 ph30 
  LOCKH_ON 
  d12 pl1:f1  
  p1 ph1 
  d0 
  p1 ph2 
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  d12 pl9:f1 
  p19 ph18 
  p16:gp1 
  d16 pl1:f1  
  p1 ph3 
  go=2 ph31 
  d11 wr #0 if #0 ip1 zd 
  lo to 3 times 2 
  d11 id0 
  lo to 4 times l3 
  LOCKH_OFF 
exit 
 
ph1 =0 2  
ph2 =0 0 0 0  0 0 0 0  2 2 2 2  2 2 2 2 




ph31=0 2 2 0  1 3 3 1  2 0 0 2  3 1 1 3 
 
;pl1 : f1 channel - power level for pulse (default) 
;pl9 : f1 channel - power level for presaturation 
;p1 : f1 channel -  90 degree high power pulse 
;d0 : incremented delay (2D)                    [3 usec] 
;d1 : relaxation delay; 1-5 * T1 
;d9 : mixing time 
;d11: delay for disk I/O                          [30 msec] 
;d12: delay for power switching             [20 usec] 
;d13: short delay                                    [3 usec] 
;L3: loop for phase sensitive 2D using States-TPPI method: 
l3 = td1/2 
;in0: 1/(1 * SW) = 2 * DW 
;nd0: 1 
;NS: 8 * n 
;DS: 16 





;2D clean CITY with water presat 
;States-TPPI t1-detection 
;DRX version with gradient purging 
;4.7.1995 vladi sklenar 















2 d11  
3 d11 
4 d12 pl9:f1 
  d13 LOCKH_OFF 
  p18*0.8 ph18 
  d13 
  p18*0.2 ph19 
  d13 LOCKH_ON 
  d12 pl1:f1 
  p1 ph1 
   d0 
  p1 ph2 
   p16:gp1 
   d16 
   d12 pl11:f1 
7 (d20 p6*2 ph22 d20*2 p6*2 ph22 d20) 
  (p6*0.533 ph23 p6*3.067 ph21 p6*0.533 ph23) 
  (d20 p6*2 ph22 d20*2 p6*2 ph22 d20) 
  (d20 p6*2 ph22 d20*2 p6*2 ph22 d20) 
  (p6*0.533 ph23 p6*3.067 ph21 p6*0.533 ph23) 
  (d20 p6*2 ph22 d20*2 p6*2 ph22 d20) 
  (d20 p6*2 ph24 d20*2 p6*2 ph24 d20) 
  (p6*0.533 ph21 p6*3.067 ph23 p6*0.533 ph21) 
  (d20 p6*2 ph24 d20*2 p6*2 ph24 d20) 
  (d20 p6*2 ph24 d20*2 p6*2 ph24 d20) 
  (p6*0.533 ph21 p6*3.067 ph23 p6*0.533 ph21) 
  (d20 p6*2 ph24 d20*2 p6*2 ph24 d20) 
  lo to 7 times l1 
   p16:gp2 
   d16  
  d12 pl1:f1 
  p1 ph3 
  go=2 ph31  
   d11 wr #0 if #0 ip1 zd 
    lo to 3 times 2 
     d11 id0 
      lo to 4 times l3 
   mix 
   3u LOCKH_OFF 
exit 
 
ph1  = 0 2 0 2  0 2 0 2  1 3 1 3  1 3 1 3 
ph2  = 0 0 0 0  2 2 2 2  1 1 1 1  3 3 3 3 
ph3  = 0 0 2 2  0 0 2 2  1 1 3 3  1 1 3 3 
ph4  = 0 
ph9  = 0 
ph10 = 0 0 0 0  0 0 0 0  1 1 1 1  1 1 1 1 
ph11 = 1 1 1 1  1 1 1 1  2 2 2 2  2 2 2 2 
ph21 = 0 0 0 0  0 0 0 0  1 1 1 1  1 1 1 1 
ph22 = 1 1 1 1  1 1 1 1  2 2 2 2  2 2 2 2 
ph23 = 2 2 2 2  2 2 2 2  3 3 3 3  3 3 3 3 
ph24 = 3 3 3 3  3 3 3 3  0 0 0 0  0 0 0 0 
ph18 = 0 
ph19 = 1 




;pl9 : transmitte water presat level 
;pl1 : transmitter excitation level 
;pl11 : transmitter TOCSY mixing level 
;p1  : 90 transmitter pulse at pl1 level 
;p6  : 90 transmitter pulse at pl2 level 
;p18 : presaturation pulse with pl9 
;d0  : incremented delay 
;d11 : disc I/O delay 
;d20 : delay for NOE-ROE compensation (1.1*p6? to be 
optimized) 
;l1  : loop for TOCSY mixing (48.532*p6+32*d20) 
;NS=8  minimal phase cycle for pure phase spectra 
incuding ax.peak suppr. 
;NS=16 + short CYCLOPS 





;2D homonuclear shift correlation 
;with presaturation during relaxation delay 
;phase sensitive using States-TPPI method 
;with double quantum filter 
;phasecycle: A. Derome & M. Williamson, J. Magn. Reson. 
88, 














4 d12 pl9:f1 
  p18*0.8 ph29 
  d13 
  p18*0.2 ph30 
  d12 pl1:f1 
  p1 ph1 
  d0 
  p1 ph2 
  d13 
  p1 ph3 
  go=2 ph31 
  d11 wr #0 if #0 ip1 zd 
  lo to 3 times 2 
  d11 id0 
  lo to 4 times l3 
exit 
 
ph1=1 1 1 1 0 0 0 0 
ph2=0 0 0 0 1 1 1 1 
ph3=1 2 3 0 2 3 0 1 
ph29=0 
ph30=1 
ph31=0 3 2 1 3 2 1 0 
 
;pl1 : f1 channel - power level for pulse (default) 
;pl9 : f1 channel - power level for presaturation 
;p1 : f1 channel -  90 degree high power pulse 
;d0 : incremented delay (2D)                    [3 usec] 
;d1 : relaxation delay; 1-5 * T1 
;d11: delay for disk I/O                          [30 msec] 
;d12: delay for power switching            [20 usec] 
;d13: short delay                                       [3 usec] 
;L3: loop for phase sensitive 2D using States-TPPI method: 
l3 = td1/2 
;in0: 1/(1 * SW) = 2 * DW 
;nd0: 1 
;NS: 8 * n 
;DS: 16 
;td1: number of experiments 
;MC2: States-TPPI 
 
2D 13C HSQC 
;SD_hsqchcgsse 
;avance-version 
;2D H-1/13C correlation via double inept transfer 
;   using sensitivity improvement 
;phase sensitive using Echo/Antiecho gradient selection 
;with decoupling during acquisition 
;A.G. Palmer III, J. Cavanagh, P.E. Wright & M. Rance, J. 
Magn. 
;   Reson. 93, 151-170 (1991) 
;L.E. Kay, P. Keifer & T. Saarinen, J. Am. Chem. Soc. 114, 
;   10663-5 (1992) 
;J. Schleucher et al., Angew. Chem. 114(10), 1518 (1993) 
 
; !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! 
; !!                                                       !! 
; !!     Attention: DS has to be a multiple of 2*NS        !! 





















  d11 pl12:f2 
2 d1 do:f2  
  6m 
3 d11 
4 (p1 ph1) 
  d4 pl2:f2  
  (p2 ph1) (p4 ph1):f2 
  d4 
  (p1 ph2) (p3 ph3):f2 
  d0  
  p2 ph1 
  d0 
  50u 
  GRADIENT(cnst21) 
  d16 
  (p4 ph4):f2 
  d20 
  (p1 ph1) (p3 ph4):f2 
  d24 
  (p2 ph1) (p4 ph1):f2 
  d24 
  (p1 ph2) (p3 ph5):f2 
  d4 
  (p2 ph1) (p4 ph1):f2 
  d4 
  (p1 ph1) 
  d21 
  (p2 ph1) 
  d13 
  GRADIENT(cnst22) 
  d16 pl12:f2 
  4u  
  go=2 ph31 cpd2:f2 
  d1 do:f2 wr #0 if #0 zd 
  3m ip5  
  3m ip5 
  lo to 3 times 2 
  d11 id0 
  lo to 4 times l3 
exit 




ph4=0 0 2 2 
ph5=1 1 3 3 
ph31=0 2 2 0 
   
;pl1 : f1 channel - power level for pulse (default) 
;pl2 : f2 channel - power level for pulse (default) 
;pl12: f2 channel - power level for CPD/BB decoupling 
;p1 : f1 channel -  90 degree high power pulse 
;p2 : f1 channel - 180 degree high power pulse 
;p3 : f2 channel -  90 degree high power pulse 
;p4 : f2 channel - 180 degree high power pulse 
;p16: homospoil/gradient pulse 
;p28: f1 channel - trim pulse 
;p31:  - 90 degree pulse for decoupling sequence 
;d0 : incremented delay (2D)                  [3 usec] 
;d1 : relaxation delay; 1-5 * T1 
;d4 : 1/(4J)XH 
;d11: delay for disk I/O                          [30 msec] 
;d13: short delay (e.g. to compensate delay line)    [3 usec] 
;d16: delay for homospoil/gradient recovery 
;d20: = p16+d16+50u+p2+d0*2 
;d21: = d13+p16+d16+4u 
;d24: 1/(4J)XH for XH 
;     1/(6J)XH for all multiplicities 
;L3: loop for phase sensitive 2D using  E/A method : l3 = 
td1/2 
;in0: 1/(2 * SW(X)) = DW(X) 
;nd0: 2 
;NS: 1 * n 
;DS: >= 16, but 2 * ns * m 
;td1: number of experiments 
;MC2: echo-antiecho 
;cpd2: decoupling according to sequence defined by 
cpdprg2 
 
;use gradient program (GRDPROG) : SD_2sineea3 
 
;use gradient ratio: cnst21 : cnst22 : cnst23 : cnst24 : 
cnst25 
;        4 :      1 :      4 :      1 :     -1      
for C-13 
 




;2D H-1/X correlation via double inept transfer 
;phase sensitive using Echo/Antiecho-TPPI gradient 
selection 
;with decoupling during acquisition 
;using trim pulses in inept transfer 
;using f3 - channel 
; 
























#   ifdef LABEL_CN 
"DELTA=p16+d16+larger(p2,p14)+d0*2" 
#   else 
"DELTA=p16+d16+p2+d0*2" 
#   endif /*LABEL_CN*/ 
 
1 ze 
  d11 pl16:f3 
2 d1 do:f3 
3 (p1 ph1) 
  d26 pl3:f3 
  (center (p2 ph1) (p22 ph6):f3 ) 
  d26 UNBLKGRAD 
  p28 ph1 
  d13 
  (p1 ph2)  
  3u 
  p16:gp1 
  d16 
  (p21 ph3):f3 
  d0  
 
#   ifdef LABEL_CN 
  (center (p2 ph5) (p14:sp3 ph1):f2 ) 
#   else 
  (p2 ph5) 
#   endif /*LABEL_CN*/ 
 
  d0 
  p16:gp2*EA 
  d16 
  (p22 ph4):f3 
  DELTA 
  (ralign (p1 ph1) (p21 ph4):f3 ) 
  d26 
  (center (p2 ph1) (p22 ph1):f3 ) 
  d13 
  p16:gp3 
  DELTA1 pl16:f3 
  4u BLKGRAD 
  go=2 ph31 cpd3:f3 
  d1 do:f3 mc #0 to 2  
     F1EA(igrad EA, id0 & ip3*2 & ip6*2 & ip31*2) 
exit 





ph4=0 0 0 0 2 2 2 2 
ph5=0 0 2 2 
ph6=0 
ph31=0 2 0 2 2 0 2 0 
 
;pl1 : f1 channel - power level for pulse (default) 
;pl3 : f3 channel - power level for pulse (default) 
;pl16: f3 channel - power level for CPD/BB decoupling 
;sp3: f2 channel - shaped pulse 180 degree (adiabatic) 
;p1 : f1 channel -  90 degree high power pulse 
;p2 : f1 channel - 180 degree high power pulse 
;p14: f2 channel - 180 degree shaped pulse for inversion 
(adiabatic) 
;p16: homospoil/gradient pulse              [1 msec] 
;p21: f3 channel -  90 degree high power pulse 
;p22: f3 channel - 180 degree high power pulse 
;p28: f1 channel - trim pulse                    [1 msec] 
;d0 : incremented delay (2D)                    [3 usec] 
;d1 : relaxation delay; 1-5 * T1 
;d11: delay for disk I/O                           [30 msec] 
;d13: short delay                                         [4 usec] 
;d16: delay for homospoil/gradient recovery 
;d26: 1/(4J(YH)) 
;cnst4: = J(YH) 
;in0: 1/(2 * SW(X)) = DW(X) 
;nd0: 2 
;NS: 1 * n 
;DS: >= 16 
;td1: number of experiments 
;FnMODE: echo-antiecho 
;cpd3: decoupling according to sequence defined by 
cpdprg3 
;pcpd3: f3 channel - 90 degree pulse for decoupling 
sequence 
 
;use gradient ratio: gp 1 : gp 2 : gp 3 
;50 :   80 : 20.1     for C-13 
;50 :   80 :  8.1     for N-15 
 
;for z-only gradients: 
;gpz1: 50% 
;gpz2: 80% 
;gpz3: 20.1% for C-13, 8.1% for N-15 
 






                                          ;preprocessor-flags-start 
;LABEL_CN: for C-13 and N-15 labeled samples start 
experiment with  
;             option -DLABEL_CN (eda: ZGOPTNS) 
                                          ;preprocessor-flags-end 
 
;$Id: hsqcetf3gp,v 1.2.8.1 2005/11/10 13:18:57 ber Exp $ 
 






;3D sequence with 
;   inverse correlation using multiple inept transfer and 
; 
;      F1(H,t1) -> F2(C,t2) -> F2(C') -> F1(H',t3) 
; 
;off resonance C=O pulse using shaped pulse 
;phase sensitive using States-TPPI 
;(L.E. Kay, G.Y. Xu, A.U. Singer, D.R. Muhandiram & J. D. 
Forman-Kay 



































1 d11 ze 
  d11 pl12:f2 
2 d11 do:f2 
  d11 
3 d11 
4 d11  
5 d11  
6 d1 
  50u UNBLKGRAD 
  d12 pl1:f1 
 
  (p1 ph3) 
  4u 
  p16:gp1 
  d16 
  DELTA1 pl2:f2 
  d0 
  (p4 ph1):f2 
  d0 
  (p2 ph1) 
  4u 
  p16:gp1 
  d16 
  DELTA2 pl3:f3 
  (p1 ph2) 
 
  p19:gp3 
  d16 
 
  (p3 ph4):f2 
  d10 
 ; (p22 ph1):f3 
  4u 
  p29:gp2 
  d16 
  DELTA3 pl0:f2 
 ; (p14:sp5 ph1):f2 
  4u 
  p29:gp2 
  d16 
  DELTA3 pl2:f2 
  p2 ph1 
  d10 
  d22 
  (p4 ph1):f2 
  DELTA4 
  p29:gp2 
  d16 
  DELTA3 
 ; (p14:sp5 ph1):f2 
  4u 
  p29:gp2 
  d16 
  DELTA3 pl2:f2 
  d22 
 
  (p3 ph1):f2 
  4u 
  p29:gp2 
  d16 
  DELTA5 
  (p4 ph1):f2 
  4u 
  p29:gp2 
  d16 
  DELTA5 
  (p3 ph2):f2 
 
  (p17 ph1) 
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  (p17*2 ph2) 
  4u 
  p30:gp4 
  d16 
  (p1 ph1) 
  4u 
  p31:gp4 
  d16 
 
  (p3 ph2):f2 
  4u 
  p16:gp1 
  d16 
  DELTA6 pl2:f2 
  (CEN_HC2 p2 ph1) (p4 ph1):f2 
  4u 
  p16:gp1 
  d16 
  DELTA6 
  (CEN_HC1 p1 ph1) (p3 ph1):f2 
 
  4u 
  p16:gp1 
  d16 
  DELTA1 
  (CEN_HC2 p2 ph1) (p4 ph1):f2 
  4u 
  p16:gp1 
  d16 
  DELTA7  
  (TAU p1 ph1) (p3 ph1 3u p3 ph5):f2 
  4u pl12:f2  
  4u BLKGRAD 
  go=2 ph31 cpd2:f2 
  d11 do:f2 wr #0 if #0 zd 
 
  d11 ip3 
  lo to 3 times 2 
  d11 id0 
  lo to 4 times l3  
  d11 rd0 ip4 
  lo to 5 times 2 
  d11 id10 







ph4=0 0 2 2 
ph5=0 0 0 0 2 2 2 2 
ph31=0 2 2 0 
 
;pl0 : 120dB 
;pl1 : f1 channel - power level for pulse (default) 
;pl2 : f2 channel - power level for pulse (default) 
;pl3 : f3 channel - power level for pulse (default) 
;pl12: f2 channel - power level for CPD/BB decoupling 
;sp5: f2 channel - shaped pulse 180 degree   (C=O off 
resonance) 
;p1 : f1 channel -  90 degree high power pulse 
;p2 : f1 channel - 180 degree high power pulse 
;p3 : f2 channel -  90 degree high power pulse 
;p4 : f2 channel - 180 degree high power pulse 
;p14: f2 channel - 180 degree shaped pulse 
;p16: homospoil/gradient pulse                         [500 usec] 
;p17: f1 channel - trim pulse                     [1 msec] 
;p19: gradient pulse 2                                [2 msec] 
;p22: f3 channel - 180 degree high power pulse 
;p27: f2 channel - trim pulse                     [2 msec] 
;p29: gradient pulse 3                             [300 usec] 
;p30: gradient pulse 4                               [5 msec] 
;p31: gradient pulse 5                             [4.4 msec] 
;d0 : incremented delay (F1 in 3D)           [3 usec] 
;d4 : 1/(4J(CH)) - tau a                            [1.6 msec] 
;d10: incremented delay (F2 in 3D)          [3 usec] 
;d11: delay for disk I/O                            [30 msec] 
;d12: delay for power switching             [20 usec] 
;d16: delay for homospoil/gradient recovery 
;d21: 1/(6J'(CH)) - tau c                          [1.1 msec] 
;d22: d22+d23*2+t2max*0.5 = 1/(4J(CC)) : 3.6m-d23*2-
(in10*l13/2) 
;d23: tau b                                            [475 usec] 
;d24: 1/(4J(CC))                                       [3.6 msec] 
;l3: loop for phase sensitive 3D using  States-TPPI : l3 = 
td1/2 
;l13: loop for phase sensitive 3D using  States-TPPI : l13 = 
td2/2 
;in0: 1/(2 * SW(H)) = DW(H) 
;nd0: 2 
;in10: 1/(2 * SW(C)) = DW(C) 
;nd10: 2 
;NS: 16 * n 
;DS: 32 
;td1: number of experiments in F1 
;td2: number of experiments in F2 
;MC2: States-TPPI in F1 
;MC2: States-TPPI in F2 
;cpd2: decoupling according to sequence defined by 
cpdprg2 
;pcpd2: f2 channel - 90 degree pulse for decoupling 
sequence 
 
;use gradient ratio:    gp 1 : gp 2 : gp 3 : gp 4 
;                         16 :   16 :   30 :   60 
 














2D NOESY with X-Half Filter in F2 
;noesygpphwgx2 
;avance-version (05/02/17) 
;2D homonuclear correlation via dipolar coupling  
;   with C-13 and N-15 filter in F2 
; 
;   H (t1) -> H[C12,N14] (t2) 
; 
;dipolar coupling may be due to noe or chemical exchange. 
;phase sensitive 
;with gradient pulses in mixing time 
;water suppression using watergate sequence 
; 
;A.L. Breeze, Prog. NMR Spectrosc. 36, 323-372 (2000) 
;C. Zwahlen, P. Legault, S.J.F. Vincent, J. Greenblatt, R. 
Konrat & 
;   L.E. Kay, J. Am. Chem. Soc. 119 6711-6721 (1997) 
;K. Ogura, H. Terasawa & F. Inagaki, J. Biomol. NMR 8, 492-
498 (1996) 


































3 d1 pl1:f1 
  (p1 ph4) 
  DELTA 
  (p2 ph5) 
  d0 
  (center (p8:sp13 ph1):f2 (p22 ph1):f3 ) 
  d0 
  (p1 ph6) 
  TAU UNBLKGRAD 
  p16:gp1 
  d16 pl2:f2 
 
  (p1 ph1) 
  p19:gp2 
  d16 
  DELTA1 
  (p15:sp18 ph1):f2 
  DELTA2 
  (center (p2 ph2) (p22 ph1):f3 ) 
  DELTA3 
  p19:gp2 
  d16 pl2:f2 
  (p1 ph3) 
 
  (p3 ph8):f2 
  (p21 ph8):f3 
  p16:gp3 
  d16 
 
  (p1 ph1) 
  p19:gp4 
  d16 
  DELTA4 
  (p15:sp18 ph1):f2 
  DELTA5 
  (center (p2 ph2) (p22 ph1):f3 ) 
  DELTA3 
  p19:gp4 
  d16 pl2:f2 
  (p1 ph3) 
 
  (p3 ph8):f2 
  (p21 ph8):f3 
  p16:gp5 
  d16 
 
  (p1 ph7) 
  4u 
  p16:gp6 
  d16 pl0:f1 
  (p11:sp1 ph9:r):f1 
  4u 
  4u pl1:f1 
  (p2 ph10) 
  4u pl0:f1 
  (p11:sp1 ph9:r):f1 
  4u 
  p16:gp6 
  d16 
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  4u BLKGRAD 
 
  go=2 ph31 






ph4=0 0 0 0 2 2 2 2  
ph5=1 1 1 1 3 3 3 3 
ph6=0 0 0 0 0 0 0 0 2 2 2 2 2 2 2 2 
ph7=0 1 2 3 
ph8=0 1 2 3 
ph9=2 2 2 2 3 3 3 3 0 0 0 0 1 1 1 1 
ph10=0 0 0 0 1 1 1 1 2 2 2 2 3 3 3 3 
ph31=0 3 2 1 0 3 2 1 2 1 0 3 2 1 0 3 
 
;pl0 : 120dB 
;pl1 : f1 channel - power level for pulse (default) 
;pl2 : f2 channel - power level for pulse (default) 
;pl3 : f3 channel - power level for pulse (default) 
;sp1: f1 channel - shaped pulse  90 degree 
;sp13: f2 channel - shaped pulse 180 degree (adiabatic) 
;spnam13: Crp60,0.5,20.1 
;sp18: f2 channel - shaped pulse 180 degree (adiabatic) 
;p1 : f1 channel -  90 degree high power pulse 
;p2 : f1 channel - 180 degree high power pulse 
;p3 : f2 channel -  90 degree high power pulse 
;p8 : f2 channel - 180 degree shaped pulse for inversion 
(adiabatic) 
;p11: f1 channel -  90 degree shaped pulse 
;p15: f2 channel - 180 degree shaped pulse for inversion 
(adiabatic) 
;p16: homospoil/gradient pulse               [1 msec] 
;p19: gradient pulse 2                            [500 usec] 
;p21: f3 channel -  90 degree high power pulse 
;p22: f3 channel - 180 degree high power pulse 
;d0 : incremented delay (2D)                    [3 usec] 
;d1 : relaxation delay; 1-5 * T1 
;d11: delay for disk I/O                           [30 msec] 
;d8 : mixing time 




;cnst4: = J(NH) 
;cnst6: = 1J(CH)min 
;cnst7: = 1J(CH)max 
;in0: 1/(2 * SW) = DW 
;nd0: 2 
;NS: 8 * n 
;DS: 32 
;td1: number of experiments 
;FnMODE: States-TPPI, TPPI, States or QSEQ 
 
;use gradient ratio:    gp 1 : gp 2 : gp 3 : gp 4 : gp 5 : gp 6 
;                         50 :    7 :   40 :    5 :    3 :   30 
 
















;for p15:sp18 use either "Crp60,0.5,20.1" or adiabatic 
pulse  
;   with matched sweep  
;for matched sweep use  
;   low to high field sweep,  
;   carrier shifted to low field end via spoffs18 
;   d28 = d29 = 1/(4*J(CH)aro) 
 
;$Id: noesygpphwgx2,v 1.2.6.2 2006/04/03 14:25:11 ber 
Exp $ 
 
2D NOESY with Double X-Half Filters 
;noesygpphwgxf 
;avance-version (05/09/23) 
;2D homonuclear correlation via dipolar coupling 
;dipolar coupling may be due to noe or chemical exchange 
;phase sensitive 
;selecting C-12 or N-14 bound protons in F1 and F2 
;water suppression using watergate sequence 
; 
;M. Ikura & A. Bax, J. Am. Chem. Soc. 114, 2433-2440 
(1992) 
;M. Piotto, V. Saudek & V. Sklenar, J. Biomol. NMR 2, 661 - 
666 (1992) 
;V. Sklenar, M. Piotto, R. Leppik $ V. Saudek, J. Magn. 
Reson., 






































3 d1 pl1:f1 
  (p1 ph1) 
  d2 
  (p3 ph6):f2  
  (center (p2 ph2) (p22 ph7):f3 ) 
  DELTA 
  (p21 ph6):f3 
  DELTA1 
  (p3 ph7):f2 
  d0 
  (p1 ph3) 
  TAU UNBLKGRAD 
  (p3 ph1):f2  
  (p21 ph1):f3 
  4u 
  p19:gp1 
  TAU1 
  (p1 ph4):f1 
  4u 
  p16:gp2 
  DELTA2 pl0:f1 
  (p11:sp1 ph5:r):f1 
  4u 
  d12 pl1:f1 
  (p3 ph6):f2  
  (center (p2 ph1) (p22 ph7):f3 ) 
  4u 
  d12 pl0:f1 
  (p11:sp1 ph5:r):f1 
  4u 
  p16:gp3 
  DELTA3 
  (p21 ph9):f3 
  DELTA4 
  (p3 ph8):f2 
  4u BLKGRAD 
  go=2 ph31 




ph2=0 1 0 1 0 1 0 1 0 1 0 1 0 1 0 1 
    2 3 2 3 2 3 2 3 2 3 2 3 2 3 2 3 
ph3=0 
ph4=0 0 1 1 2 2 3 3 
ph5=2 
ph6=0 0 0 0 0 0 0 0 2 2 2 2 2 2 2 2  
ph7=0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
    2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2  
ph8=0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
    2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2  
    2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2  
    2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
    2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2  
ph9=0 0 0 0 2 2 2 2 
ph31=0 2 3 1 2 0 1 3 
 
 
;pl0 : 120dB 
;pl1 : f1 channel - power level for pulse (default) 
;pl2 : f2 channel - power level for pulse (default) 
;pl3 : f3 channel - power level for pulse (default) 
;sp1 : f1 channel - shaped pulse  90 degree 
;p1 : f1 channel -  90 degree high power pulse 
;p2 : f1 channel - 180 degree high power pulse 
;p3 : f2 channel -  90 degree high power pulse 
;p11: f1 channel -  90 degree shaped pulse           [1 msec] 
;p16: homospoil/gradient pulse               [1 msec] 
;p19: gradient pulse 2                               [3 msec] 
;p21: f3 channel -  90 degree high power pulse 
;p22: f3 channel - 180 degree high power pulse 
;d0 : incremented delay (2D)                     [3 usec] 
;d1 : relaxation delay; 1-5 * T1 
;d2 : 1/(2J(CH)) 
;d8 : mixing time 
;d11: delay for disk I/O                           [30 msec] 
;d12: delay for power switching             [20 usec] 
;d16: delay for homospoil/gradient recovery 
;d21: 1/(2J(NH)) 
;d24: 1/(2J'(CH)) 
;in0: 1/(1 * SW) = 2 * DW 
;nd0: 1 
;NS: 8 * n 
;DS: 16 
;td1: number of experiments 
;FnMODE: States-TPPI, TPPI, States or QSEQ 
 
 
;use gradient ratio: gp 1 : gp 2 : gp 3 














;$Id: noesygpphwgxf,v 1.5.10.2 2006/04/03 14:25:11 ber 
Exp $ 
 




;3D sequence with 
;   homonuclear correlation via dipolar coupling  
;   dipolar coupling may be due to noe or chemical 
exchange. 
;   H-1/X correlation via double inept transfer 
;phase sensitive (t1) 
;phase sensitive using Echo/Antiecho-TPPI gradient 
selection (t2) 
;using trim pulses in inept transfer 
;with decoupling during acquisition 
;using shaped pulses for inversion on f2 - channel 
;(use parameterset NOESYHSQCETGP3D) 
; 
;A.L. Davis, J. Keeler, E.D. Laue & D. Moskau, J. Magn. 
Reson. 98,  




















#   ifdef LABEL_CN 
"p22=p21*2" 
#   else 





#   ifdef LABEL_CN 
"DELTA=larger(p14,p22)+d0*2" 
"DELTA1=p16+d16+larger(p2,p22)+d10*2" 
#   else 
"DELTA=p14+d0*2" 
"DELTA1=p16+d16+p2+d10*2" 





  d11 pl12:f2 
2 d1 do:f2 
3 d12 pl0:f2 
  (p1 ph7) 
  DELTA 
  (p2 ph8) 
  d0 
 
#   ifdef LABEL_CN 
  (center (p14:sp3 ph1):f2 (p22 ph1):f3 ) 
#   else 
  (p14:sp3 ph1):f2 
#   endif /*LABEL_CN*/ 
 
  d0 
  (p1 ph1):f1 
  d8 
  (p1 ph1):f1 
  DELTA3 pl0:f2 
  4u 
  (center (p2 ph1) (p14:sp3 ph6):f2 ) 
  4u 
  DELTA3 pl2:f2 UNBLKGRAD 
  p28 ph1 
  4u 
  (p1 ph2) (p3 ph3):f2 
  d10  
 
#   ifdef LABEL_CN 
  (center (p2 ph5) (p22 ph1):f3 ) 
#   else 
  (p2 ph5) 
#   endif /*LABEL_CN*/ 
 
  d10 
  p16:gp1*EA 
  d16 
  (p4 ph4):f2 
  DELTA1 
  (ralign (p1 ph1) (p3 ph4):f2 ) 
  DELTA3 pl0:f2 
  (center (p2 ph1) (p14:sp3 ph1):f2 ) 
  4u 
  p16:gp2 
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  DELTA2 pl12:f2 
  4u BLKGRAD 
  go=2 ph31 cpd2:f2 
  d1 do:f2 mc #0 to 2  
     F1PH(rd10 & rp3 & rp6 & rp31 & ip7 & ip8, id0)  






ph4=0 0 0 0 0 0 0 0 2 2 2 2 2 2 2 2 
ph5=0 0 2 2 
ph6=0 
ph7=0 0 0 0 2 2 2 2 
ph8=1 1 1 1 3 3 3 3 
ph31=0 2 0 2 2 0 2 0 2 0 2 0 0 2 0 2 
 
;pl0 : 120dB 
;pl1 : f1 channel - power level for pulse (default) 
;pl2 : f2 channel - power level for pulse (default) 
;pl3 : f3 channel - power level for pulse (default) 
;pl12: f2 channel - power level for CPD/BB decoupling 
;sp3: f2 channel - shaped pulse 180 degree 
;p1 : f1 channel -  90 degree high power pulse 
;p2 : f1 channel - 180 degree high power pulse 
;p3 : f2 channel -  90 degree high power pulse 
;p4 : f2 channel - 180 degree high power pulse 
;p14: f2 channel - 180 degree shaped pulse for inversion 
;p16: homospoil/gradient pulse 
;p22: f3 channel - 180 degree high power pulse 
;p28: f1 channel - trim pulse 
;d0 : incremented delay (F1 in 3D)           [3 usec] 
;d1 : relaxation delay; 1-5 * T1 
;d4 : 1/(4J)XH 
;d8 : mixing time 
;d10: incremented delay (F2 in 3D)          [3 usec] 
;d11: delay for disk I/O                            [30 msec] 
;d12: delay for power switching             [20 usec] 
;d16: delay for homospoil/gradient recovery 
;cnst2: = J(XH) 
;in0: 1/(2 * SW(H)) =  DW(H) 
;nd0: 2 
;in10: 1/(2 * SW(X)) = DW(X) 
;nd10: 2 
;NS: 8 * n 
;DS: >= 16 
;td1: number of experiments in F1 
;td2: number of experiments in F2 
;FnMODE: States-TPPI (or TPPI) in F1 
;FnMODE: echo-antiecho in F2 
;cpd2: decoupling according to sequence defined by 
cpdprg2 
;pcpd2: f2 channel - 90 degree pulse for decoupling 
sequence 
 
;use gradient ratio:    gp 1 : gp 2 
;                         80 : 20.1    for C-13 
;                         80 :  8.1    for N-15 
 
;for z-only gradients: 
;gpz1: 80% 
;gpz2: 20.1% for C-13, 8.1% for N-15 
 




                                          ;preprocessor-flags-start 
;LABEL_CN: for C-13 and N-15 labeled samples start 
experiment with  
;             option -DLABEL_CN (eda: ZGOPTNS) 
                                          ;preprocessor-flags-end 
 








;3D sequence with 
;   inverse correlation for triple resonance 
;      via inept transfer steps 
;      and DIPSI3 CC spinlock 
; 
;   in U: 
;      F1(H6/5,t1) -> F2(C6/5 -> C4) -> F3(N3,t2) -> F1(H3,t3) 
; 
;   in C: 
;      F1(H6/5,t1) -> F2(C6/5 -> C4) -> F3(N4,t2) -> F1(H4,t3) 
; 
;on/off resonance C pulses using shaped pulse 
;phase sensitive (t1) 
;phase sensitive (t2) 
;using constant time in t2 
;water suppression using watergate sequence 
;(use parameterset NA_H56C56C4N3H_3D) 
; 
;J. Woehnert, M. Goerlach & H. Schwalbe, 

















































  d11 pl16:f3 
2 d11 do:f3 
 
3 d1 pl1:f1 pl3:f3  
  30u fq=cnst0(bf ppm):f2 
  50u UNBLKGRAD 
 
  (p3 ph1):f2 
  (p21 ph1):f3 
  p16:gp3 
  d16 
 
  (p1 ph3) 
  DELTA1 
  d0 
  (p8:sp13 ph1):f2 
  d0 
  (p2 ph1) 
  DELTA2 
  (p1 ph2)  
 
  p16:gp4 
  d16 
 
  (p3 ph4):f2 
  DELTA3 
  4u 
  (center (p2 ph1) (p8:sp13 ph1):f2 ) 
  4u 
  DELTA3 pl15:f2 
     
 ;begin DIPSI3 
4 (p9*2.722 ph11):f2 
  (p9*4.389 ph12):f2 
  (p9*2.778 ph11):f2 
  (p9*3.056 ph12):f2 
  (p9*0.333 ph11):f2 
  (p9*2.556 ph12):f2 
  (p9*4.000 ph11):f2 
  (p9*2.722 ph12):f2 
  (p9*4.111 ph11):f2 
  (p9*3.778 ph12):f2 
  (p9*3.889 ph11):f2 
  (p9*2.889 ph12):f2 
  (p9*3.000 ph11):f2 
  (p9*0.333 ph12):f2 
  (p9*2.500 ph11):f2 
  (p9*4.050 ph12):f2 
  (p9*2.830 ph11):f2 
  (p9*4.389 ph12):f2 
 
  (p9*2.722 ph12):f2 
  (p9*4.389 ph11):f2 
  (p9*2.778 ph12):f2 
  (p9*3.056 ph11):f2 
  (p9*0.333 ph12):f2 
  (p9*2.556 ph11):f2 
  (p9*4.000 ph12):f2 
  (p9*2.722 ph11):f2 
  (p9*4.111 ph12):f2 
  (p9*3.778 ph11):f2 
  (p9*3.889 ph12):f2 
  (p9*2.889 ph11):f2 
  (p9*3.000 ph12):f2 
  (p9*0.333 ph11):f2 
  (p9*2.500 ph12):f2 
  (p9*4.050 ph11):f2 
  (p9*2.830 ph12):f2 
  (p9*4.389 ph11):f2 
 
  (p9*2.722 ph12):f2 
  (p9*4.389 ph11):f2 
  (p9*2.778 ph12):f2 
  (p9*3.056 ph11):f2 
  (p9*0.333 ph12):f2 
  (p9*2.556 ph11):f2 
  (p9*4.000 ph12):f2 
  (p9*2.722 ph11):f2 
  (p9*4.111 ph12):f2 
  (p9*3.778 ph11):f2 
  (p9*3.889 ph12):f2 
  (p9*2.889 ph11):f2 
  (p9*3.000 ph12):f2 
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  (p9*0.333 ph11):f2 
  (p9*2.500 ph12):f2 
  (p9*4.050 ph11):f2 
  (p9*2.830 ph12):f2 
  (p9*4.389 ph11):f2 
 
  (p9*2.722 ph11):f2 
  (p9*4.389 ph12):f2 
  (p9*2.778 ph11):f2 
  (p9*3.056 ph12):f2 
  (p9*0.333 ph11):f2 
  (p9*2.556 ph12):f2 
  (p9*4.000 ph11):f2 
  (p9*2.722 ph12):f2 
  (p9*4.111 ph11):f2 
  (p9*3.778 ph12):f2 
  (p9*3.889 ph11):f2 
  (p9*2.889 ph12):f2 
  (p9*3.000 ph11):f2 
  (p9*0.333 ph12):f2 
  (p9*2.500 ph11):f2 
  (p9*4.050 ph12):f2 
  (p9*2.830 ph11):f2 
  (p9*4.389 ph12):f2 
  lo to 4 times l1 
     
 ;end DIPSI3 
  4u pl2:f2 
  (p3 ph2):f2 
 
  4u 
  30u fq=cnst24(bf ppm):f2 
 
  (p13:sp2 ph5):f2 
  d25 
  (center (p14:sp3 ph1):f2 (p30:sp9 ph1):f3 ) 
  d25 
  (p13:sp8 ph2):f2 
 
  (p21 ph6):f3 
  d10 
  d24 
  (p2 ph1) 
  DELTA4 
  (center (p14:sp3 ph1):f2 (p30:sp9 ph1):f3 ) 
  d30 
  (p21 ph1):f3 
 
  p16:gp4 
  d16 
 
  (p1 ph1)  
  p16:gp5 
  d16 
  DELTA5 pl0:f1 
  (p11:sp1 ph7):f1 
  4u 
  4u pl1:f1 
  (center (p2 ph1) (p22 ph1):f3 ) 
  4u pl0:f1 
  (p11:sp1 ph7):f1 
  DELTA5 
  p16:gp5 
  d16 pl16:f3 
  4u BLKGRAD 
 
  go=2 ph31 cpd3:f3  
  d11 do:f3 mc #0 to 2  
     F1PH(ip3, id0) 
     F2PH(rd0 & rp3 & ip6, id10 & dd30) 
exit 
    
ph1=0  
ph2=1 
ph3=0 0 0 0 2 2 2 2 
ph4=0 0 0 0 0 0 0 0 2 2 2 2 2 2 2 2 





ph31=0 2 2 0 2 0 0 2 2 0 0 2 0 2 2 0 
 
;pl0 : 120db 
;pl1 : f1 channel - power level for pulse (default) 
;pl2 : f2 channel - power level for pulse (default) 
;pl3 : f3 channel - power level for pulse (default) 
;pl15: f2 channel - power level for TOCSY-spinlock 
;pl16: f3 channel - power level for CPD/BB decoupling 
;sp1: f1 channel - shaped pulse  90 degree  (H2O on 
resonance) 
;sp2 : f2 channel - shaped pulse  90 degree  (on resonance) 
;sp3 : f2 channel - shaped pulse 180 degree (on resonance) 
;sp8 : f2 channel - shaped pulse  90 degree  (on resonance) 
;                  for time reversed pulse 
;sp9 : f3 channel - shaped pulse 180 degree (N on 
resonance) 
;sp13: f2 channel - shaped pulse 180 degree (adiabatic) 
;spnam13: Crp60,0.5,20.1 
;p1 : f1 channel -  90 degree high power pulse 
;p2 : f1 channel - 180 degree high power pulse 
;p3 : f2 channel -  90 degree high power pulse 
;p8 : f2 channel - 180 degree shaped pulse for inversion 
(adiabatic) 
;     = 500usec for Crp60,0.5,20.1 
;p9 : f2 channel -  90 degree low power pulse 
;p11: f1 channel -  90 degree shaped pulse             [1 msec] 
;p13: f2 channel -  90 degree shaped pulse 
;p14: f2 channel - 180 degree shaped pulse 
;p16: homospoil/gradient pulse                         [1 msec] 
;p21: f3 channel -  90 degree high power pulse 
;p22: f3 channel - 180 degree high power pulse 
;p30: f3 channel - 180 degree shaped pulse 
;d0 : incremented delay (F1 in 3D)                     [3 usec] 
;d1 : relaxation delay: 1-5 * T1 
;d4 : 1/(4J(C5H5))                                     [1.25 msec] 
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;d10: incremented delay (F2 in 3D)                     [3 usec] 
;d11: delay for disk I/O                               [30 msec] 
;d15: TOCSY mixing time (CC)                           [19.5 msec] 
;d16: delay for homospoil/gradient recovery 
;d24: for U: 1/((4J)NH))                               [2.7 msec] 
;     for C: 1/((8J)NH))                               [1.4 msec] 
;d25: 1/(4J(C4N))                                      [10 msec] 
;d26: 1/(4J(NH))                                       [2.5 msec] 
;d30: decremented delay (F2 in 3D) = d25 
;cnst0 : (cnst28 + cnst24)/2 
;cnst24: C4 (C/U) chemical shift (offset, in ppm)      [169 
ppm] 
;cnst28: C5 (C/U) chemical shift (offset, in ppm)      [105 
ppm] 
;o3p: for U: 160 ppm, for C: 100 ppm 
;l1: loop for DIPSI cycle: 
;       mixing time = ((p9*217.3) * l1)                [19.5 msec] 
;in0: 1/(2 * SW(H)) = DW(H) 
;nd0: 2 
;in10: 1/(2 * SW(N)) = DW(N) 
;nd10: 2 
;in30: = in10 
;NS: 16 * n 
;DS: >= 32 
;td1: number of experiments in F1 
;td2: number of experiments in F2       td2 max = 2 * d30 / 
in30 
;FnMODE: States-TPPI (or TPPI) in F1 
;FnMODE: States-TPPI (or TPPI) in F2 
;cpd3: decoupling according to sequence defined by 
cpdprg3 
;pcpd3: f3 channel - 90 degree pulse for decoupling 
sequence 
 
;use gradient ratio: gp 3 : gp 4 : gp 5 
;     50 :   80 :   30 
 










;calculate pulselength according to: 
; 
;   (DeltaOmega * DeltaT) / (width of region[ppm] * 
SFOn{MHz}) 
; 
;for p13 (sp2/sp8) use Q5/Q5tr pulse (DeltaOmega * 
DeltaT = 6.180) 
;      to cover 41.0ppm on resonance 
;      (pulselength: 1.0ms at 600.13 MHz) 
;for p14 (sp3) use Q3 pulse (DeltaOmega * DeltaT = 3.448) 
;      to cover 22.8ppm on or off resonance 
;      (pulselength: 1.0ms at 600.13 MHz) 
;for p30 (sp9) use Q3 pulse (DeltaOmega * DeltaT = 3.448) 
;   to cover 81ppm (N1/N9) 
;   (pulselength: 700us at 600.13 MHz) 
 
;$Id: na_h56c56c4n3h_3d,v 1.1.2.2 2006/01/26 08:40:39 





;HCCNH-TOCSY: H6/8(CCC)NH                    
;3D sequence with 
;   inverse correlation for triple resonance  
;      via multiple inept transfer steps 
;      and DIPSI3 CC spinlock and CN hetero TOCSY 
; 
;   in U: 
;      F1(H6,t1) -> F2(C) -> F3(N3,t2) -> F1(NH,t3) 
; 
;   in G: 
;      F1(H8,t1) -> F2(C) -> F3(N1,t2) -> F1(NH,t3) 
; 
;phase sensitive (t1) 
;phase sensitive (t2) 
;water suppression using watergate sequence 
;(use parameterset NA_HCCNHDIGPWG3D) 
; 
;V. Sklenar, T. Dieckmann, S. E.Butcher & J. Feigon, 


































  d11 pl16:f3 
2 d11 do:f3 
3 d12 pl9:f1 pl2:f2 
  d1 cw:f1 ph29 
  4u do:f1 
  d12 pl1:f1 
   
  (p1 ph3):f1 
  DELTA UNBLKGRAD 
  d0 
  (p4 ph6):f2 
  d0 
  (p2 ph1) 
  d4 
  (p1 ph2)  
 
  d13 
  p16:gp1 
  d16 
 
  (p3 ph4):f2 
  d4 
  (center (p2 ph1) (p4 ph1):f2 ) 
  d4 pl26:f2 pl23:f3 
 
  (p20 ph7):f2      
     ;begin 
DIPSI3:f2 
4 (p25*2.722 ph7):f2 
  (p25*4.389 ph9):f2 
  (p25*2.778 ph7):f2 
  (p25*3.056 ph9):f2 
  (p25*0.333 ph7):f2 
  (p25*2.556 ph9):f2 
  (p25*4.000 ph7):f2 
  (p25*2.722 ph9):f2 
  (p25*4.111 ph7):f2 
  (p25*3.778 ph9):f2 
  (p25*3.889 ph7):f2 
  (p25*2.889 ph9):f2 
  (p25*3.000 ph7):f2 
  (p25*0.333 ph9):f2 
  (p25*2.500 ph7):f2 
  (p25*4.050 ph9):f2 
  (p25*2.830 ph7):f2 
  (p25*4.389 ph9):f2 
  (p25*2.722 ph9):f2 
  (p25*4.389 ph7):f2 
  (p25*2.778 ph9):f2 
  (p25*3.056 ph7):f2 
  (p25*0.333 ph9):f2 
  (p25*2.556 ph7):f2 
  (p25*4.000 ph9):f2 
  (p25*2.722 ph7):f2 
  (p25*4.111 ph9):f2 
  (p25*3.778 ph7):f2 
  (p25*3.889 ph9):f2 
  (p25*2.889 ph7):f2 
  (p25*3.000 ph9):f2 
  (p25*0.333 ph7):f2 
  (p25*2.500 ph9):f2 
  (p25*4.050 ph7):f2 
  (p25*2.830 ph9):f2 
  (p25*4.389 ph7):f2 
  (p25*2.722 ph9):f2 
  (p25*4.389 ph7):f2 
  (p25*2.778 ph9):f2 
  (p25*3.056 ph7):f2 
  (p25*0.333 ph9):f2 
  (p25*2.556 ph7):f2 
  (p25*4.000 ph9):f2 
  (p25*2.722 ph7):f2 
  (p25*4.111 ph9):f2 
  (p25*3.778 ph7):f2 
  (p25*3.889 ph9):f2 
  (p25*2.889 ph7):f2 
  (p25*3.000 ph9):f2 
  (p25*0.333 ph7):f2 
  (p25*2.500 ph9):f2 
  (p25*4.050 ph7):f2 
  (p25*2.830 ph9):f2 
  (p25*4.389 ph7):f2 
  (p25*2.722 ph7):f2 
  (p25*4.389 ph9):f2 
  (p25*2.778 ph7):f2 
  (p25*3.056 ph9):f2 
  (p25*0.333 ph7):f2 
  (p25*2.556 ph9):f2 
  (p25*4.000 ph7):f2 
  (p25*2.722 ph9):f2 
  (p25*4.111 ph7):f2 
  (p25*3.778 ph9):f2 
  (p25*3.889 ph7):f2 
  (p25*2.889 ph9):f2 
  (p25*3.000 ph7):f2 
  (p25*0.333 ph9):f2 
  (p25*2.500 ph7):f2 
  (p25*4.050 ph9):f2 
  (p25*2.830 ph7):f2 
  (p25*4.389 ph9):f2 
  lo to 4 times l1 
 
     ;begin 
DIPSI3:f3 
5 (p25*2.722 ph7):f2 (p25*2.722 ph7):f3 
  (p25*4.389 ph9):f2 (p25*4.389 ph9):f3 
  (p25*2.778 ph7):f2 (p25*2.778 ph7):f3 
  (p25*3.056 ph9):f2 (p25*3.056 ph9):f3 
  (p25*0.333 ph7):f2 (p25*0.333 ph7):f3 
  (p25*2.556 ph9):f2 (p25*2.556 ph9):f3 
  (p25*4.000 ph7):f2 (p25*4.000 ph7):f3 
  (p25*2.722 ph9):f2 (p25*2.722 ph9):f3 
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  (p25*4.111 ph7):f2 (p25*4.111 ph7):f3 
  (p25*3.778 ph9):f2 (p25*3.778 ph9):f3 
  (p25*3.889 ph7):f2 (p25*3.889 ph7):f3 
  (p25*2.889 ph9):f2 (p25*2.889 ph9):f3 
  (p25*3.000 ph7):f2 (p25*3.000 ph7):f3 
  (p25*0.333 ph9):f2 (p25*0.333 ph9):f3 
  (p25*2.500 ph7):f2 (p25*2.500 ph7):f3 
  (p25*4.050 ph9):f2 (p25*4.050 ph9):f3 
  (p25*2.830 ph7):f2 (p25*2.830 ph7):f3 
  (p25*4.389 ph9):f2 (p25*4.389 ph9):f3 
  (p25*2.722 ph9):f2 (p25*2.722 ph9):f3 
  (p25*4.389 ph7):f2 (p25*4.389 ph7):f3 
  (p25*2.778 ph9):f2 (p25*2.778 ph9):f3 
  (p25*3.056 ph7):f2 (p25*3.056 ph7):f3 
  (p25*0.333 ph9):f2 (p25*0.333 ph9):f3 
  (p25*2.556 ph7):f2 (p25*2.556 ph7):f3 
  (p25*4.000 ph9):f2 (p25*4.000 ph9):f3 
  (p25*2.722 ph7):f2 (p25*2.722 ph7):f3 
  (p25*4.111 ph9):f2 (p25*4.111 ph9):f3 
  (p25*3.778 ph7):f2 (p25*3.778 ph7):f3 
  (p25*3.889 ph9):f2 (p25*3.889 ph9):f3 
  (p25*2.889 ph7):f2 (p25*2.889 ph7):f3 
  (p25*3.000 ph9):f2 (p25*3.000 ph9):f3 
  (p25*0.333 ph7):f2 (p25*0.333 ph7):f3 
  (p25*2.500 ph9):f2 (p25*2.500 ph9):f3 
  (p25*4.050 ph7):f2 (p25*4.050 ph7):f3 
  (p25*2.830 ph9):f2 (p25*2.830 ph9):f3 
  (p25*4.389 ph7):f2 (p25*4.389 ph7):f3 
  (p25*2.722 ph9):f2 (p25*2.722 ph9):f3 
  (p25*4.389 ph7):f2 (p25*4.389 ph7):f3 
  (p25*2.778 ph9):f2 (p25*2.778 ph9):f3 
  (p25*3.056 ph7):f2 (p25*3.056 ph7):f3 
  (p25*0.333 ph9):f2 (p25*0.333 ph9):f3 
  (p25*2.556 ph7):f2 (p25*2.556 ph7):f3 
  (p25*4.000 ph9):f2 (p25*4.000 ph9):f3 
  (p25*2.722 ph7):f2 (p25*2.722 ph7):f3 
  (p25*4.111 ph9):f2 (p25*4.111 ph9):f3 
  (p25*3.778 ph7):f2 (p25*3.778 ph7):f3 
  (p25*3.889 ph9):f2 (p25*3.889 ph9):f3 
  (p25*2.889 ph7):f2 (p25*2.889 ph7):f3 
  (p25*3.000 ph9):f2 (p25*3.000 ph9):f3 
  (p25*0.333 ph7):f2 (p25*0.333 ph7):f3 
  (p25*2.500 ph9):f2 (p25*2.500 ph9):f3 
  (p25*4.050 ph7):f2 (p25*4.050 ph7):f3 
  (p25*2.830 ph9):f2 (p25*2.830 ph9):f3 
  (p25*4.389 ph7):f2 (p25*4.389 ph7):f3 
  (p25*2.722 ph7):f2 (p25*2.722 ph7):f3 
  (p25*4.389 ph9):f2 (p25*4.389 ph9):f3 
  (p25*2.778 ph7):f2 (p25*2.778 ph7):f3 
  (p25*3.056 ph9):f2 (p25*3.056 ph9):f3 
  (p25*0.333 ph7):f2 (p25*0.333 ph7):f3 
  (p25*2.556 ph9):f2 (p25*2.556 ph9):f3 
  (p25*4.000 ph7):f2 (p25*4.000 ph7):f3 
  (p25*2.722 ph9):f2 (p25*2.722 ph9):f3 
  (p25*4.111 ph7):f2 (p25*4.111 ph7):f3 
  (p25*3.778 ph9):f2 (p25*3.778 ph9):f3 
  (p25*3.889 ph7):f2 (p25*3.889 ph7):f3 
  (p25*2.889 ph9):f2 (p25*2.889 ph9):f3 
  (p25*3.000 ph7):f2 (p25*3.000 ph7):f3 
  (p25*0.333 ph9):f2 (p25*0.333 ph9):f3 
  (p25*2.500 ph7):f2 (p25*2.500 ph7):f3 
  (p25*4.050 ph9):f2 (p25*4.050 ph9):f3 
  (p25*2.830 ph7):f2 (p25*2.830 ph7):f3 
  (p25*4.389 ph9):f2 (p25*4.389 ph9):f3 
  lo to 5 times l4 
     ;end 
DIPSI3:f2, DIPSI3:f3 
 
  d13  
  d12 pl2:f2 pl3:f3 
  DELTA2 
  d10 gron0 
  2u groff 
  (center (p2 ph1):f1 (p4 ph1):f2 ) 
  d10 gron0*-1 
  2u groff 
  (p22 ph1):f3 
  d26 
  (p21 ph5):f3 
 
  d13 
  p16:gp2  
  d16 pl0:f1 
  (p29:sp11 ph10:r):f1    
  d13      
  d12 pl1:f1 
 
  (p1 ph1):f1 
  DELTA1 
  p16:gp3    
  d16 
  d12 pl0:f1   
  (p11:sp1 ph11:r):f1    
  d13      
  d12 pl1:f1 
  (center (p2 ph1):f1 (p22 ph8):f3 ) 
  d13 
  d12 pl0:f1 
  (p11:sp1 ph11:r):f1    
  d12 
  p16:gp3     
  d16 
  DELTA1 pl16:f3 
  4u BLKGRAD 
  go=2 ph31 cpd3:f3 
  d11 do:f3 mc #0 to 2 
     F1PH(ip3 & ip29, id0) 
     F2PH(rd0 & rp3 & ip5 & ip8, id10) 
exit 
 
ph1 = 0   
ph2 = 1 
ph3 = 0 
ph4 = 1 3 
ph5 = 1 1 3 3  
ph6 = 0 0 0 0 2 2 2 2 
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ph7 = 1  
ph8 = 0 
ph9 = 3 
ph10= 2  
ph11= 2 
ph29=0 
ph31= 0 2 2 0 
 
;pl0 : 120db 
;pl1 : f1 channel - power level for pulse (default) 
;pl2 : f2 channel - power level for pulse (default) 
;pl3 : f3 channel - power level for pulse (default) 
;pl9 : f1 channel - power level for presaturation 
;pl16: f3 channel - power level for CPD/BB decoupling 
;pl23: f3 channel - power level for TOCSY-spinlock 
;pl26: f2 channel - power level for TOCSY-spinlock (higher 
sel. II) 
;         to match p25/pl23 
;sp1 : f1 channel - shaped pulse  90 degree  (H2O on 
resonance) 
;sp11: f1 channel - shaped pulse  90 degree  (H2O on 
resonance) 
;p1 : f1 channel -  90 degree high power pulse 
;p2 : f1 channel - 180 degree high power pulse 
;p3 : f2 channel -  90 degree high power pulse 
;p4 : f2 channel - 180 degree high power pulse 
;p11: f1 channel -  90 degree shaped pulse              [1 msec] 
;p16: homospoil/gradient pulse 1                        [1 msec] 
;p20: f2 channel - trim pulse                           [2 msec] 
;p21: f3 channel -  90 degree high power pulse 
;p22: f3 channel - 180 degree high power pulse 
;p25: f3 channel -  90 degree pulse at pl23 
;p29: f1 channel -  90 degree shaped pulse 
 [1 msec] 
;d0 : incremented delay (F1 in 3D)                      [3 usec] 
;d1 : relaxation delay; 1-5 * T1 
;d4 : 1/(4J(HC))                                        [1.3 msec] 
;d10: incremented delay (F2 in 3D)                      [6 usec] 
;d11: delay for disk I/O                                [30 msec] 
;d12: delay for power switching                         [20 usec] 
;d13: short delay                                       [4 usec] 
;d16: delay for homospoil/gradient recovery 
;d26: 1/(4J(HN))    
 [2.5 msec] 
;cnst2: = J(HC) 
;cnst4: = J(HN) 
;o2p: 149 ppm 
;o3p: 160 ppm 
;l1: loop for DIPSI cycle: mixing time C-13 only 
;       mixing time = ((p25*217.3) * l1) + (p20) [19.4 
msec] 
;l4: loop for DIPSI cycle: mixing time C-13/N-15 
;       mixing time = ((p25*217.3) * l4)  [58 msec] 
;in0: 1/(2 * SW(H)) = DW(H) 
;nd0: 2 
;in10: 1/(2 * SW(C)) = DW(C) 
;nd10: 2 
;NS: 16 * n 
;DS: 32 
;td1: number of experiments in F1 
;td2: number of experiments in F2        
;FnMODE: States-TPPI (or TPPI) in F1 
;FnMODE: States-TPPI (or TPPI) in F2 
;cpd3: decoupling according to sequence defined by 
cpdprg3 




;use gradient ratio:    gp 0 : gp 1 : gp 2 : gp 3 
;                          3 :   35 :   25 :   60 
 











;set pl9 to 120dB when presaturation is not required 
;   use 75 - 80dB to reduce radiation damping 
 
;$Id: na_hccnhdigpwg3d,v 1.1.2.2 2006/03/10 18:08:32 






;3D sequence with 
;   inverse correlation for triple resonance using multiple 
;      inept transfer steps 
; 
;      F1(H6/8) -> F2(C6/8) -> F3(N1/9,t1)  
;                    -> F2(C6/8,t2) -> F1(H6/8,t3) 
;      and/or 
;      F1(H1') -> F2(C1') -> F3(N1/9,t1)  
;                    -> F2(C1',t2) -> F1(H1',t3) 
; 
;using shaped pulses on f2 and f3 
;phase sensitive (t1) 
;phase sensitive using Echo/Antiecho gradient selection 
(t2) 
;using constant time in t2 
;with decoupling during acquisition 
;(use parameterset NA_HCNETGPSISP3D) 
; 
;V. Sklenar, R.D. Peterson, M.R. Rejante & J. Feigon, 







































1 ze  
  d11 pl12:f2 pl16:f3 
2 d11 do:f2 do:f3 
3 d1 
  (p1 ph1) 
  d4 pl2:f2 pl3:f3 
  (center (p2 ph1) (p4 ph1):f2 ) 
  d4 UNBLKGRAD              
  p28 ph1 
  d13 
  (p1 ph2) 
 
  d13 
  p16:gp1 
  d16 
   
  (p3 ph3):f2 
  DELTA1 
  d13 
  p16:gp2 
  d16 pl0:f2 pl0:f3 
  (center (p14:sp3 ph1):f2 (p30:sp9 ph1):f3 ) 
  d13 
  p16:gp2 
  d16 pl2:f2 pl3:f3 
  DELTA1 
  (p3 ph2):f2 
  
  (p21 ph5):f3 
  d0 
  (center (p2 ph1) (p4 ph6):f2 ) 
  d0 
  (p22 ph1):f3 
  DELTA 
  (p21 ph1):f3 
 
  d13 
  p16:gp5 
  d16 
   
  (p3 ph7):f2 
  d10 
  (center (p2 ph1) (p22 ph1):f3 ) 
  DELTA2 
  p16:gp3*EA*-1 
  d16 pl0:f2 pl0:f3 
  (center (p14:sp3 ph1):f2 (p30:sp9 ph1):f3 ) 
  d13 
  p16:gp3*EA 
  d16 pl2:f2 
  d30 
  
  (center (p1 ph1) (p3 ph8):f2 ) 
  d4 
  (center (p2 ph1) (p4 ph1):f2 ) 
  d4 
  (center (p1 ph2) (p3 ph9):f2 ) 
  d4 
  (center (p2 ph1) (p4 ph1):f2 ) 
  d4 
  (p1 ph1)   
  DELTA3 
  (p2 ph1)  
  d13 
  p16:gp4 
  d16 pl12:f2 pl16:f3 
  4u  BLKGRAD                  
  go=2 ph31 cpd2:f2 cpd3:f3 
  d11 do:f2 do:f3 mc #0 to 2 
     F1PH(rd10 & rd30 & rp6 & rp7 & rp31 & ip4 & ip5, id0) 
     F2EA(igrad EA & ip9*2, id10 & dd30 & ip6*2 & ip7*2 & 
ip31*2) 
exit  
   
ph1=0 
ph2=1 
ph3=0 0 0 0 2 2 2 2  






ph8=0 0 2 2  
ph9=3 3 1 1  
ph31=0 2 2 0 2 0 0 2 
 
;pl0 : 120db 
;pl1 : f1 channel - power level for pulse (default) 
;pl2 : f2 channel - power level for pulse (default) 
;pl3 : f3 channel - power level for pulse (default) 
;pl12: f2 channel - power level for CPD/BB decoupling 
;pl16: f3 channel - power level for CPD/BB decoupling 
;sp3: f2 channel - shaped pulse 180 degree (on resonance) 
;sp9: f3 channel - shaped pulse 180 degree (on resonance) 
;p1 : f1 channel -  90 degree high power pulse 
;p2 : f1 channel - 180 degree high power pulse 
;p3 : f2 channel -  90 degree high power pulse 
;p4 : f2 channel - 180 degree high power pulse 
;p14: f2 channel - 180 degree shaped pulse 
;p16: homospoil/gradient pulse   
 [1 msec] 
;p21: f3 channel -  90 degree high power pulse 
;p22: f3 channel - 180 degree high power pulse 
;p28: f1 channel - trim pulse                           [1 msec] 
;p30: f3 channel - 180 degree shaped pulse for inversion 
;d0 : incremented delay (F1 in 3D)  
 [3 usec] 
;d1 : relaxation delay; 1-5 * T1   
;d4 : 1/(4J(HC)) for both:                              [1.4 msec] 
;                for H1':                               [1.56 msec] 
;                for H8':                               [1.25 msec] 
;d10: incremented delay (F2 in 3D)  
 [3 usec] 
;d11: delay for disk I/O                                [30 msec] 
;d13: short delay                                       [4 usec] 
;d16: delay for homospoil/gradient recovery 
;d22: 1/(4J(CN)) 
;        C1':                                           [19 msec] 
;        C6/C8:                                         [16 msec] 
;        both                                           [17.5 msec] 
;        and constant time delay T(C) = 1/(J(CC)) with J(CC)=40 
Hz 
;d30: decremented delay (F2 in 3D) = d22-d13-p16-d16-
p14/2 
;o2p: 90(C1') or 137(C6/C8) or 113.5 ppm(both) 
;o3p: 157 ppm 
;in0: 1/(2 * SW(N)) =  DW(N) 
;nd0: 2 
;in10: 1/(2 * SW(C)) = DW(C) 
;nd10: 2 
;in30: = in10 
;NS: 8 * n 
;DS: >= 32 
;td1: number of experiments in F1 
;td2: number of experiments in F2       td2 max = 2 * d30 / 
in30 
;FnMODE: States-TPPI (or TPPI) in F1 
;FnMODE: echo-antiecho in F2 
;cpd2: decoupling according to sequence defined by 
cpdprg2 
;cpd3: decoupling according to sequence defined by 
cpdprg3 
;pcpd2: f2 channel - 90 degree pulse for decoupling 
sequence 




;use gradient ratio:   gp 1 : gp 2 : gp 3 : gp 4 : gp 5 
;    -40 :   25 :   40 : 20.1 :  -50 
 




;gpz4: 20.1%   
;gpz5: -50% 
 









;F2 reverse: true 
 
;calculate pulselength according to: 
;    
;   (DeltaOmega * DeltaT) / (width of region[ppm] * 
SFOn{MHz}) 
; 
;for p14 (sp3) use Q3 pulse (DeltaOmega * DeltaT = 3.448) 
;   either one pulse to cover 22.8ppm (C1' or C6/C8 in 
separate  
;      experiments) 
;   (pulselength: 1ms at 600.13 MHz) 
;   or a twofold modulated pulse to cover 8.8ppm at 
90ppm (C1')  
;      and 137ppm (C6/C8) (both in one experiment) 
;   (pulselength: 2.6ms at 600.13 MHz) 
;for p30 (sp9) use Q3 pulse (DeltaOmega * DeltaT = 3.448) 
;   to cover 81ppm (N1/N9) 
;   (pulselength: 700us at 600.13 MHz) 
 














Appendix C: UUCG Chemical Shifts and Restraints for Structure Calculations 
UUCG 16mer Assigned Chemical Shifts 
   1   7.633 0.000 H6      9 
   2   2.634 0.000 H5pp    9 
   3   3.533 0.000 H5p     9 
   4   3.727 0.000 H4p     9 
   5   4.418 0.000 H3p     9 
   6   6.074 0.000 H5      9 
   7   5.893 0.000 H1p     9 
   8   7.966 0.000 H6      8 
   9   5.799 0.000 H5      8 
  10   6.047 0.000 H1p     8 
  11   4.606 0.000 H2p     8 
  12   3.982 0.000 H5pp    8 
  13   4.196 0.000 H5p     8 
  14   3.962 0.000 H3p     8 
  15   4.438 0.000 H4p     8 
  16   7.719 0.000 H6      7 
  17   5.671 0.000 H5      7 
  18   5.607 0.000 H1p     7 
  19   3.727 0.000 H2p     7 
  20   4.022 0.000 H5pp    7 
  21   4.324 0.000 H4p     7 
  22   4.438 0.000 H5p     7 
  23   4.458 0.000 H3p     7 
  24   7.795 0.000 H8     10 
  25   5.893 0.000 H1p    10 
  26   5.558 0.000 H3p    10 
  27   4.773 0.000 H2p    10 
  28   4.129 0.000 H5pp   10 
  29   8.235 0.000 H8     11 
  30   4.207 0.000 H3p    11 
  34   7.524 0.000 H6      4 
  35   5.158 0.000 H5      4 
  36   7.419 0.000 H6      6 
  37   5.162 0.000 H5      6 
  38   8.097 0.000 H8      3 
  39   5.767 0.000 H1p     3 
  40   8.148 0.000 H8      1 
  41   5.872 0.000 H1p     1 
  44   7.634 0.000 H6     15 
  45   5.452 0.000 H1p    15 
  46   7.391 0.000 H8      2 
  47   5.783 0.000 H1p     2 
  48   7.594 0.000 H8      5 
  49   5.688 0.000 H1p     5 
  50   7.610 0.000 H6     12 
  51   5.214 0.000 H5     12 
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  52   7.682 0.000 H6     14 
  53   5.188 0.000 H5     14 
  54   7.513 0.000 H8     13 
  55   5.700 0.000 H1p    13 
  56   5.423 0.000 H1p     6 
  58   5.487 0.000 H1p     4 
  59   4.654 0.000 H2p     2 
  60   4.798 0.000 H2p     1 
  61   4.507 0.000 H2p     4 
  62   4.874 0.000 H2p     3 
  64   5.463 0.000 H1p    14 
  65   5.469 0.000 H1p    12 
  66   4.355 0.000 H1p    11 
  67   4.038 0.000 H2p     9 
  68   4.334 0.000 H5p    10 
  69   4.343 0.000 H4p    10 
  70   4.443 0.000 H5p    11 
  71   4.369 0.000 H2p    11 
  72   4.340 0.000 H4p    11 
  73   3.979 0.000 H5pp    6 
  74   4.179 0.000 H3p     6 
  75   4.495 0.000 H4p     6 
  76   4.478 0.000 H5p     6 
  77   4.437 0.000 H2p     6 
  78   4.011 0.000 H5pp    5 
  79   4.044 0.000 H5p     5 
  80   4.504 0.000 H2p     5 
  81   4.478 0.000 H3p     5 
  82   4.378 0.000 H4p     5 
  83   4.648 0.000 H3p     1 
  84   4.525 0.000 H4p     1 
  85   4.466 0.000 H5p     1 
  86   4.243 0.000 H5pp    1 
  87   4.645 0.000 H3p     2 
  88   4.628 0.000 H4p     2 
  89   4.126 0.000 H5p     2 
  90   4.117 0.000 H5pp    2 
  91   4.663 0.000 H3p     3 
  92   4.190 0.000 H5pp    3 
  93   4.217 0.000 H5p     3 
  94   4.387 0.000 H4p     3 
  95   4.425 0.000 H3p     4 
  96   4.196 0.000 H4p     4 
  97   4.035 0.000 H5p     4 
  98   4.003 0.000 H5pp    4 
  99   4.437 0.000 H3p    12 
 100   4.428 0.000 H4p    12 
 101   4.416 0.000 H5p    12 
 102   4.407 0.000 H5pp   12 
 103   4.512 0.000 H2p    13 
 104   4.438 0.000 H3p    13 
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 105   4.407 0.000 H4p    13 
 106   4.049 0.000 H5p    13 
 107   4.036 0.000 H5pp   13 
 108   4.455 0.000 H2p    14 
 109   4.429 0.000 H3p    14 
 110   4.394 0.000 H4p    14 
 111   4.018 0.000 H5p    14 
 112   4.004 0.000 H5pp   14 
 113   4.431 0.000 H2p    15 
 114   4.398 0.000 H3p    15 
 115   4.209 0.000 H4p    15 
 116   3.974 0.000 H5pp   15 
 117   3.986 0.000 H5p    15 
 119   7.738 0.000 H6     16 
 120   5.456 0.000 H1p    16 
 121   5.462 0.000 H5     16 
 122   4.378 0.000 H2p    16 
 123   4.335 0.000 H3p    16 
 124   4.215 0.000 H4p    16 
 125   4.004 0.000 H5p    16 
 126   3.974 0.000 H5pp   16 
 127   4.445 0.000 H2p    12 
 128   9.843 0.000 H1     10 
 129  13.425 0.000 H1     11 
 130  11.789 0.000 H3      7 
 131  12.116 0.000 H3      8 
 132   7.075 0.000 H42     6 
 133   6.607 0.000 H22    11 
 
UUCG 16mer NOE Restraints 
assi ( resid 10 and name H2' )( resid 10 and name H4' ) 3.8 1.0 1.0 
assi ( resid 2 and name H2' )( resid 2 and name H5'' ) 5.0 1.5 1.5 
assi ( resid 13 and name H8 )( resid 12 and name H4' ) 5.8 1.5 1.5 
assi ( resid 8 and name H2' )( resid 8 and name H4' ) 3.9 1.0 1.0 
assi ( resid 10 and name H1' )( resid 10 and name H3' ) 3.9 1.0 1.0 
assi ( resid 3 and name H2' )( resid 3 and name H3' ) 2.5 1.0 1.0 
assi ( resid 9 and name H1' )( resid 10 and name H3' ) 5.0 1.0 1.0 
assi ( resid 11 and name H1' )( resid 11 and name H4' ) 3.5 1.0 1.0 
assi ( resid 7 and name H5' )( resid 7 and name H5'' ) 1.8 0.5 0.5 
assi ( resid 9 and name H3' )( resid 9 and name H2' ) 2.5 0.5 0.5 
assi ( resid 13 and name H3' )( resid 13 and name H5' ) 3.8 1.0 1.0 
assi ( resid 9 and name H5 )( resid 9 and name H5' ) 6.2 1.0 1.0 
assi ( resid 11 and name H2' )( resid 11 and name H1' ) 2.8 1.0 1.0 
assi ( resid 8 and name H5 )( resid 8 and name H5' ) 5.9 1.0 1.0 
assi ( resid 3 and name H3' )( resid 3 and name H4' ) 3.0 1.0 1.0 
assi ( resid 8 and name H5 )( resid 8 and name H5'' ) 6.6 1.5 1.5 
assi ( resid 9 and name H6 )( resid 8 and name H5' ) 5.0 1.5 1.5 
assi ( resid 3 and name H2' )( resid 3 and name H4' ) 3.8 1.0 1.0 
assi ( resid 8 and name H5 )( resid 8 and name H4' ) 6.8 1.0 1.0 
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assi ( resid 6 and name H5' )( resid 6 and name H3' ) 3.8 1.0 1.0 
assi ( resid 9 and name H6 )( resid 8 and name H2' ) 4.0 1.5 1.5 
assi ( resid 8 and name H5 )( resid 8 and name H2' ) 4.5 1.0 1.0 
assi ( resid 8 and name H1' )( resid 8 and name H3' ) 3.9 1.0 1.0 
assi ( resid 12 and name H6 )( resid 11 and name H3' ) 3.2 1.5 1.5 
assi ( resid 3 and name H3' )( resid 3 and name H5'' ) 2.5 1.0 1.0 
assi ( resid 9 and name H6 )( resid 8 and name H4' ) 4.6 1.5 1.5 
assi ( resid 2 and name H3' )( resid 2 and name H5' ) 3.8 1.5 1.5 
assi ( resid 5 and name H3' )( resid 6 and name H3' ) 5.8 1.5 1.5 
assi ( resid 13 and name H4' )( resid 13 and name H5' ) 2.3 1.0 1.0 
assi ( resid 2 and name H1' )( resid 2 and name H2' ) 2.8 1.0 1.0 
assi ( resid 2 and name H1' )( resid 2 and name H4' ) 3.5 1.0 1.0 
assi ( resid 11 and name H2' )( resid 11 and name H4' ) 3.8 1.0 1.0 
assi ( resid 13 and name H8 )( resid 12 and name H3' ) 2.4 1.5 1.5 
assi ( resid 13 and name H8 )( resid 12 and name H2' ) 3.5 1.5 1.5 
assi ( resid 8 and name H5 )( resid 7 and name H5' ) 5.2 1.0 1.0 
assi ( resid 12 and name H6 )( resid 11 and name H2' ) 2.2 1.5 1.5 
assi ( resid 14 and name H4' )( resid 14 and name H5'' ) 4.0 2.5 2.5 
assi ( resid 1 and name H2' )( resid 1 and name H5' ) 5.3 1.5 1.5 
assi ( resid 3 and name H1' )( resid 3 and name H2' ) 2.8 1.0 1.0 
assi ( resid 3 and name H1' )( resid 3 and name H5'' ) 5.0 1.5 1.5 
assi ( resid 2 and name H2' )( resid 2 and name H5' ) 5.3 1.5 1.5 
assi ( resid 3 and name H1' )( resid 3 and name H5' ) 3.5 1.5 1.5 
assi ( resid 5 and name H4' )( resid 5 and name H5' ) 4.0 1.5 1.5 
assi ( resid 3 and name H1' )( resid 3 and name H3' ) 4.0 1.5 1.5 
assi ( resid 4 and name H3' )( resid 4 and name H5' ) 3.8 1.0 1.0 
assi ( resid 1 and name H2' )( resid 1 and name H4' ) 3.8 1.0 1.0 
assi ( resid 13 and name H3' )( resid 13 and name H5'' ) 2.5 1.0 1.0 
assi ( resid 8 and name H5 )( resid 8 and name H3' ) 6.4 1.0 1.0 
assi ( resid 9 and name H1' )( resid 9 and name H3' ) 3.7 0.5 0.5 
assi ( resid 4 and name H3' )( resid 4 and name H4' ) 3.0 1.0 1.0 
assi ( resid 10 and name H1' )( resid 10 and name H5'' ) 4.7 1.0 1.0 
assi ( resid 12 and name H6 )( resid 11 and name H5' ) 7.0 1.5 1.5 
assi ( resid 7 and name H6 )( resid 6 and name H5' ) 6.4 1.5 1.5 
assi ( resid 8 and name H6 )( resid 9 and name H5' ) 7.3 1.5 1.5 
assi ( resid 2 and name H1' )( resid 2 and name H5' ) 5.0 1.5 1.5 
assi ( resid 11 and name H8 )( resid 9 and name H4' ) 7.0 1.5 1.5 
assi ( resid 1 and name H2' )( resid 1 and name H3' ) 2.5 1.0 1.0 
assi ( resid 14 and name H4' )( resid 14 and name H5' ) 2.2 1.0 1.0 
assi ( resid 3 and name H1' )( resid 3 and name H4' ) 3.5 1.0 1.0 
assi ( resid 16 and name H2' )( resid 16 and name H3' ) 2.4 1.0 1.0 
assi ( resid 13 and name H8 )( resid 12 and name H5' ) 6.0 1.5 1.5 
assi ( resid 8 and name H4' )( resid 8 and name H5'' ) 2.4 1.0 1.0 
assi ( resid 14 and name H2' )( resid 14 and name H5' ) 5.4 1.5 1.5 
assi ( resid 9 and name H5 )( resid 9 and name H2' ) 4.5 1.0 1.0 
assi ( resid 10 and name H1' )( resid 9 and name H4' ) 4.0 1.0 1.0 
assi ( resid 8 and name H1' )( resid 8 and name H5' ) 4.6 1.0 1.0 
assi ( resid 10 and name H8 )( resid 9 and name H5' ) 3.3 1.0 1.0 
assi ( resid 14 and name H2' )( resid 14 and name H5'' ) 4.7 1.0 1.0 
assi ( resid 7 and name H3' )( resid 7 and name H5'' ) 2.9 1.0 1.0 
assi ( resid 8 and name H1' )( resid 8 and name H5'' ) 5.0 1.5 1.5 
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assi ( resid 9 and name H1' )( resid 9 and name H2' ) 3.0 0.5 0.5 
assi ( resid 9 and name H1' )( resid 9 and name H4' ) 3.2 1.0 1.0 
assi ( resid 15 and name H2' )( resid 15 and name H5'' ) 4.7 1.5 1.5 
assi ( resid 1 and name H1' )( resid 1 and name H3' ) 3.9 1.0 1.0 
assi ( resid 8 and name H1' )( resid 8 and name H2' ) 3.0 0.5 0.5 
assi ( resid 1 and name H1' )( resid 1 and name H2' ) 2.7 1.0 1.0 
assi ( resid 8 and name H1' )( resid 8 and name H4' ) 3.2 0.5 0.5 
assi ( resid 9 and name H6 )( resid 9 and name H5' ) 3.9 1.5 1.5 
assi ( resid 4 and name H6 )( resid 4 and name H4' ) 4.2 1.0 1.0 
assi ( resid 6 and name H6 )( resid 6 and name H4' ) 4.2 1.0 1.0 
assi ( resid 12 and name H6 )( resid 12 and name H5' ) 4.0 1.5 1.5 
assi ( resid 11 and name H8 )( resid 10 and name H2' ) 4.0 1.0 1.0 
assi ( resid 9 and name H5 )( resid 9 and name H1' ) 5.4 1.0 1.0 
assi ( resid 8 and name H1' )( resid 8 and name H5 ) 5.5 1.0 1.0 
assi ( resid 11 and name H8 )( resid 10 and name H3' ) 3.8 0.5 0.5 
assi ( resid 10 and name H1' )( resid 10 and name H2' ) 2.9 0.5 0.5 
assi ( resid 6 and name H6 )( resid 6 and name H2' ) 3.7 2.5 2.5 
assi ( resid 13 and name H8 )( resid 13 and name H5'' ) 3.8 1.0 1.0 
assi ( resid 9 and name H6 )( resid 9 and name H5'' ) 4.2 1.5 1.5 
assi ( resid 15 and name H6 )( resid 15 and name H5'' ) 4.0 1.0 1.0 
assi ( resid 5 and name H8 )( resid 5 and name H5'' ) 3.8 1.0 1.0 
assi ( resid 5 and name H3' )( resid 5 and name H5'' ) 2.5 1.0 1.0 
assi ( resid 15 and name H6 )( resid 15 and name H2' ) 3.7 1.0 1.0 
assi ( resid 14 and name H6 )( resid 14 and name H5 ) 2.5 1.0 1.0 
assi ( resid 5 and name H2' )( resid 5 and name H5' ) 5.4 1.5 1.5 
assi ( resid 16 and name H6 )( resid 16 and name H1' ) 3.5 1.0 1.0 
assi ( resid 10 and name H8 )( resid 10 and name H2' ) 4.0 1.0 1.0 
assi ( resid 4 and name H6 )( resid 4 and name H3' ) 3.2 1.0 1.0 
assi ( resid 5 and name H8 )( resid 5 and name H4' ) 4.3 1.0 1.0 
assi ( resid 6 and name H6 )( resid 6 and name H3' ) 3.2 1.5 1.5 
assi ( resid 14 and name H6 )( resid 14 and name H5' ) 4.0 1.0 1.0 
assi ( resid 5 and name H8 )( resid 5 and name H3' ) 3.0 1.0 1.0 
assi ( resid 15 and name H6 )( resid 15 and name H5' ) 4.0 1.0 1.0 
assi ( resid 15 and name H6 )( resid 15 and name H4' ) 4.2 1.0 1.0 
assi ( resid 12 and name H6 )( resid 11 and name H1' ) 5.0 1.5 1.5 
assi ( resid 12 and name H6 )( resid 12 and name H3' ) 3.2 1.5 1.5 
assi ( resid 15 and name H6 )( resid 15 and name H3' ) 3.2 1.5 1.5 
assi ( resid 5 and name H8 )( resid 5 and name H1' ) 3.8 1.0 1.0 
assi ( resid 1 and name H8 )( resid 1 and name H3' ) 3.0 1.0 1.0 
assi ( resid 11 and name H8 )( resid 11 and name H5' ) 4.2 1.0 1.0 
assi ( resid 4 and name H6 )( resid 3 and name H1' ) 5.2 1.0 1.0 
assi ( resid 4 and name H2' )( resid 4 and name H5'' ) 4.7 1.0 1.0 
assi ( resid 10 and name H8 )( resid 9 and name H1' ) 7.1 1.5 1.5 
assi ( resid 10 and name H8 )( resid 10 and name H1' ) 2.4 1.0 1.0 
assi ( resid 6 and name H6 )( resid 6 and name H5' ) 4.0 1.0 1.0 
assi ( resid 9 and name H6 )( resid 10 and name H3' ) 7.3 1.5 1.5 
assi ( resid 9 and name H6 )( resid 9 and name H2' ) 2.7 1.0 1.0 
assi ( resid 5 and name H2' )( resid 5 and name H5'' ) 4.7 1.0 1.0 
assi ( resid 1 and name H8 )( resid 1 and name H4' ) 4.3 1.0 1.0 
assi ( resid 3 and name H8 )( resid 2 and name H1' ) 5.0 1.0 1.0 
assi ( resid 9 and name H6 )( resid 8 and name H1' ) 6.0 1.5 1.5 
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assi ( resid 13 and name H8 )( resid 13 and name H3' ) 3.0 1.0 1.0 
assi ( resid 4 and name H6 )( resid 4 and name H2' ) 3.7 1.5 1.5 
assi ( resid 15 and name H6 )( resid 14 and name H1' ) 5.0 1.5 1.5 
assi ( resid 13 and name H8 )( resid 13 and name H2' ) 3.8 1.0 1.0 
assi ( resid 13 and name H8 )( resid 12 and name H1' ) 5.0 1.5 1.5 
assi ( resid 10 and name H1' )( resid 10 and name H4' ) 3.1 0.5 0.5 
assi ( resid 3 and name H8 )( resid 3 and name H5' ) 4.2 1.5 1.5 
assi ( resid 8 and name H6 )( resid 7 and name H1' ) 5.5 1.0 1.0 
assi ( resid 9 and name H6 )( resid 9 and name H4' ) 4.3 1.5 1.5 
assi ( resid 12 and name H6 )( resid 12 and name H2' ) 4.0 1.5 1.5 
assi ( resid 5 and name H3' )( resid 6 and name H5'' ) 5.2 1.5 1.5 
assi ( resid 12 and name H6 )( resid 12 and name H4' ) 4.2 1.0 1.0 
assi ( resid 6 and name H6 )( resid 6 and name H5'' ) 4.0 1.5 1.5 
assi ( resid 3 and name H8 )( resid 3 and name H3' ) 3.0 1.5 1.5 
assi ( resid 12 and name H6 )( resid 12 and name H5'' ) 4.0 1.5 1.5 
assi ( resid 11 and name H8 )( resid 12 and name H5 ) 4.0 1.5 1.5 
assi ( resid 7 and name H6 )( resid 7 and name H5 ) 2.4 0.5 0.5 
assi ( resid 6 and name H5' )( resid 5 and name H5'' ) 6.2 1.5 1.5 
assi ( resid 6 and name H6 )( resid 6 and name H5 ) 2.5 1.0 1.0 
assi ( resid 13 and name H8 )( resid 13 and name H1' ) 3.8 1.0 1.0 
assi ( resid 6 and name H5' )( resid 5 and name H5' ) 7.0 1.5 1.5 
assi ( resid 1 and name H8 )( resid 1 and name H5' ) 4.0 1.5 1.5 
assi ( resid 7 and name H6 )( resid 7 and name H2' ) 3.9 1.0 1.0 
assi ( resid 10 and name H8 )( resid 10 and name H3' ) 5.4 1.5 1.5 
assi ( resid 6 and name H6 )( resid 6 and name H1' ) 3.5 1.0 1.0 
assi ( resid 13 and name H8 )( resid 13 and name H5' ) 4.2 1.5 1.5 
assi ( resid 4 and name H6 )( resid 4 and name H5' ) 4.3 1.5 1.5 
assi ( resid 13 and name H8 )( resid 13 and name H4' ) 4.3 1.0 1.0 
assi ( resid 5 and name H8 )( resid 5 and name H2' ) 3.8 1.0 1.0 
assi ( resid 14 and name H6 )( resid 14 and name H5'' ) 4.0 1.0 1.0 
assi ( resid 5 and name H8 )( resid 5 and name H5' ) 4.2 1.0 1.0 
assi ( resid 14 and name H6 )( resid 14 and name H3' ) 3.2 1.0 1.0 
assi ( resid 11 and name H5' )( resid 11 and name H1' ) 4.9 1.0 1.0 
assi ( resid 13 and name H2' )( resid 13 and name H5'' ) 4.7 1.0 1.0 
assi ( resid 4 and name H2' )( resid 4 and name H5' ) 5.4 1.5 1.5 
assi ( resid 14 and name H6 )( resid 14 and name H2' ) 3.7 1.0 1.0 
assi ( resid 7 and name H3' )( resid 7 and name H4' ) 3.0 1.0 1.0 
assi ( resid 13 and name H1' )( resid 13 and name H3' ) 4.0 1.0 1.0 
assi ( resid 11 and name H1 )( resid 10 and name H1 ) 5.3 1.0 1.0 
assi ( resid 13 and name H2' )( resid 13 and name H5' ) 5.3 1.5 1.5 
assi ( resid 11 and name H8 )( resid 10 and name H1' ) 6.8 1.0 1.0 
assi ( resid 11 and name H8 )( resid 11 and name H2' ) 3.8 1.0 1.0 
assi ( resid 16 and name H6 )( resid 16 and name H5'' ) 4.0 1.0 1.0 
assi ( resid 14 and name H6 )( resid 14 and name H4' ) 4.2 1.0 1.0 
assi ( resid 7 and name H6 )( resid 7 and name H1' ) 3.5 1.0 1.0 
assi ( resid 4 and name H6 )( resid 4 and name H5'' ) 4.0 1.0 1.0 
assi ( resid 11 and name H8 )( resid 11 and name H3' ) 3.0 1.0 1.0 
assi ( resid 1 and name H1' )( resid 1 and name H4' ) 3.5 1.0 1.0 
assi ( resid 7 and name H6 )( resid 7 and name H5'' ) 4.0 1.0 1.0 
assi ( resid 11 and name H8 )( resid 11 and name H1' ) 3.8 1.5 1.5 
assi ( resid 7 and name H6 )( resid 7 and name H4' ) 4.1 1.0 1.0 
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assi ( resid 16 and name H6 )( resid 15 and name H1' ) 5.0 1.5 1.5 
assi ( resid 9 and name H6 )( resid 9 and name H1' ) 3.5 1.0 1.0 
assi ( resid 4 and name H6 )( resid 4 and name H5 ) 2.5 1.0 1.0 
assi ( resid 8 and name H6 )( resid 8 and name H5 ) 2.4 0.5 0.5 
assi ( resid 8 and name H6 )( resid 8 and name H5' ) 3.8 0.5 0.5 
assi ( resid 4 and name H6 )( resid 4 and name H1' ) 3.5 1.0 1.0 
assi ( resid 14 and name H6 )( resid 13 and name H1' ) 5.0 1.5 1.5 
assi ( resid 3 and name H8 )( resid 3 and name H1' ) 3.8 1.0 1.0 
assi ( resid 1 and name H8 )( resid 1 and name H1' ) 3.8 1.0 1.0 
assi ( resid 7 and name H6 )( resid 7 and name H3' ) 3.0 1.0 1.0 
assi ( resid 3 and name H8 )( resid 3 and name H4' ) 4.3 1.5 1.5 
assi ( resid 10 and name H8 )( resid 10 and name H4' ) 5.4 1.5 1.5 
assi ( resid 11 and name H5' )( resid 11 and name H4' ) 2.3 1.0 1.0 
assi ( resid 7 and name H6 )( resid 7 and name H5' ) 3.7 1.0 1.0 
assi ( resid 12 and name H6 )( resid 12 and name H1' ) 3.5 1.0 1.0 
assi ( resid 7 and name H6 )( resid 6 and name H1' ) 5.2 1.0 1.0 
assi ( resid 15 and name H6 )( resid 15 and name H1' ) 3.5 1.0 1.0 
assi ( resid 8 and name H6 )( resid 8 and name H3' ) 4.1 1.0 1.0 
assi ( resid 8 and name H6 )( resid 8 and name H2' ) 2.5 0.5 0.5 
assi ( resid 8 and name H6 )( resid 8 and name H5'' ) 4.3 1.0 1.0 
assi ( resid 8 and name H6 )( resid 8 and name H1' ) 3.7 0.5 0.5 
assi ( resid 16 and name H6 )( resid 16 and name H4' ) 4.2 1.0 1.0 
assi ( resid 16 and name H6 )( resid 16 and name H2' ) 3.7 1.0 1.0 
assi ( resid 9 and name H6 )( resid 9 and name H5 ) 2.4 1.5 1.5 
assi ( resid 3 and name H8 )( resid 3 and name H2' ) 3.8 1.0 1.0 
assi ( resid 9 and name H6 )( resid 9 and name H3' ) 4.5 1.5 1.5 
assi ( resid 10 and name H8 )( resid 10 and name H5'' ) 6.3 1.5 1.5 
assi ( resid 1 and name H8 )( resid 1 and name H2' ) 3.8 1.0 1.0 
assi ( resid 12 and name H6 )( resid 12 and name H5 ) 2.5 0.5 0.5 
assi ( resid 4 and name H6 )( resid 3 and name H4' ) 5.8 1.5 1.5 
assi ( resid 5 and name H8 )( resid 4 and name H1' ) 5.0 1.0 1.0 
assi ( resid 1 and name H4' )( resid 1 and name H5' ) 2.3 1.0 1.0 
assi ( resid 3 and name H8 )( resid 2 and name H2' ) 2.0 0.5 0.5 
assi ( resid 12 and name H2' )( resid 12 and name H5'' ) 4.7 1.0 1.0 
assi ( resid 14 and name H2' )( resid 14 and name H4' ) 3.8 1.0 1.0 
assi ( resid 6 and name H6 )( resid 5 and name H4' ) 5.8 1.5 1.5 
assi ( resid 16 and name H6 )( resid 16 and name H3' ) 3.2 1.0 1.0 
assi ( resid 6 and name H6 )( resid 5 and name H1' ) 5.0 1.5 1.5 
assi ( resid 6 and name H6 )( resid 5 and name H2' ) 2.2 1.0 1.0 
assi ( resid 12 and name H2' )( resid 13 and name H4' ) 4.2 1.5 1.5 
assi ( resid 13 and name H3' )( resid 13 and name H4' ) 3.0 1.5 1.5 
assi ( resid 2 and name H8 )( resid 2 and name H2' ) 3.8 1.0 1.0 
assi ( resid 3 and name H8 )( resid 3 and name H5'' ) 3.8 1.0 1.0 
assi ( resid 14 and name H6 )( resid 13 and name H3' ) 3.3 1.5 1.5 
assi ( resid 16 and name H6 )( resid 16 and name H5 ) 2.5 1.0 1.0 
assi ( resid 15 and name H6 )( resid 14 and name H5'' ) 5.7 1.5 1.5 
assi ( resid 6 and name H6 )( resid 5 and name H3' ) 3.3 1.5 1.5 
assi ( resid 16 and name H6 )( resid 16 and name H5' ) 4.0 1.0 1.0 
assi ( resid 11 and name H8 )( resid 11 and name H4' ) 4.3 1.0 1.0 
assi ( resid 6 and name H5' )( resid 5 and name H4' ) 4.8 1.5 1.5 
assi ( resid 14 and name H6 )( resid 13 and name H5'' ) 5.7 1.5 1.5 
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assi ( resid 13 and name H2' )( resid 13 and name H4' ) 3.8 1.0 1.0 
assi ( resid 14 and name H6 )( resid 14 and name H1' ) 3.5 1.0 1.0 
assi ( resid 12 and name H2' )( resid 12 and name H5' ) 5.3 1.5 1.5 
assi ( resid 13 and name H2' )( resid 13 and name H3' ) 2.4 1.0 1.0 
assi ( resid 4 and name H6 )( resid 3 and name H3' ) 3.3 1.0 1.0 
assi ( resid 4 and name H6 )( resid 3 and name H5' ) 7.0 1.5 1.5 
assi ( resid 7 and name H5' )( resid 7 and name H4' ) 2.4 1.0 1.0 
assi ( resid 9 and name H5 )( resid 9 and name H4' ) 7.6 1.5 1.5 
assi ( resid 1 and name H1' )( resid 1 and name H5' ) 5.0 1.5 1.5 
assi ( resid 9 and name H5 )( resid 9 and name H3' ) 6.7 1.5 1.5 
assi ( resid 14 and name H3' )( resid 14 and name H4' ) 3.0 1.0 1.0 
assi ( resid 4 and name H6 )( resid 3 and name H5'' ) 5.7 1.5 1.5 
assi ( resid 6 and name H4' )( resid 6 and name H2' ) 3.8 1.0 1.0 
assi ( resid 15 and name H2' )( resid 15 and name H5' ) 5.3 1.5 1.5 
assi ( resid 6 and name H2' )( resid 6 and name H5'' ) 4.7 1.5 1.5 
assi ( resid 11 and name H5' )( resid 11 and name H3' ) 3.7 1.0 1.0 
assi ( resid 10 and name H1' )( resid 9 and name H5' ) 4.0 1.0 1.0 
assi ( resid 15 and name H2' )( resid 16 and name H5'' ) 4.5 1.0 1.0 
assi ( resid 5 and name H2' )( resid 5 and name H4' ) 3.8 1.0 1.0 
assi ( resid 3 and name H8 )( resid 2 and name H3' ) 3.0 1.5 1.5 
assi ( resid 4 and name H2' )( resid 4 and name H3' ) 2.4 1.0 1.0 
assi ( resid 6 and name H6 )( resid 5 and name H5' ) 7.0 1.5 1.5 
assi ( resid 9 and name H1' )( resid 9 and name H5' ) 4.7 1.0 1.0 
assi ( resid 6 and name H5' )( resid 6 and name H5'' ) 1.7 0.5 0.5 
assi ( resid 7 and name H6 )( resid 6 and name H4' ) 5.4 1.0 1.0  
assi ( resid 2 and name H3' )( resid 2 and name H5'' ) 2.5 1.0 1.0 
assi ( resid 16 and name H2' )( resid 16 and name H5' ) 5.4 1.5 1.5 
assi ( resid 5 and name H1' )( resid 5 and name H5' ) 5.0 1.5 1.5 
assi ( resid 8 and name H2' )( resid 8 and name H5' ) 4.3 1.0 1.0 
assi ( resid 15 and name H3' )( resid 16 and name H5'' ) 5.2 1.5 1.5 
assi ( resid 10 and name H4' )( resid 10 and name H5' ) 2.3 0.5 0.5 
assi ( resid 8 and name H6 )( resid 7 and name H5' ) 6.2 1.0 1.0 
assi ( resid 13 and name H1' )( resid 13 and name H5'' ) 5.1 1.5 1.5 
assi ( resid 14 and name H6 )( resid 13 and name H2' ) 2.2 1.0 1.0 
assi ( resid 13 and name H8 )( resid 12 and name H5'' ) 6.0 1.5 1.5 
assi ( resid 8 and name H6 )( resid 7 and name H4' ) 4.0 1.0 1.0 
assi ( resid 10 and name H2' )( resid 10 and name H5'' ) 4.5 1.0 1.0 
assi ( resid 6 and name H4' )( resid 6 and name H3' ) 3.0 1.0 1.0 
assi ( resid 14 and name H6 )( resid 13 and name H4' ) 5.8 1.5 1.5 
assi ( resid 7 and name H5 )( resid 7 and name H5'' ) 6.2 1.5 1.5 
assi ( resid 16 and name H2' )( resid 16 and name H5'' ) 4.7 1.5 1.5 
assi ( resid 13 and name H1' )( resid 13 and name H5' ) 5.0 1.5 1.5 
assi ( resid 5 and name H4' )( resid 5 and name H5'' ) 2.6 1.0 1.0 
assi ( resid 10 and name H2' )( resid 10 and name H5' ) 5.0 1.0 1.0 
assi ( resid 2 and name H3' )( resid 2 and name H2' ) 2.4 1.0 1.0 
assi ( resid 12 and name H5'' )( resid 13 and name H5' ) 6.2 1.5 1.5 
assi ( resid 8 and name H6 )( resid 7 and name H5'' ) 5.3 1.0 1.0 
assi ( resid 4 and name H3' )( resid 4 and name H5'' ) 2.5 1.0 1.0 
assi ( resid 6 and name H2' )( resid 6 and name H3' ) 2.4 1.0 1.0 
assi ( resid 8 and name H6 )( resid 7 and name H3' ) 4.7 1.5 1.5 
assi ( resid 1 and name H3' )( resid 1 and name H5' ) 3.7 1.0 1.0 
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assi ( resid 3 and name H2' )( resid 3 and name H5' ) 5.3 1.5 1.5 
assi ( resid 7 and name H5 )( resid 7 and name H4' ) 6.5 1.0 1.0 
assi ( resid 7 and name H5 )( resid 7 and name H2' ) 5.3 1.0 1.0 
assi ( resid 6 and name H5 )( resid 6 and name H4' ) 6.5 1.5 1.5 
assi ( resid 1 and name H3' )( resid 1 and name H4' ) 3.0 1.0 1.0 
assi ( resid 6 and name H5 )( resid 5 and name H3' ) 3.8 1.5 1.5 
assi ( resid 11 and name H8 )( resid 10 and name H5' ) 5.0 1.5 1.5 
assi ( resid 2 and name H2' )( resid 2 and name H4' ) 3.8 1.0 1.0 
assi ( resid 5 and name H1' )( resid 5 and name H4' ) 3.4 1.0 1.0 
assi ( resid 6 and name H5 )( resid 6 and name H5' ) 6.3 1.5 1.5 
assi ( resid 4 and name H5 )( resid 4 and name H2' ) 5.2 1.5 1.5 
assi ( resid 9 and name H6 )( resid 8 and name H3' ) 2.2 1.5 1.5 
assi ( resid 9 and name H6 )( resid 8 and name H5'' ) 3.4 1.5 1.5 
assi ( resid 3 and name H4' )( resid 3 and name H5' ) 2.3 0.5 0.5 
assi ( resid 8 and name H4' )( resid 8 and name H3' ) 2.7 1.0 1.0 
assi ( resid 15 and name H3' )( resid 15 and name H4' ) 3.0 1.0 1.0 
assi ( resid 3 and name H2' )( resid 3 and name H5'' ) 4.7 1.5 1.5 
assi ( resid 2 and name H3' )( resid 2 and name H4' ) 3.0 1.0 1.0 
assi ( resid 12 and name H5'' )( resid 13 and name H5'' ) 6.8 1.5 1.5 
assi ( resid 13 and name H4' )( resid 13 and name H5'' ) 2.6 0.5 0.5 
assi ( resid 15 and name H3' )( resid 15 and name H5'' ) 2.5 1.0 1.0 
assi ( resid 7 and name H5 )( resid 7 and name H5' ) 6.0 1.0 1.0 
assi ( resid 10 and name H8 )( resid 9 and name H4' ) 4.5 1.5 1.5 
assi ( resid 5 and name H1' )( resid 5 and name H5'' ) 5.0 1.5 1.5 
assi ( resid 13 and name H1' )( resid 13 and name H4' ) 3.5 1.0 1.0 
assi ( resid 4 and name H4' )( resid 4 and name H5' ) 2.3 1.0 1.0 
assi ( resid 6 and name H1' )( resid 6 and name H4' ) 3.4 1.0 1.0 
assi ( resid 2 and name H4' )( resid 2 and name H5'' ) 2.6 1.0 1.0 
assi ( resid 5 and name H1' )( resid 5 and name H2' ) 2.8 1.0 1.0 
assi ( resid 8 and name H2' )( resid 8 and name H3' ) 2.4 1.0 1.0 
assi ( resid 16 and name H5 )( resid 16 and name H3' ) 5.2 1.5 1.5 
assi ( resid 13 and name H1' )( resid 13 and name H2' ) 2.8 1.0 1.0 
assi ( resid 2 and name H4' )( resid 2 and name H5' ) 2.3 0.5 0.5 
assi ( resid 12 and name H5 )( resid 12 and name H4' ) 6.6 1.5 1.5 
assi ( resid 4 and name H4' )( resid 4 and name H5'' ) 2.6 1.0 1.0 
assi ( resid 16 and name H3' )( resid 16 and name H4' ) 3.0 1.0 1.0 
assi ( resid 9 and name H3' )( resid 9 and name H4' ) 2.7 1.0 1.0 
assi ( resid 16 and name H5 )( resid 16 and name H5' ) 6.3 1.5 1.5 
assi ( resid 16 and name H5 )( resid 16 and name H4' ) 6.6 1.5 1.5 
assi ( resid 5 and name H1' )( resid 5 and name H3' ) 3.9 1.0 1.0 
assi ( resid 8 and name H4' )( resid 8 and name H5' ) 2.4 1.0 1.0 
assi ( resid 5 and name H1' )( resid 6 and name H5' ) 6.0 1.5 1.5 
assi ( resid 12 and name H5 )( resid 12 and name H3' ) 5.2 1.5 1.5 
assi ( resid 15 and name H1' )( resid 16 and name H5'' ) 7.0 1.5 1.5 
assi ( resid 3 and name H3' )( resid 3 and name H5' ) 3.8 1.0 1.0 
assi ( resid 4 and name H1' )( resid 4 and name H4' ) 4.0 1.0 1.0 
assi ( resid 4 and name H1' )( resid 4 and name H3' ) 3.5 1.0 1.0 
assi ( resid 11 and name H8 )( resid 10 and name H4' ) 6.5 1.5 1.5 
assi ( resid 16 and name H1' )( resid 16 and name H5' ) 4.9 1.0 1.0 
assi ( resid 4 and name H5 )( resid 4 and name H5'' ) 6.3 1.5 1.5 
assi ( resid 16 and name H3' )( resid 16 and name H5' ) 3.8 1.0 1.0 
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assi ( resid 12 and name H5 )( resid 12 and name H2' ) 5.2 1.5 1.5 
assi ( resid 16 and name H4' )( resid 16 and name H5' ) 2.3 1.0 1.0 
assi ( resid 15 and name H3' )( resid 15 and name H5' ) 3.8 1.0 1.0 
assi ( resid 14 and name H1' )( resid 14 and name H4' ) 3.5 1.0 1.0 
assi ( resid 16 and name H4' )( resid 16 and name H5'' ) 2.6 1.0 1.0 
assi ( resid 8 and name H2' )( resid 8 and name H5'' ) 4.0 1.0 1.0 
assi ( resid 9 and name H4' )( resid 9 and name H5'' ) 2.6 0.5 0.5 
assi ( resid 7 and name H1' )( resid 7 and name H5'' ) 5.2 1.0 1.0 
assi ( resid 7 and name H5' )( resid 7 and name H2' ) 4.0 1.5 1.5 
assi ( resid 12 and name H5 )( resid 12 and name H5' ) 6.3 1.5 1.5 
assi ( resid 15 and name H4' )( resid 15 and name H5'' ) 2.6 1.0 1.0 
assi ( resid 14 and name H1' )( resid 14 and name H5'' ) 5.0 1.5 1.5 
assi ( resid 16 and name H1' )( resid 16 and name H5'' ) 5.0 1.5 1.5 
assi ( resid 3 and name H4' )( resid 3 and name H5'' ) 2.6 1.0 1.0 
assi ( resid 16 and name H1' )( resid 16 and name H2' ) 2.8 1.0 1.0 
assi ( resid 11 and name H2' )( resid 11 and name H3' ) 2.4 1.0 1.0 
assi ( resid 14 and name H1' )( resid 14 and name H5' ) 5.0 1.0 1.0 
assi ( resid 10 and name H5' )( resid 10 and name H5'' ) 1.7 0.5 0.5 
assi ( resid 6 and name H1' )( resid 6 and name H5' ) 5.0 1.0 1.0 
assi ( resid 6 and name H1' )( resid 6 and name H2' ) 2.8 1.0 1.0 
assi ( resid 16 and name H1' )( resid 16 and name H4' ) 3.5 1.0 1.0 
assi ( resid 9 and name H2' )( resid 9 and name H5'' ) 3.5 0.5 0.5 
assi ( resid 15 and name H4' )( resid 15 and name H5' ) 2.3 1.0 1.0 
assi ( resid 9 and name H3' )( resid 9 and name H5'' ) 2.3 0.5 0.5 
assi ( resid 15 and name H1' )( resid 15 and name H3' ) 3.9 1.0 1.0 
assi ( resid 6 and name H1' )( resid 6 and name H3' ) 4.0 1.0 1.0 
assi ( resid 11 and name H4' )( resid 11 and name H3' ) 3.0 1.0 1.0 
assi ( resid 16 and name H1' )( resid 16 and name H3' ) 3.5 1.0 1.0 
assi ( resid 16 and name H5 )( resid 16 and name H2' ) 5.2 1.5 1.5 
assi ( resid 4 and name H5 )( resid 4 and name H4' ) 6.6 1.5 1.5 
assi ( resid 4 and name H1' )( resid 4 and name H5' ) 5.0 1.0 1.0 
assi ( resid 4 and name H5 )( resid 4 and name H5' ) 6.3 1.5 1.5 
assi ( resid 9 and name H5' )( resid 9 and name H5'' ) 1.8 0.5 0.5 
assi ( resid 7 and name H1' )( resid 7 and name H2' ) 2.8 1.0 1.0 
assi ( resid 7 and name H4' )( resid 7 and name H5'' ) 2.4 1.0 1.0 
assi ( resid 6 and name H1' )( resid 5 and name H3' ) 6.0 1.5 1.5 
assi ( resid 7 and name H1' )( resid 7 and name H5' ) 4.6 1.0 1.0 
assi ( resid 12 and name H1' )( resid 12 and name H2' ) 2.8 1.0 1.0 
assi ( resid 6 and name H5 )( resid 6 and name H3' ) 5.2 1.5 1.5 
assi ( resid 12 and name H1' )( resid 12 and name H4' ) 3.5 1.5 1.5 
assi ( resid 4 and name H2' )( resid 4 and name H4' ) 3.8 1.0 1.0 
assi ( resid 14 and name H5 )( resid 14 and name H5' ) 6.3 1.5 1.5 
assi ( resid 4 and name H1' )( resid 4 and name H5'' ) 5.0 1.0 1.0 
assi ( resid 9 and name H2' )( resid 9 and name H4' ) 3.8 0.5 0.5 
assi ( resid 7 and name H1' )( resid 7 and name H3' ) 3.9 1.0 1.0 
assi ( resid 12 and name H1' )( resid 12 and name H3' ) 4.0 1.0 1.0 
assi ( resid 14 and name H1' )( resid 14 and name H2' ) 2.8 1.0 1.0 
assi ( resid 8 and name H4' )( resid 7 and name H4' ) 8.0 1.5 1.5 
assi ( resid 6 and name H1' )( resid 6 and name H5'' ) 5.0 1.5 1.5 
assi ( resid 10 and name H3' )( resid 10 and name H5'' ) 2.4 0.5 0.5 
assi ( resid 14 and name H1' )( resid 14 and name H3' ) 4.0 1.0 1.0 
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assi ( resid 11 and name H1' )( resid 11 and name H3' ) 4.0 1.0 1.0 
assi ( resid 10 and name H3' )( resid 10 and name H4' ) 3.0 0.5 0.5 
assi ( resid 15 and name H1' )( resid 15 and name H2' ) 2.8 1.0 1.0 
assi ( resid 11 and name H5' )( resid 11 and name H2' ) 5.3 1.5 1.5 
assi ( resid 9 and name H4' )( resid 9 and name H5' ) 2.3 0.5 0.5 
assi ( resid 15 and name H1' )( resid 15 and name H5' ) 5.0 1.0 1.0 
assi ( resid 7 and name H1' )( resid 7 and name H4' ) 3.3 1.0 1.0 
assi ( resid 14 and name H5 )( resid 14 and name H2' ) 5.2 1.5 1.5 
assi ( resid 6 and name H5 )( resid 6 and name H2' ) 5.2 1.5 1.5 
assi ( resid 12 and name H5 )( resid 12 and name H5'' ) 6.3 1.5 1.5 
assi ( resid 15 and name H2' )( resid 15 and name H4' ) 3.8 1.0 1.0 
assi ( resid 5 and name H3' )( resid 5 and name H4' ) 3.0 1.0 1.0 
assi ( resid 8 and name H4' )( resid 7 and name H2' ) 6.2 1.5 1.5 
assi ( resid 10 and name H3' )( resid 10 and name H5' ) 3.2 0.5 0.5 
assi ( resid 10 and name H4' )( resid 10 and name H5'' ) 2.4 0.5 0.5 
assi ( resid 4 and name H5 )( resid 4 and name H3' ) 5.2 1.5 1.5 
assi ( resid 7 and name H4' )( resid 7 and name H2' ) 3.8 1.0 1.0 
assi ( resid 16 and name H5 )( resid 15 and name H5'' ) 6.3 1.5 1.5 
assi ( resid 9 and name H3' )( resid 9 and name H5' ) 3.6 0.5 0.5 
assi ( resid 1 and name H5'' )( resid 1 and name H2' ) 4.7 1.5 1.5 
assi ( resid 7 and name H5'' )( resid 7 and name H2' ) 4.9 1.0 1.0 
assi ( resid 14 and name H5 )( resid 14 and name H4' ) 6.6 1.5 1.5 
assi ( resid 8 and name H5' )( resid 8 and name H3' ) 3.7 1.0 1.0 
assi ( resid 12 and name H1' )( resid 12 and name H5 ) 5.2 1.5 1.5 
assi ( resid 8 and name H4' )( resid 9 and name H4' ) 7.6 1.5 1.5 
assi ( resid 4 and name H6 )( resid 3 and name H2' ) 2.2 1.0 1.0 
assi ( resid 15 and name H1' )( resid 15 and name H5'' ) 5.1 1.0 1.0 
assi ( resid 10 and name H3' )( resid 10 and name H2' ) 2.4 0.5 0.5 
assi ( resid 6 and name H1' )( resid 6 and name H5 ) 5.2 1.5 1.5 
assi ( resid 9 and name H2' )( resid 9 and name H5' ) 4.2 0.5 0.5 
assi ( resid 14 and name H5 )( resid 14 and name H3' ) 5.2 1.5 1.5 
assi ( resid 4 and name H1' )( resid 4 and name H5 ) 5.2 1.5 1.5 
assi ( resid 4 and name H1' )( resid 4 and name H2' ) 2.8 1.0 1.0 
assi ( resid 14 and name H1' )( resid 14 and name H5 ) 5.2 1.5 1.5 
assi ( resid 16 and name H2' )( resid 16 and name H4' ) 3.8 1.0 1.0 
assi ( resid 8 and name H5' )( resid 8 and name H5'' ) 1.7 1.0 1.0 
assi ( resid 7 and name H3' )( resid 7 and name H2' ) 2.4 1.0 1.0 
assi ( resid 6 and name H5 )( resid 6 and name H5'' ) 6.3 1.5 1.5 
assi ( resid 6 and name H3' )( resid 6 and name H5'' ) 2.5 1.0 1.0 
assi ( resid 16 and name H5 )( resid 16 and name H5'' ) 6.3 1.5 1.5 
assi ( resid 14 and name H5 )( resid 14 and name H5'' ) 6.3 1.5 1.5 
assi ( resid 2 and name H8 )( resid 1 and name H2' ) 2.0 1.0 1.0 
assi ( resid 12 and name H1' )( resid 12 and name H5' ) 5.0 1.0 1.0 
assi ( resid 14 and name H2' )( resid 14 and name H3' ) 2.4 1.0 1.0 
assi ( resid 12 and name H1' )( resid 12 and name H5'' ) 5.0 1.0 1.0 
assi ( resid 16 and name H3' )( resid 16 and name H5'' ) 2.5 1.0 1.0 
assi ( resid 6 and name H5' )( resid 6 and name H2' ) 5.3 1.5 1.5 
assi ( resid 5 and name H8 )( resid 4 and name H5' ) 7.5 1.5 1.5 
assi ( resid 1 and name H5'' )( resid 1 and name H3' ) 2.5 1.0 1.0 
assi ( resid 6 and name H6 )( resid 5 and name H5'' ) 5.8 1.5 1.5 
assi ( resid 7 and name H6 )( resid 6 and name H3' ) 2.7 1.0 1.0 
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assi ( resid 1 and name H5'' )( resid 1 and name H5' ) 1.7 0.5 0.5 
assi ( resid 12 and name H2' )( resid 12 and name H3' ) 2.4 0.5 0.5 
assi ( resid 15 and name H2' )( resid 15 and name H3' ) 2.4 0.5 0.5 
assi ( resid 1 and name H5'' )( resid 1 and name H1' ) 5.0 1.5 1.5 
assi ( resid 1 and name H5'' )( resid 1 and name H8 ) 3.8 1.0 1.0 
assi ( resid 2 and name H8 )( resid 2 and name H5' ) 4.2 1.0 1.0 
assi ( resid 1 and name H5'' )( resid 1 and name H4' ) 2.6 1.0 1.0 
assi ( resid 12 and name H5' )( resid 12 and name H5'' ) 1.7 0.5 0.5 
assi ( resid 2 and name H8 )( resid 2 and name H1' ) 3.8 1.0 1.0 
assi ( resid 2 and name H8 )( resid 1 and name H4' ) 5.8 1.5 1.5 
assi ( resid 2 and name H8 )( resid 2 and name H5'' ) 6.3 1.5 1.5 
assi ( resid 9 and name H6 )( resid 7 and name H5 ) 8.0 2.5 2.5 
assi ( resid 2 and name H8 )( resid 1 and name H1' ) 5.0 1.5 1.5 
assi ( resid 7 and name H3 )( resid 10 and name H1 ) 3.7 0.5 0.5 
assi ( resid 2 and name H8 )( resid 2 and name H3' ) 3.0 1.5 1.5 
assi ( resid 16 and name H6 )( resid 15 and name H5'' ) 5.7 1.5 1.5 
assi ( resid 5 and name H3' )( resid 6 and name H2' ) 6.8 1.5 1.5 
assi ( resid 6 and name H4' )( resid 5 and name H3' ) 5.8 1.5 1.5 
assi ( resid 16 and name H6 )( resid 15 and name H2' ) 2.2 1.5 1.5 
assi ( resid 16 and name H6 )( resid 15 and name H4' ) 5.8 1.5 1.5 
assi ( resid 12 and name H4' )( resid 13 and name H4' ) 6.5 1.5 1.5 
assi ( resid 2 and name H8 )( resid 2 and name H4' ) 4.3 1.0 1.0 
assi ( resid 7 and name H6 )( resid 6 and name H5'' ) 5.0 1.0 1.0 
assi ( resid 12 and name H3' )( resid 12 and name H5' ) 3.8 1.0 1.0 
assi ( resid 2 and name H8 )( resid 1 and name H3' ) 3.0 1.5 1.5 
assi ( resid 12 and name H2' )( resid 12 and name H4' ) 3.8 1.0 1.0 
assi ( resid 16 and name H6 )( resid 15 and name H3' ) 3.3 1.5 1.5 
assi ( resid 5 and name H8 )( resid 4 and name H3' ) 3.0 1.5 1.5 
assi ( resid 1 and name H8 )( resid 2 and name H8 ) 5.0 1.5 1.5 
assi ( resid 3 and name H8 )( resid 4 and name H6 ) 5.5 1.5 1.5 
assi ( resid 5 and name H8 )( resid 4 and name H2' ) 2.0 1.5 1.5 
assi ( resid 11 and name H8 )( resid 12 and name H6 ) 5.5 1.5 1.5 
assi ( resid 16 and name H6 )( resid 15 and name H5' ) 7.0 1.5 1.5 
assi ( resid 12 and name H4' )( resid 12 and name H5'' ) 2.6 1.0 1.0 
assi ( resid 6 and name H4' )( resid 6 and name H5' ) 2.3 0.5 0.5 
assi ( resid 15 and name H6 )( resid 14 and name H4' ) 5.8 1.5 1.5 
assi ( resid 10 and name H8 )( resid 9 and name H5'' ) 4.9 1.5 1.5 
assi ( resid 7 and name H3' )( resid 7 and name H5' ) 3.8 1.0 1.0 
assi ( resid 7 and name H3' )( resid 8 and name H4' ) 7.0 1.5 1.5 
assi ( resid 15 and name H6 )( resid 14 and name H3' ) 3.3 1.5 1.5 
assi ( resid 15 and name H6 )( resid 14 and name H5' ) 7.0 1.5 1.5 
assi ( resid 10 and name H1 )( resid 11 and name H8 ) 5.8 1.0 1.0 
assi ( resid 8 and name H6 )( resid 9 and name H6 ) 5.8 1.5 1.5 
assi ( resid 8 and name H6 )( resid 7 and name H2' ) 4.4 1.0 1.0 
assi ( resid 7 and name H6 )( resid 6 and name H6 ) 4.8 1.0 1.0 
assi ( resid 5 and name H8 )( resid 4 and name H5'' ) 6.3 1.5 1.5 
assi ( resid 5 and name H2' )( resid 6 and name H5' ) 4.0 1.5 1.5 
assi ( resid 12 and name H3' )( resid 12 and name H4' ) 3.0 1.0 1.0 
assi ( resid 5 and name H8 )( resid 4 and name H4' ) 5.8 1.5 1.5 
assi ( resid 12 and name H4' )( resid 12 and name H5' ) 2.3 1.0 1.0 
assi ( resid 7 and name H6 )( resid 6 and name H2' ) 2.6 1.0 1.0 
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assi ( resid 5 and name H2' )( resid 5 and name H3' ) 2.4 1.0 1.0 
assi ( resid 12 and name H3' )( resid 12 and name H5'' ) 2.5 1.0 1.0 
assi ( resid 11 and name H1 )( resid 7 and name H3 ) 3.0 1.5 1.5 
assi ( resid 8 and name H5 )( resid 7 and name H5'' ) 4.8 1.0 1.0 
assi ( resid 8 and name H5 )( resid 7 and name H1' ) 5.7 1.0 1.0 
assi ( resid 8 and name H5 )( resid 7 and name H2' ) 5.6 1.0 1.0 
assi ( resid 8 and name H5 )( resid 7 and name H3' ) 5.4 1.0 1.0 
assi ( resid 8 and name H5 )( resid 7 and name H4' ) 3.3 1.0 1.0 
assi ( resid 8 and name H2' )( resid 7 and name H4' ) 5.4 1.0 1.0 
assi ( resid 8 and name H2' )( resid 7 and name H1' ) 5.4 1.0 1.0 
assi ( resid 8 and name H3' )( resid 8 and name H5'' ) 2.5 1.0 1.0 
assi ( resid 8 and name H3' )( resid 9 and name H5 ) 3.0 1.0 1.0 
assi ( resid 1 and name H1' )( resid 2 and name H8 ) 5.0 1.5 1.5 
assi ( resid 2 and name H8 )( resid 3 and name H8 ) 5.0 1.5 1.5 
assi ( resid 3 and name H1' )( resid 4 and name H6 ) 5.0 1.5 1.5 
assi ( resid 4 and name H1' )( resid 5 and name H8 ) 5.0 1.5 1.5 
assi ( resid 12 and name H6 )( resid 13 and name H8 ) 5.5 1.5 1.5 
assi ( resid 13 and name H1' )( resid 14 and name H6 ) 5.0 1.5 1.5 
assi ( resid 14 and name H1' )( resid 15 and name H6 ) 5.0 1.5 1.5 
assi ( resid 14 and name H6 )( resid 15 and name H6 ) 5.0 1.5 1.5 
assi ( resid 15 and name H1' )( resid 16 and name H6 ) 5.0 1.5 1.5 
assi ( resid 15 and name H6 )( resid 16 and name H6 ) 5.0 1.5 1.5 
 
List of Hydrogen Bond Restraints 
! for G1/ C16  base pair 
assign (resid 1 and name N1)  (resid 16 and name N3)    2.91   0.5     0.5   
assign (resid 1 and name O6)  (resid 16 and name N4)    2.71   0.5     0.5   
assign (resid 1 and name N2)  (resid 16 and name O2)    3.08   0.5     0.5   
assign (resid 1 and name H1)  (resid 16 and name N3)    1.89   0.5     0.5   
assign (resid 1 and name O6)  (resid 16 and name H42)   1.71   0.5     0.5   
assign (resid 1 and name H22) (resid 16 and name O2)    2.08   0.5     0.5   
 
! for G2/ C15  base pair 
assign (resid 2 and name N1)  (resid 15 and name N3)    2.91   0.5     0.5   
assign (resid 2 and name O6)  (resid 15 and name N4)    2.71   0.5     0.5   
assign (resid 2 and name N2)  (resid 15 and name O2)    3.08   0.5     0.5   
assign (resid 2 and name H1)  (resid 15 and name N3)    1.89   0.5     0.5   
assign (resid 2 and name O6)  (resid 15 and name H42)   1.71   0.5     0.5   
assign (resid 2 and name H22) (resid 15 and name O2)    2.08   0.5     0.5   
 
! for G3/ C14  base pair 
assign (resid 3 and name N1)  (resid 14 and name N3)    2.91   0.5     0.5   
assign (resid 3 and name O6)  (resid 14 and name N4)    2.71   0.5     0.5   
assign (resid 3 and name N2)  (resid 14 and name O2)    3.08   0.5     0.5   
assign (resid 3 and name H1)  (resid 14 and name N3)    1.89   0.5     0.5   
assign (resid 3 and name O6)  (resid 14 and name H42)   1.71   0.5     0.5   
assign (resid 3 and name H22) (resid 14 and name O2)    2.08   0.5     0.5   
 
! for C4/ G13  base pair 
assign (resid 13 and name N1)  (resid 4 and name N3)    2.91   0.5     0.5   
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assign (resid 13 and name O6)  (resid 4 and name N4)    2.71   0.5     0.5   
assign (resid 13 and name N2)  (resid 4 and name O2)    3.08   0.5     0.5   
assign (resid 13 and name H1)  (resid 4 and name N3)    1.89   0.5     0.5   
assign (resid 13 and name O6)  (resid 4 and name H42)   1.71   0.5     0.5   
assign (resid 13 and name H22) (resid 4 and name O2)    2.08   0.5     0.5   
 
! for G5/ C12  base pair 
assign (resid 5 and name N1)  (resid 12 and name N3)    2.91   0.5     0.5   
assign (resid 5 and name O6)  (resid 12 and name N4)    2.71   0.5     0.5   
assign (resid 5 and name N2)  (resid 12 and name O2)    3.08   0.5     0.5   
assign (resid 5 and name H1)  (resid 12 and name N3)    1.89   0.5     0.5   
assign (resid 5 and name O6)  (resid 12 and name H42)   1.71   0.5     0.5   
assign (resid 5 and name H22) (resid 12 and name O2)    2.08   0.5     0.5 
 
! for C6/ G11  base pair 
assign (resid 11 and name N1)  (resid 6 and name N3)    2.91   0.5     0.5   
assign (resid 11 and name O6)  (resid 6 and name N4)    2.71   0.5     0.5   
assign (resid 11 and name N2)  (resid 6 and name O2)    3.08   0.5     0.5   
assign (resid 11 and name H1)  (resid 6 and name N3)    1.89   0.5     0.5   
assign (resid 11 and name O6)  (resid 6 and name H42)   1.71   0.5     0.5   
assign (resid 11 and name H22) (resid 6 and name O2)    2.08   0.5     0.5   
 
! for U7/ G10  base pair 
assign (resid 7 and name O2)  (resid 10 and name N2)    3.08   0.5     0.5 
assign (resid 7 and name O2)  (resid 10 and name H22)   2.50   1.0     1.0 
 
! for U8/ C9  base pair 
assign (resid 8 and name O1P)   (resid 9 and name H41)    2.50   1.0     1.0  
 
! for U8/ G10  base pair 
assign (resid 8 and name O2')   (resid 10 and name O6)    2.50   1.0     1.0  
 
 
UUCG 16mer Dihedral Angle Restraints 
! G1 chi 
assign (resid 1 and name O4') (resid 1 and name C1') 
       (resid 1 and name N9 ) (resid 1 and name C4 ) 
       1 -158 30 2 
! G1 nu0 
assign (resid 1 and name C4') (resid 1 and name O4') 
       (resid 1 and name C1') (resid 1 and name C2') 
       1 6 15 2 
! G1 nu1 
assign (resid 1 and name O4') (resid 1 and name C1') 
       (resid 1 and name C2') (resid 1 and name C3') 
       1 -25 15 2 
! G1 nu2 
assign (resid 1 and name C1') (resid 1 and name C2') 
       (resid 1 and name C3') (resid 1 and name C4') 
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       1 37 15 2 
! G1 nu3 
assign (resid 1 and name C2') (resid 1 and name C3') 
       (resid 1 and name C4') (resid 1 and name O4') 
       1 -33 15 2 
! G1 nu4 
assign (resid 1 and name C3') (resid 1 and name C4') 
       (resid 1 and name O4') (resid 1 and name C1') 
       1 17 15 2 
! G2 alpha 
assign (resid 1 and name O3') (resid 2 and name P  ) 
       (resid 2 and name O5') (resid 2 and name C5') 
       1 -65 15 2 
! G2 beta 
assign (resid 2 and name P  ) (resid 2 and name O5') 
       (resid 2 and name C5') (resid 2 and name C4') 
       1 178 25 2 
! G2 gamma 
assign (resid 2 and name O5') (resid 2 and name C5') 
       (resid 2 and name C4') (resid 2 and name C3') 
       1 54 15 2 
! G2 epsilon 
assign (resid 2 and name C4') (resid 2 and name C3') 
       (resid 2 and name O3') (resid 3 and name P  ) 
       1 200 40 2 
! G2 zeta 
assign (resid 2 and name C3') (resid 2 and name O3') 
       (resid 3 and name P  ) (resid 3 and name O5') 
       1 -71 15 2 
! G2 chi 
assign (resid 2 and name O4') (resid 2 and name C1') 
       (resid 2 and name N9 ) (resid 2 and name C4 ) 
       1 -158 20 2 
! G2 nu0 
assign (resid 2 and name C4') (resid 2 and name O4') 
       (resid 2 and name C1') (resid 2 and name C2') 
       1 6 15 2 
! G2 nu1 
assign (resid 2 and name O4') (resid 2 and name C1') 
       (resid 2 and name C2') (resid 2 and name C3') 
       1 -25 15 2 
! G2 nu2 
assign (resid 2 and name C1') (resid 2 and name C2') 
       (resid 2 and name C3') (resid 2 and name C4') 
       1 37 15 2 
! G2 nu3 
assign (resid 2 and name C2') (resid 2 and name C3') 
       (resid 2 and name C4') (resid 2 and name O4') 
       1 -33 15 2 
! G2 nu4 
assign (resid 2 and name C3') (resid 2 and name C4') 
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       (resid 2 and name O4') (resid 2 and name C1') 
       1 17 15 2 
! G3 alpha 
assign (resid 2 and name O3') (resid 3 and name P  ) 
       (resid 3 and name O5') (resid 3 and name C5') 
       1 -68 15 2 
! G3 beta 
assign (resid 3 and name P  ) (resid 3 and name O5') 
       (resid 3 and name C5') (resid 3 and name C4') 
       1 178 25 2 
! G3 gamma 
assign (resid 3 and name O5') (resid 3 and name C5') 
       (resid 3 and name C4') (resid 3 and name C3') 
       1 54 15 2 
! G3 epsilon 
assign (resid 3 and name C4') (resid 3 and name C3') 
       (resid 3 and name O3') (resid 4 and name P  ) 
       1 200 40 2 
! G3 zeta 
assign (resid 3 and name C3') (resid 3 and name O3') 
       (resid 4 and name P  ) (resid 4 and name O5') 
       1 -71 15 2 
! G3 chi 
assign (resid 3 and name O4') (resid 3 and name C1') 
       (resid 3 and name N9 ) (resid 3 and name C4 ) 
       1 -158 20 2 
! G3 nu0 
assign (resid 3 and name C4') (resid 3 and name O4') 
       (resid 3 and name C1') (resid 3 and name C2') 
       1 6 15 2 
! G3 nu1 
assign (resid 3 and name O4') (resid 3 and name C1') 
       (resid 3 and name C2') (resid 3 and name C3') 
       1 -25 15 2 
! G3 nu2 
assign (resid 3 and name C1') (resid 3 and name C2') 
       (resid 3 and name C3') (resid 3 and name C4') 
       1 37 15 2 
! G3 nu3 
assign (resid 3 and name C2') (resid 3 and name C3') 
       (resid 3 and name C4') (resid 3 and name O4') 
       1 -33 15 2 
! G3 nu4 
assign (resid 3 and name C3') (resid 3 and name C4') 
       (resid 3 and name O4') (resid 3 and name C1') 
       1 17 15 2 
! C4 alpha 
assign (resid 3 and name O3') (resid 4 and name P  ) 
       (resid 4 and name O5') (resid 4 and name C5') 
       1 -65 15 2 
! C4 beta 
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assign (resid 4 and name P  ) (resid 4 and name O5') 
       (resid 4 and name C5') (resid 4 and name C4') 
       1 160 25 2 
! C4 gamma 
assign (resid 4 and name O5') (resid 4 and name C5') 
       (resid 4 and name C4') (resid 4 and name C3') 
       1 70 15 2 
! C4 epsilon 
assign (resid 4 and name C4') (resid 4 and name C3') 
       (resid 4 and name O3') (resid 5 and name P  ) 
       1 200 30 2 
! C4 zeta 
assign (resid 4 and name C3') (resid 4 and name O3') 
       (resid 5 and name P  ) (resid 5 and name O5') 
       1 -85 15 2 
! C4 chi 
assign (resid 4 and name O4') (resid 4 and name C1') 
       (resid 4 and name N1 ) (resid 4 and name C2 ) 
       1 -158 20 2 
! C4 nu0 
assign (resid 4 and name C4') (resid 4 and name O4') 
       (resid 4 and name C1') (resid 4 and name C2') 
       1 6 15 2 
! C4 nu1 
assign (resid 4 and name O4') (resid 4 and name C1') 
       (resid 4 and name C2') (resid 4 and name C3') 
       1 -25 15 2 
! C4 nu2 
assign (resid 4 and name C1') (resid 4 and name C2') 
       (resid 4 and name C3') (resid 4 and name C4') 
       1 37 15 2 
! C4 nu3 
assign (resid 4 and name C2') (resid 4 and name C3') 
       (resid 4 and name C4') (resid 4 and name O4') 
       1 -33 15 2 
! C4 nu4 
assign (resid 4 and name C3') (resid 4 and name C4') 
       (resid 4 and name O4') (resid 4 and name C1') 
       1 17 15 2 
! G5 alpha 
assign (resid 4 and name O3') (resid 5 and name P  ) 
       (resid 5 and name O5') (resid 5 and name C5') 
       1 -50 15 2 
! G5 beta 
assign (resid 5 and name P  ) (resid 5 and name O5') 
       (resid 5 and name C5') (resid 5 and name C4') 
       1 165 15 2 
! G5 gamma 
assign (resid 5 and name O5') (resid 5 and name C5') 
       (resid 5 and name C4') (resid 5 and name C3') 
       1 54 15 2 
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! G5 epsilon 
assign (resid 5 and name C4') (resid 5 and name C3') 
       (resid 5 and name O3') (resid 6 and name P  ) 
       1 220 30 2 
! G5 zeta 
assign (resid 5 and name C3') (resid 5 and name O3') 
       (resid 6 and name P  ) (resid 6 and name O5') 
       1 -80 15 2 
! G5 chi 
assign (resid 5 and name O4') (resid 5 and name C1') 
       (resid 5 and name N9 ) (resid 5 and name C4 ) 
       1 -158 20 2 
! G5 nu0 
assign (resid 5 and name C4') (resid 5 and name O4') 
       (resid 5 and name C1') (resid 5 and name C2') 
       1 6 15 2 
! G5 nu1 
assign (resid 5 and name O4') (resid 5 and name C1') 
       (resid 5 and name C2') (resid 5 and name C3') 
       1 -25 15 2 
! G5 nu2 
assign (resid 5 and name C1') (resid 5 and name C2') 
       (resid 5 and name C3') (resid 5 and name C4') 
       1 37 15 2 
! G5 nu3 
assign (resid 5 and name C2') (resid 5 and name C3') 
       (resid 5 and name C4') (resid 5 and name O4') 
       1 -33 15 2 
! G5 nu4 
assign (resid 5 and name C3') (resid 5 and name C4') 
       (resid 5 and name O4') (resid 5 and name C1') 
       1 17 15 2 
! C6 alpha 
assign (resid 5 and name O3') (resid 6 and name P  ) 
       (resid 6 and name O5') (resid 6 and name C5') 
       1 -40 30 2 
! C6 beta 
assign (resid 6 and name P  ) (resid 6 and name O5') 
       (resid 6 and name C5') (resid 6 and name C4') 
       1 160 20 2 
! C6 gamma 
assign (resid 6 and name O5') (resid 6 and name C5') 
       (resid 6 and name C4') (resid 6 and name C3') 
       1 54 20 2 
! C6 epsilon 
assign (resid 6 and name C4') (resid 6 and name C3') 
       (resid 6 and name O3') (resid 7 and name P  ) 
       1 220 40 2 
! C6 zeta 
assign (resid 6 and name C3') (resid 6 and name O3') 
       (resid 7 and name P  ) (resid 7 and name O5') 
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       1 -80 20 2 
! C6 chi 
assign (resid 6 and name O4') (resid 6 and name C1') 
       (resid 6 and name N1 ) (resid 6 and name C2 ) 
       1 -158 20 2 
! C6 nu0 
assign (resid 6 and name C4') (resid 6 and name O4') 
       (resid 6 and name C1') (resid 6 and name C2') 
       1 6 15 2 
! C6 nu1 
assign (resid 6 and name O4') (resid 6 and name C1') 
       (resid 6 and name C2') (resid 6 and name C3') 
       1 -25 15 2 
! C6 nu2 
assign (resid 6 and name C1') (resid 6 and name C2') 
       (resid 6 and name C3') (resid 6 and name C4') 
       1 37 15 2 
! C6 nu3 
assign (resid 6 and name C2') (resid 6 and name C3') 
       (resid 6 and name C4') (resid 6 and name O4') 
       1 -33 15 2 
! C6 nu4 
assign (resid 6 and name C3') (resid 6 and name C4') 
       (resid 6 and name O4') (resid 6 and name C1') 
       1 17 15 2 
! U7 alpha 
assign (resid 6 and name O3') (resid 7 and name P  ) 
       (resid 7 and name O5') (resid 7 and name C5') 
       1 -68 30 2 
! U7 beta 
assign (resid 7 and name P  ) (resid 7 and name O5') 
       (resid 7 and name C5') (resid 7 and name C4') 
       1 178 30 2 
! U7 gamma 
assign (resid 7 and name O5') (resid 7 and name C5') 
       (resid 7 and name C4') (resid 7 and name C3') 
       1 54 25 2 
! U7 epsilon 
assign (resid 7 and name C4') (resid 7 and name C3') 
       (resid 7 and name O3') (resid 8 and name P  ) 
       1 215 50 2 
! U7 zeta 
assign (resid 7 and name C3') (resid 7 and name O3') 
       (resid 8 and name P  ) (resid 8 and name O5') 
       1 -71 30 2 
! U7 chi 
assign (resid 7 and name O4') (resid 7 and name C1') 
       (resid 7 and name N1 ) (resid 7 and name C2 ) 
       1 -158 20 2 
! U7 nu0 
assign (resid 7 and name C4') (resid 7 and name O4') 
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       (resid 7 and name C1') (resid 7 and name C2') 
       1 6 15 2 
! U7 nu1 
assign (resid 7 and name O4') (resid 7 and name C1') 
       (resid 7 and name C2') (resid 7 and name C3') 
       1 -25 15 2 
! U7 nu2 
assign (resid 7 and name C1') (resid 7 and name C2') 
       (resid 7 and name C3') (resid 7 and name C4') 
       1 37 15 2 
! U7 nu3 
assign (resid 7 and name C2') (resid 7 and name C3') 
       (resid 7 and name C4') (resid 7 and name O4') 
       1 -33 15 2 
! U7 nu4 
assign (resid 7 and name C3') (resid 7 and name C4') 
       (resid 7 and name O4') (resid 7 and name C1') 
       1 17 15 2 
! U8 chi 
assign (resid 8 and name O4') (resid 8 and name C1') 
       (resid 8 and name N1 ) (resid 8 and name C2 ) 
       1 -150 40 2 
! U8 nu1 
assign (resid 8 and name O4') (resid 8 and name C1') 
       (resid 8 and name C2') (resid 8 and name C3') 
       1 25 15 2 
! U8 nu2 
assign (resid 8 and name C1') (resid 8 and name C2') 
       (resid 8 and name C3') (resid 8 and name C4') 
       1 -25 15 2 
! C9 chi 
assign (resid 9 and name O4') (resid 9 and name C1') 
       (resid 9 and name N1 ) (resid 9 and name C2 ) 
       1 -140 50 2 
! C9 nu1 
assign (resid 9 and name O4') (resid 9 and name C1') 
       (resid 9 and name C2') (resid 9 and name C3') 
       1 30 25 2 
! C9 nu2 
assign (resid 9 and name C1') (resid 9 and name C2') 
       (resid 9 and name C3') (resid 9 and name C4') 
       1 -35 25 2 
! G11 alpha 
assign (resid 10 and name O3') (resid 11 and name P  ) 
       (resid 11 and name O5') (resid 11 and name C5') 
       1 -135 50 2 
! G11 beta 
assign (resid 11 and name P  ) (resid 11 and name O5') 
       (resid 11 and name C5') (resid 11 and name C4') 
       1 165 30 2 
! G11 gamma 
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assign (resid 11 and name O5') (resid 11 and name C5') 
       (resid 11 and name C4') (resid 11 and name C3') 
       1 110 50 2 
! G11 epsilon 
assign (resid 11 and name C4') (resid 11 and name C3') 
       (resid 11 and name O3') (resid 12 and name P  ) 
       1 200 30 2 
! G11 zeta 
assign (resid 11 and name C3') (resid 11 and name O3') 
       (resid 12 and name P  ) (resid 12 and name O5') 
       1 -100 30 2 
! G11 chi 
assign (resid 11 and name O4') (resid 11 and name C1') 
       (resid 11 and name N9 ) (resid 11 and name C4 ) 
       1 -150 20 2 
! G11 nu0 
assign (resid 11 and name C4') (resid 11 and name O4') 
       (resid 11 and name C1') (resid 11 and name C2') 
       1 6 15 2 
! G11 nu1 
assign (resid 11 and name O4') (resid 11 and name C1') 
       (resid 11 and name C2') (resid 11 and name C3') 
       1 -25 15 2 
! G11 nu2 
assign (resid 11 and name C1') (resid 11 and name C2') 
       (resid 11 and name C3') (resid 11 and name C4') 
       1 37 15 2 
! G11 nu3 
assign (resid 11 and name C2') (resid 11 and name C3') 
       (resid 11 and name C4') (resid 11 and name O4') 
       1 -33 15 2 
! G11 nu4 
assign (resid 11 and name C3') (resid 11 and name C4') 
       (resid 11 and name O4') (resid 11 and name C1') 
       1 17 15 2 
! C12 alpha 
assign (resid 11 and name O3') (resid 12 and name P  ) 
       (resid 12 and name O5') (resid 12 and name C5') 
       1 -65 25 2 
! C12 beta 
assign (resid 12 and name P  ) (resid 12 and name O5') 
       (resid 12 and name C5') (resid 12 and name C4') 
       1 178 25 2 
! C12 gamma 
assign (resid 12 and name O5') (resid 12 and name C5') 
       (resid 12 and name C4') (resid 12 and name C3') 
       1 54 25 2 
! C12 epsilon 
assign (resid 12 and name C4') (resid 12 and name C3') 
       (resid 12 and name O3') (resid 13 and name P  ) 
       1 200 40 2 
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! C12 zeta 
assign (resid 12 and name C3') (resid 12 and name O3') 
       (resid 13 and name P  ) (resid 13 and name O5') 
       1 -71 25 2 
! C12 chi 
assign (resid 12 and name O4') (resid 12 and name C1') 
       (resid 12 and name N1 ) (resid 12 and name C2 ) 
       1 -158 25 2 
! C12 nu0 
assign (resid 12 and name C4') (resid 12 and name O4') 
       (resid 12 and name C1') (resid 12 and name C2') 
       1 6 15 2 
! C12 nu1 
assign (resid 12 and name O4') (resid 12 and name C1') 
       (resid 12 and name C2') (resid 12 and name C3') 
       1 -25 15 2 
! C12 nu2 
assign (resid 12 and name C1') (resid 12 and name C2') 
       (resid 12 and name C3') (resid 12 and name C4') 
       1 37 15 2 
! C12 nu3 
assign (resid 12 and name C2') (resid 12 and name C3') 
       (resid 12 and name C4') (resid 12 and name O4') 
       1 -33 15 2 
! C12 nu4 
assign (resid 12 and name C3') (resid 12 and name C4') 
       (resid 12 and name O4') (resid 12 and name C1') 
       1 17 15 2 
! G13 alpha 
assign (resid 12 and name O3') (resid 13 and name P  ) 
       (resid 13 and name O5') (resid 13 and name C5') 
       1 -65 20 2 
! G13 beta 
assign (resid 13 and name P  ) (resid 13 and name O5') 
       (resid 13 and name C5') (resid 13 and name C4') 
       1 178 20 2 
! G13 gamma 
assign (resid 13 and name O5') (resid 13 and name C5') 
       (resid 13 and name C4') (resid 13 and name C3') 
       1 54 20 2 
! G13 epsilon 
assign (resid 13 and name C4') (resid 13 and name C3') 
       (resid 13 and name O3') (resid 14 and name P  ) 
       1 200 40 2 
! G13 zeta 
assign (resid 13 and name C3') (resid 13 and name O3') 
       (resid 14 and name P  ) (resid 14 and name O5') 
       1 -71 20 2 
! G13 chi 
assign (resid 13 and name O4') (resid 13 and name C1') 
       (resid 13 and name N9 ) (resid 13 and name C4 ) 
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       1 -158 20 2 
! G13 nu0 
assign (resid 13 and name C4') (resid 13 and name O4') 
       (resid 13 and name C1') (resid 13 and name C2') 
       1 6 15 2 
! G13 nu1 
assign (resid 13 and name O4') (resid 13 and name C1') 
       (resid 13 and name C2') (resid 13 and name C3') 
       1 -25 15 2 
! G13 nu2 
assign (resid 13 and name C1') (resid 13 and name C2') 
       (resid 13 and name C3') (resid 13 and name C4') 
       1 37 15 2 
! G13 nu3 
assign (resid 13 and name C2') (resid 13 and name C3') 
       (resid 13 and name C4') (resid 13 and name O4') 
       1 -33 15 2 
! G13 nu4 
assign (resid 13 and name C3') (resid 13 and name C4') 
       (resid 13 and name O4') (resid 13 and name C1') 
       1 17 15 2 
! C14 alpha 
assign (resid 13 and name O3') (resid 14 and name P  ) 
       (resid 14 and name O5') (resid 14 and name C5') 
       1 -65 15 2 
! C14 beta 
assign (resid 14 and name P  ) (resid 14 and name O5') 
       (resid 14 and name C5') (resid 14 and name C4') 
       1 178 25 2 
! C14 gamma 
assign (resid 14 and name O5') (resid 14 and name C5') 
       (resid 14 and name C4') (resid 14 and name C3') 
       1 54 15 2 
! C14 epsilon 
assign (resid 14 and name C4') (resid 14 and name C3') 
       (resid 14 and name O3') (resid 15 and name P  ) 
       1 200 40 2 
! C14 zeta 
assign (resid 14 and name C3') (resid 14 and name O3') 
       (resid 15 and name P  ) (resid 15 and name O5') 
       1 -71 15 2 
! C14 chi 
assign (resid 14 and name O4') (resid 14 and name C1') 
       (resid 14 and name N1 ) (resid 14 and name C2 ) 
       1 -158 20 2 
! C14 nu0 
assign (resid 14 and name C4') (resid 14 and name O4') 
       (resid 14 and name C1') (resid 14 and name C2') 
       1 6 15 2 
! C14 nu1 
assign (resid 14 and name O4') (resid 14 and name C1') 
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       (resid 14 and name C2') (resid 14 and name C3') 
       1 -25 15 2 
! C14 nu2 
assign (resid 14 and name C1') (resid 14 and name C2') 
       (resid 14 and name C3') (resid 14 and name C4') 
       1 37 15 2 
! C14 nu3 
assign (resid 14 and name C2') (resid 14 and name C3') 
       (resid 14 and name C4') (resid 14 and name O4') 
       1 -33 15 2 
! C14 nu4 
assign (resid 14 and name C3') (resid 14 and name C4') 
       (resid 14 and name O4') (resid 14 and name C1') 
       1 17 15 2 
! C15 alpha 
assign (resid 14 and name O3') (resid 15 and name P  ) 
       (resid 15 and name O5') (resid 15 and name C5') 
       1 -65 15 2 
! C15 beta 
assign (resid 15 and name P  ) (resid 15 and name O5') 
       (resid 15 and name C5') (resid 15 and name C4') 
       1 178 15 2 
! C15 gamma 
assign (resid 15 and name O5') (resid 15 and name C5') 
       (resid 15 and name C4') (resid 15 and name C3') 
       1 54 15 2 
! C15 epsilon 
assign (resid 15 and name C4') (resid 15 and name C3') 
       (resid 15 and name O3') (resid 16 and name P  ) 
       1 200 40 2 
! C15 zeta 
assign (resid 15 and name C3') (resid 15 and name O3') 
       (resid 16 and name P  ) (resid 16 and name O5') 
       1 -71 15 2 
! C15 chi 
assign (resid 15 and name O4') (resid 15 and name C1') 
       (resid 15 and name N1 ) (resid 15 and name C2 ) 
       1 -158 20 2 
! C15 nu0 
assign (resid 15 and name C4') (resid 15 and name O4') 
       (resid 15 and name C1') (resid 15 and name C2') 
       1 6 15 2 
! C15 nu1 
assign (resid 15 and name O4') (resid 15 and name C1') 
       (resid 15 and name C2') (resid 15 and name C3') 
       1 -25 15 2 
! C15 nu2 
assign (resid 15 and name C1') (resid 15 and name C2') 
       (resid 15 and name C3') (resid 15 and name C4') 
       1 37 15 2 
! C15 nu3 
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assign (resid 15 and name C2') (resid 15 and name C3') 
       (resid 15 and name C4') (resid 15 and name O4') 
       1 -33 15 2 
! C15 nu4 
assign (resid 15 and name C3') (resid 15 and name C4') 
       (resid 15 and name O4') (resid 15 and name C1') 
       1 17 15 2 
! C16 chi 
assign (resid 16 and name O4') (resid 16 and name C1') 
       (resid 16 and name N1 ) (resid 16 and name C2 ) 
       1 -158 30 2 
! C16 nu0 
assign (resid 16 and name C4') (resid 16 and name O4') 
       (resid 16 and name C1') (resid 16 and name C2') 
       1 6 15 2 
! C16 nu1 
assign (resid 16 and name O4') (resid 16 and name C1') 
       (resid 16 and name C2') (resid 16 and name C3') 
       1 -25 15 2 
! C16 nu2 
assign (resid 16 and name C1') (resid 16 and name C2') 
       (resid 16 and name C3') (resid 16 and name C4') 
       1 37 15 2 
! C16 nu3 
assign (resid 16 and name C2') (resid 16 and name C3') 
       (resid 16 and name C4') (resid 16 and name O4') 
       1 -33 15 2 
! C16 nu4 
assign (resid 16 and name C3') (resid 16 and name C4') 
       (resid 16 and name O4') (resid 16 and name C1') 
       1 17 15 2 
 
UUCG 16mer Planarity Restraints 
! G1-C16 WC 
!-------------------------------------------------------------------- 
group 
selection=     ((resid  1 and name N1) or (resid  1 and name N3) or 
  (resid  1 and name C5) or (resid 16 and name N1) or 
   (resid 16 and name N3) or (resid 16 and name C5)) 
weight = $pscale end 
 
! G2-C15 WC 
!-------------------------------------------------------------------- 
group 
selection=     ((resid   2 and name N1) or (resid  2 and name N3) or 
  (resid   2 and name C5) or (resid 15 and name N1) or 
   (resid  15 and name N3) or (resid 15 and name C5)) 




! G3-C14 WC 
!-------------------------------------------------------------------- 
group 
selection=     ((resid  3 and name N1) or (resid  3 and name N3) or 
  (resid  3 and name C5) or (resid 14 and name N1) or 
   (resid 14 and name N3) or (resid 14 and name C5)) 
weight = $pscale end 
 
 
! C4-G13 WC 
!-------------------------------------------------------------------- 
group 
selection=     ((resid  4 and name N1) or (resid  4 and name N3) or 
  (resid  4 and name C5) or (resid 13 and name N1) or 
   (resid 13 and name N3) or (resid 13 and name C5)) 
weight = $pscale end 
 
! G5-C12 WC 
!-------------------------------------------------------------------- 
group 
selection=     ((resid  5 and name N1) or (resid  5 and name N3) or 
  (resid  5 and name C5) or (resid 12 and name N1) or 
   (resid 12 and name N3) or (resid 12 and name C5)) 
weight = $pscale end 
 
! C6-G11 WC 
!-------------------------------------------------------------------- 
group 
selection=     ((resid  6 and name N1) or (resid  6 and name N3) or 
  (resid  6 and name C5) or (resid 11 and name N1) or 
   (resid 11 and name N3) or (resid 11 and name C5)) 
weight = $pscale end
 
